1	American	NNP	O	American	nn	2	SENT_1	[p1l456t81r628b107],
2	Journal	NNP	O	Journal	nsubj	8	SENT_1	[p1l639t81r779b107],
3	of	IN	O	of	_	0	SENT_1	[p1l791t81r826b107],
4	Medical	NNP	O	Medical	nn	7	SENT_1	[p1l834t81r974b107],
5	Genetics	NNP	O	Genetics	nn	7	SENT_1	[p1l986t81r1139b107],
6	Part	NNP	O	Part	nn	7	SENT_1	[p1l1151t82r1228b107],
7	B	NNP	O	B	prep_of	2	SENT_1	[p1l1240t82r1264b106],
8	(	VBZ	O	(	_	0	SENT_1	[p1l1278t81r1601b113],
9	Neuropsychiatric	NNP	ORGANIZATION	Neuropsychiatric	nn	10	SENT_1	[p1l1278t81r1601b113],
10	Genetics	NNP	ORGANIZATION	Genetics	nsubj	12	SENT_1	[p1l1613t81r1778b110],
11	)	CD	NUMBER	)	num	12	SENT_1	[p1l1613t81r1778b110],
12	134B	NN	O	134b	xcomp	8	SENT_1	[p1l1793t82r1986b107],
13	:76	CD	NUMBER	:76	num	14	SENT_1	[p1l1793t82r1986b107],
14	—	NN	O	—	dep	12	SENT_1	[p1l1793t82r1986b107],
15	78	CD	NUMBER	78	number	16	SENT_1	[p1l1793t82r1986b107],
16	(	CD	NUMBER	(	dep	12	SENT_1	[p1l1998t81r2100b110],
17	2005	CD	DATE	2005	num	18	SENT_1	[p1l1998t81r2100b110],
18	)	NN	O	)	dep	16	SENT_1	[p1l1998t81r2100b110],

1	Weight	NNP	O	Weight	nn	3	SENT_2	[p1l58t199r299b262],
2	Gain	NNP	O	Gain	nn	3	SENT_2	[p1l323t199r487b249],
3	Associated	NNP	O	Associated	_	0	SENT_2	[p1l506t199r878b249],
4	With	IN	O	with	dep	3	SENT_2	[p1l897t199r1061b249],
5	the	DT	O	the	det	8	SENT_2	[p1l1083t199r1192b249],
6	-759	CD	NUMBER	-759	num	8	SENT_2	[p1l1219t201r1377b249],
7	C/T	NNP	O	C/T	nn	8	SENT_2	[p1l1401t199r1516b254],
8	Polymorphism	NN	O	polymorphism	pobj	4	SENT_2	[p1l1537t199r2042b262],
9	of	IN	O	of	dep	3	SENT_2	[p1l60t273r128b323],
10	the	DT	O	the	det	12	SENT_2	[p1l146t273r255b324],
11	5HT2C	NN	O	5ht2c	nn	12	SENT_2	[p1l279t273r507b324],
12	Receptor	NN	O	receptor	pobj	9	SENT_2	[p1l531t274r845b336],
13	and	CC	O	and	_	0	SENT_2	[p1l867t273r995b324],
14	Olanzapine	NN	O	olanzapine	conj_and	12	SENT_2	[p1l1017t273r1408b336],

1	Vicki	NNP	PERSON	Vicki	nn	3	SENT_3	[p1l58t371r154b399],
2	L.	NNP	PERSON	L.	nn	3	SENT_3	[p1l166t372r199b398],
3	Ellingrod	NNP	PERSON	Ellingrod	_	0	SENT_3	[p1l212t365r427b405],
4	,1	CD	NUMBER	,1	number	5	SENT_3	[p1l212t365r427b405],
5	*	CD	NUMBER	*	dep	3	SENT_3	[p1l212t365r427b405],
6	Paul	NNP	PERSON	Paul	nn	8	SENT_3	[p1l440t371r524b399],
7	J.	NNP	PERSON	J.	nn	8	SENT_3	[p1l535t372r566b399],
8	Pe	NNP	PERSON	Pe	dep	5	SENT_3	[p1l579t372r625b399],
9	,1	CD	NUMBER	,1	num	10	SENT_3	[p1l685t365r730b404],
10	’	NN	O	’	dep	3	SENT_3	[p1l685t365r730b404],
11	2	CD	NUMBER	2	dep	10	SENT_3	[p1l685t365r730b404],
12	John	NNP	PERSON	John	nn	14	SENT_3	[p1l742t371r835b399],
13	C.	NNP	PERSON	C.	nn	14	SENT_3	[p1l847t371r882b399],
14	Ringold	NNP	PERSON	Ringold	dep	3	SENT_3	[p1l894t365r1064b405],
15	,3	CD	NUMBER	,3	dep	14	SENT_3	[p1l894t365r1064b405],
16	Brian	NNP	PERSON	Brian	nn	20	SENT_3	[p1l1075t371r1180b399],
17	C.	NNP	PERSON	C.	nn	20	SENT_3	[p1l1192t371r1227b399],
18	Lund	NNP	PERSON	Lund	nn	20	SENT_3	[p1l1239t365r1360b404],
19	,1	CD	NUMBER	,1	num	20	SENT_3	[p1l1239t365r1360b404],
20	Kristy	NNP	PERSON	Kristy	dep	3	SENT_3	[p1l1372t371r1487b405],
21	Bever-Stille	NNP	PERSON	Bever-Stille	nn	24	SENT_3	[p1l1498t365r1738b404],
22	,1	CD	NUMBER	,1	num	24	SENT_3	[p1l1498t365r1738b404],
23	Frank	NNP	PERSON	Frank	nn	24	SENT_3	[p1l1750t371r1863b399],
24	Fleming	NNP	PERSON	Fleming	dep	20	SENT_3	[p1l1874t365r2049b405],
25	?	.	O	?	_	0	SENT_3	[p1l1874t365r2049b405],

1	Timothy	NNP	PERSON	Timothy	nn	3	SENT_4	[p1l59t411r214b445],
2	L.	NNP	PERSON	L.	nn	3	SENT_4	[p1l225t412r258b438],
3	Holman	NNP	PERSON	Holman	_	0	SENT_4	[p1l271t405r462b443],
4	,	,	O	,	_	0	SENT_4	[p1l271t405r462b443],
5	”	NN	O	”	conj_and	3	SENT_4	[p1l271t405r462b443],
6	and	CC	O	and	_	0	SENT_4	[p1l474t411r543b438],
7	Del	NNP	O	Del	poss	10	SENT_4	[p1l554t411r615b438],
8	'	POS	O	'	_	0	SENT_4	[p1l664t411r670b418],
9	ler2	NN	O	ler2	nn	10	SENT_4	[p1l687t405r752b438],
10	1University	NN	O	1university	conj_and	3	SENT_4	[p1l60t456r231b494],
11	of	IN	O	of	_	0	SENT_4	[p1l241t462r274b494],
12	Iowa	NNP	LOCATION	Iowa	nn	14	SENT_4	[p1l278t462r360b492],
13	,	,	O	,	_	0	SENT_4	[p1l278t462r360b492],
14	College	NNP	ORGANIZATION	College	prep_of	10	SENT_4	[p1l375t462r482b494],
15	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l493t462r526b494],
16	Pharmacy	NNP	ORGANIZATION	Pharmacy	nn	20	SENT_4	[p1l530t462r693b494],
17	,	,	O	,	_	0	SENT_4	[p1l530t462r693b494],
18	Iowa	NNP	LOCATION	Iowa	appos	20	SENT_4	[p1l705t462r780b488],
19	2	CD	NUMBER	2	num	20	SENT_4	[p1l58t494r72b510],
20	University	NNP	ORGANIZATION	University	prep_of	3	SENT_4	[p1l75t500r231b532],
21	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l241t499r274b532],
22	Iowa	NNP	ORGANIZATION	Iowa	prep_of	20	SENT_4	[p1l278t500r360b530],
23	,	,	ORGANIZATION	,	_	0	SENT_4	[p1l278t500r360b530],
24	College	NNP	ORGANIZATION	College	appos	20	SENT_4	[p1l375t499r482b532],
25	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l493t500r526b532],
26	Medicine	NNP	ORGANIZATION	Medicine	prep_of	24	SENT_4	[p1l529t499r675b530],
27	,	,	O	,	_	0	SENT_4	[p1l529t499r675b530],
28	Department	NNP	ORGANIZATION	Department	appos	20	SENT_4	[p1l688t500r870b532],
29	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l880t499r912b532],
30	Psychiatry	NNP	ORGANIZATION	Psychiatry	prep_of	28	SENT_4	[p1l917t499r1086b532],
31	,	,	O	,	_	0	SENT_4	[p1l917t499r1086b532],
32	Iowa	NNP	LOCATION	Iowa	nn	33	SENT_4	[p1l1098t500r1173b525],
33	3University	NN	O	3university	appos	20	SENT_4	[p1l59t532r231b570],
34	of	IN	O	of	_	0	SENT_4	[p1l241t538r274b570],
35	Iowa	NNP	LOCATION	Iowa	prep_of	33	SENT_4	[p1l278t538r360b568],
36	,	,	O	,	_	0	SENT_4	[p1l278t538r360b568],
37	College	NNP	ORGANIZATION	College	appos	20	SENT_4	[p1l375t538r482b570],
38	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l493t538r526b570],
39	Medicine	NNP	ORGANIZATION	Medicine	prep_of	37	SENT_4	[p1l529t537r675b568],
40	,	,	O	,	_	0	SENT_4	[p1l529t537r675b568],
41	Department	NNP	O	Department	appos	20	SENT_4	[p1l688t538r870b570],
42	of	IN	O	of	_	0	SENT_4	[p1l880t538r912b570],
43	Surgery	NNP	O	Surgery	nn	45	SENT_4	[p1l918t538r1045b570],
44	,	,	O	,	_	0	SENT_4	[p1l918t538r1045b570],
45	Iowa	NNP	LOCATION	Iowa	prep_of	41	SENT_4	[p1l1057t538r1132b563],

1	Background	NN	O	background	_	0	SENT_5	[p1l115t732r619b805],
2	:	:	O	:	_	0	SENT_5	[p1l115t732r619b805],
3	Weight	NNP	O	Weight	nn	4	SENT_5	[p1l651t732r927b805],
4	gain	NN	O	gain	nsubj	13	SENT_5	[p1l961t733r1131b805],
5	from	IN	O	from	_	0	SENT_5	[p1l1160t732r1348b790],
6	atypical	JJ	O	atypical	amod	8	SENT_5	[p1l1379t732r1695b805],
7	antipsychotic	JJ	O	antipsychotic	amod	8	SENT_5	[p1l1728t733r2043b805, p1l117t816r357b874],
8	use	NN	O	use	prep_from	4	SENT_5	[p1l409t835r540b874],
9	has	VBZ	O	have	aux	13	SENT_5	[p1l594t816r728b874],
10	become	VBN	O	become	cop	13	SENT_5	[p1l779t816r1076b874],
11	a	DT	O	a	det	13	SENT_5	[p1l1131t835r1174b874],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_5	[p1l1228t816r1643b889],
13	problem	NN	O	problem	dep	1	SENT_5	[p1l1696t816r2042b889],
14	.	.	O	.	_	0	SENT_5	[p1l1696t816r2042b889],

1	Recent	JJ	O	recent	amod	2	SENT_6	[p1l116t902r388b959],
2	reports	NNS	O	report	nsubj	4	SENT_6	[p1l405t905r693b973],
3	have	VBP	O	have	aux	4	SENT_6	[p1l710t901r897b959],
4	liked	VBN	O	like	_	0	SENT_6	[p1l914t901r1113b958],
5	the	DT	O	the	det	8	SENT_6	[p1l1129t901r1254b959],
6	-7	CD	NUMBER	-7	number	7	SENT_6	[p1l1277t903r1371b959],
7	59	CD	NUMBER	59	num	8	SENT_6	[p1l1374t903r1457b959],
8	polymorphism	NN	O	polymorphism	dobj	4	SENT_6	[p1l1474t901r2045b973],
9	of	IN	O	of	_	0	SENT_6	[p1l117t985r194b1042],
10	the	DT	O	the	det	12	SENT_6	[p1l236t985r361b1042],
11	5HT2C	NN	O	5ht2c	nn	12	SENT_6	[p1l410t985r670b1042],
12	receptor	NN	O	receptor	prep_of	8	SENT_6	[p1l720t989r1056b1057],
13	and	CC	O	and	_	0	SENT_6	[p1l1103t985r1250b1042],
14	obesity	NN	O	obesity	prep_of	8	SENT_6	[p1l1297t985r1580b1057],
15	as	RB	O	as	_	0	SENT_6	[p1l1626t1003r1707b1042],
16	well	RB	O	well	_	0	SENT_6	[p1l1753t985r1916b1042],
17	as	IN	O	as	_	0	SENT_6	[p1l1964t1003r2045b1042],
18	weight	NN	O	weight	nn	19	SENT_6	[p1l114t1069r383b1141],
19	gain	NN	O	gain	dobj	4	SENT_6	[p1l429t1069r600b1141],
20	from	IN	O	from	_	0	SENT_6	[p1l642t1069r830b1126],
21	chlorpromazine	NN	O	chlorpromazine	prep_from	4	SENT_6	[p1l874t1069r1518b1141],
22	,	,	O	,	_	0	SENT_6	[p1l874t1069r1518b1141],
23	risperidone	NN	O	risperidone	prep_from	4	SENT_6	[p1l1564t1069r2042b1141],
24	,	,	O	,	_	0	SENT_6	[p1l1564t1069r2042b1141],
25	and	CC	O	and	_	0	SENT_6	[p1l117t1152r264b1210],
26	clozapine	NN	O	clozapine	prep_from	4	SENT_6	[p1l308t1152r702b1225],
27	.	.	O	.	_	0	SENT_6	[p1l308t1152r702b1225],

1	Aim	NNP	O	Aim	_	0	SENT_7	[p1l746t1153r924b1210],
2	:	:	O	:	_	0	SENT_7	[p1l746t1153r924b1210],
3	To	TO	O	to	aux	4	SENT_7	[p1l971t1154r1069b1210],
4	determine	VB	O	determine	infmod	1	SENT_7	[p1l1115t1152r1518b1210],
5	associations	NNS	O	association	dobj	4	SENT_7	[p1l1564t1153r2044b1210],
6	between	IN	O	between	_	0	SENT_7	[p1l113t1236r445b1294],
7	weight	NN	O	weight	nn	8	SENT_7	[p1l492t1236r761b1309],
8	gain	NN	O	gain	prep_between	5	SENT_7	[p1l812t1237r983b1309],
9	during	IN	O	during	_	0	SENT_7	[p1l1031t1236r1300b1309],
10	olanzapine	NN	O	olanzapine	nn	11	SENT_7	[p1l1347t1236r1778b1309],
11	treatment	NN	O	treatment	prep_during	4	SENT_7	[p1l1828t1241r2043b1294, p1l116t1325r313b1378],
12	and	CC	O	and	_	0	SENT_7	[p1l369t1320r515b1378],
13	the	DT	O	the	det	16	SENT_7	[p1l567t1320r692b1378],
14	-759	CD	NUMBER	-759	num	16	SENT_7	[p1l751t1322r931b1378],
15	C/T	NN	O	c/t	nn	16	SENT_7	[p1l986t1320r1118b1384],
16	polymorphism	NN	O	polymorphism	conj_and	11	SENT_7	[p1l1169t1320r1741b1392],
17	of	IN	O	of	_	0	SENT_7	[p1l1794t1320r1872b1378],
18	the	DT	O	the	det	22	SENT_7	[p1l1919t1320r2044b1378],
19	5H	NN	O	5h	nn	22	SENT_7	[p1l113t1405r227b1462],
20	T2C	NN	O	t2c	nn	22	SENT_7	[p1l228t1404r381b1462],
21	receptor	NN	O	receptor	nn	22	SENT_7	[p1l425t1409r761b1476],
22	gene	NN	O	gene	prep_of	16	SENT_7	[p1l809t1419r1010b1476],
23	.	.	O	.	_	0	SENT_7	[p1l809t1419r1010b1476],

1	Methods	NNS	O	method	_	0	SENT_8	[p1l1057t1404r1412b1462],
2	:	:	O	:	_	0	SENT_8	[p1l1057t1404r1412b1462],
3	This	DT	O	this	det	4	SENT_8	[p1l1460t1404r1631b1462],
4	study	NN	O	study	nsubj	5	SENT_8	[p1l1679t1404r1898b1476],
5	included	VBD	O	include	dep	1	SENT_8	[p1l1942t1404r2043b1461, p1l117t1488r380b1546],
6	42	CD	NUMBER	42	num	9	SENT_8	[p1l405t1491r487b1545],
7	acutely	RB	O	acutely	advmod	8	SENT_8	[p1l516t1488r805b1560],
8	ill	JJ	O	ill	amod	9	SENT_8	[p1l829t1488r908b1545],
9	patients	NNS	O	patient	dobj	5	SENT_8	[p1l933t1488r1256b1560],
10	with	IN	O	with	_	0	SENT_8	[p1l1281t1488r1460b1546],
11	schizophrenia	NN	O	schizophrenia	nn	14	SENT_8	[p1l1487t1488r2046b1560],
12	(	CD	NUMBER	(	num	14	SENT_8	[p1l119t1572r496b1638],
13	DSM-IV	NN	O	dsm-iv	nn	14	SENT_8	[p1l119t1572r496b1638],
14	)	NN	O	)	prep_with	9	SENT_8	[p1l119t1572r496b1638],
15	.	.	O	.	_	0	SENT_8	[p1l119t1572r496b1638],

1	Weekly	NNP	SET	Weekly	nn	2	SENT_9	[p1l557t1572r844b1644],
2	assessments	NNS	O	assessment	nsubj	3	SENT_9	[p1l905t1577r1381b1630],
3	included	VBD	O	include	ccomp	18	SENT_9	[p1l1443t1572r1788b1630],
4	Brief	JJ	O	brief	amod	9	SENT_9	[p1l1847t1572r2050b1630],
5	Psychiatric	JJ	O	psychiatric	amod	9	SENT_9	[p1l116t1657r567b1729],
6	Rating	NNP	O	Rating	nn	9	SENT_9	[p1l584t1657r853b1729],
7	Scale	NNP	O	Scale	nn	9	SENT_9	[p1l870t1657r1074b1714],
8	(	CD	NUMBER	(	num	9	SENT_9	[p1l1094t1657r1396b1726],
9	BPRS	NNP	O	BPRS	dobj	3	SENT_9	[p1l1094t1657r1396b1726],
10	)	CD	NUMBER	)	tmod	3	SENT_9	[p1l1094t1657r1396b1726],
11	,	,	O	,	_	0	SENT_9	[p1l1094t1657r1396b1726],
12	Scale	NNP	O	Scale	nsubj	18	SENT_9	[p1l1418t1657r1621b1714],
13	for	IN	O	for	_	0	SENT_9	[p1l1638t1657r1753b1714],
14	Assessment	NNP	O	Assessment	prep_for	12	SENT_9	[p1l1766t1657r2043b1715, p1l116t1745r313b1799],
15	of	IN	O	of	_	0	SENT_9	[p1l346t1741r424b1798],
16	Negative	JJ	O	negative	amod	17	SENT_9	[p1l449t1741r798b1813],
17	Symptoms	NNS	O	symptom	prep_of	14	SENT_9	[p1l832t1741r1237b1813],
18	(	VBP	O	(	_	0	SENT_9	[p1l1271t1741r1566b1810],
19	SANS	NNS	O	san	dobj	18	SENT_9	[p1l1271t1741r1566b1810],
20	)	CD	NUMBER	)	num	19	SENT_9	[p1l1271t1741r1566b1810],
21	,	,	O	,	_	0	SENT_9	[p1l1271t1741r1566b1810],
22	and	CC	O	and	_	0	SENT_9	[p1l1600t1741r1747b1798],
23	weight	NN	O	weight	nn	24	SENT_9	[p1l1775t1741r2044b1813],
24	measurements	NNS	O	measurement	conj_and	19	SENT_9	[p1l116t1829r708b1882],
25	.	.	O	.	_	0	SENT_9	[p1l116t1829r708b1882],

1	Olanzapine	NNP	O	Olanzapine	nsubjpass	3	SENT_10	[p1l732t1825r1179b1897],
2	was	VBD	O	be	auxpass	3	SENT_10	[p1l1198t1843r1349b1882],
3	titrated	VBN	O	titrate	_	0	SENT_10	[p1l1369t1825r1674b1882],
4	to	TO	O	to	aux	14	SENT_10	[p1l1693t1829r1769b1882],
5	a	DT	O	a	det	14	SENT_10	[p1l1791t1843r1835b1882],
6	ﬁxed	JJ	O	ﬁxed	amod	14	SENT_10	[p1l1854t1824r2046b1882],
7	dose	NN	O	dose	nn	14	SENT_10	[p1l117t1909r291b1966],
8	(	NN	O	(	nn	14	SENT_10	[p1l312t1909r379b1974],
9	7	CD	NUMBER	7	num	14	SENT_10	[p1l312t1909r379b1974],
10	.5	CD	NUMBER	.5	num	14	SENT_10	[p1l383t1911r582b1966],
11	—	NN	O	—	nn	14	SENT_10	[p1l383t1911r582b1966],
12	20	CD	NUMBER	20	num	14	SENT_10	[p1l383t1911r582b1966],
13	mg/day	NN	O	mg/day	nn	14	SENT_10	[p1l598t1909r907b1981],
14	)	NN	O	)	xcomp	3	SENT_10	[p1l598t1909r907b1981],
15	for	IN	O	for	_	0	SENT_10	[p1l926t1909r1041b1966],
16	2-6	CD	NUMBER	2-6	num	17	SENT_10	[p1l1056t1911r1191b1966],
17	weeks	NNS	NUMBER	week	prep_for	14	SENT_10	[p1l1207t1909r1468b1966],
18	.	.	O	.	_	0	SENT_10	[p1l1207t1909r1468b1966],

1	A	DT	O	a	det	5	SENT_11	[p1l1484t1909r1544b1965],
2	24	CD	DURATION	24	num	5	SENT_11	[p1l1558t1911r1643b1965],
3	hr	NN	DURATION	hr	nn	5	SENT_11	[p1l1659t1909r1750b1965],
4	plasma	NN	O	plasma	nn	5	SENT_11	[p1l1765t1909r2046b1981],
5	level	NN	O	level	nsubjpass	7	SENT_11	[p1l116t1992r300b2050],
6	was	VBD	O	be	auxpass	7	SENT_11	[p1l321t2011r471b2050],
7	obtained	VBN	O	obtain	_	0	SENT_11	[p1l494t1992r842b2050],
8	at	IN	O	at	_	0	SENT_11	[p1l864t1997r939b2050],
9	the	DT	O	the	det	11	SENT_11	[p1l961t1992r1086b2050],
10	endpoint	JJ	O	endpoint	amod	11	SENT_11	[p1l1108t1992r1461b2065],
11	visit	NN	O	visit	prep_at	7	SENT_11	[p1l1482t1993r1674b2050],
12	.	.	O	.	_	0	SENT_11	[p1l1482t1993r1674b2050],

1	Genomic	JJ	O	genomic	amod	2	SENT_12	[p1l1700t1992r2044b2050],
2	DNA	NN	O	dna	nsubjpass	11	SENT_12	[p1l116t2077r299b2134],
3	was	VBD	O	be	auxpass	4	SENT_12	[p1l319t2095r469b2134],
4	isolated	VBN	O	isolate	_	0	SENT_12	[p1l493t2076r805b2134],
5	from	IN	O	from	_	0	SENT_12	[p1l826t2076r1013b2134],
6	a	DT	O	a	det	9	SENT_12	[p1l1036t2095r1080b2134],
7	whole	JJ	O	whole	amod	9	SENT_12	[p1l1100t2076r1335b2134],
8	blood	NN	O	blood	nn	9	SENT_12	[p1l1356t2076r1577b2134],
9	sample	NN	O	sample	prep_from	4	SENT_12	[p1l1600t2076r1874b2149],
10	and	CC	O	and	_	0	SENT_12	[p1l1899t2076r2046b2134],
11	analyzed	VBN	O	analyze	conj_and	4	SENT_12	[p1l117t2160r469b2232],
12	for	IN	O	for	_	0	SENT_12	[p1l508t2160r623b2218],
13	the	DT	O	the	det	16	SENT_12	[p1l663t2160r788b2218],
14	—	NN	O	—	nn	16	SENT_12	[p1l836t2160r1153b2224],
15	759C/T	NN	O	759c/t	nn	16	SENT_12	[p1l836t2160r1153b2224],
16	polymorphism	NN	O	polymorphism	prep_for	11	SENT_12	[p1l1192t2160r1764b2232],
17	of	IN	O	of	_	0	SENT_12	[p1l1805t2160r1884b2218],
18	the	DT	O	the	det	20	SENT_12	[p1l1919t2160r2044b2218],
19	5HT2C	NN	O	5ht2c	nn	20	SENT_12	[p1l117t2244r378b2302],
20	receptor	NN	O	receptor	prep_of	16	SENT_12	[p1l421t2249r776b2316],
21	.	.	O	.	_	0	SENT_12	[p1l421t2249r776b2316],

1	Results	NNS	O	result	_	0	SENT_13	[p1l819t2244r1129b2302],
2	:	:	O	:	_	0	SENT_13	[p1l819t2244r1129b2302],
3	A	DT	O	a	det	5	SENT_13	[p1l1169t2245r1228b2301],
4	chi-square	JJ	O	chi-square	amod	5	SENT_13	[p1l1269t2244r1682b2316],
5	analysis	NN	O	analysis	nsubjpass	7	SENT_13	[p1l1725t2244r2044b2316],
6	was	VBD	O	be	auxpass	7	SENT_13	[p1l114t2347r265b2386],
7	conducted	VBN	O	conduct	dep	1	SENT_13	[p1l302t2328r712b2386],
8	comparing	VBG	O	compare	xcomp	7	SENT_13	[p1l749t2328r1174b2400],
9	the	DT	O	the	det	10	SENT_13	[p1l1208t2328r1333b2386],
10	distribution	NN	O	distribution	dobj	8	SENT_13	[p1l1371t2328r1847b2386],
11	of	IN	O	of	_	0	SENT_13	[p1l1884t2328r1962b2386],
12	T	NN	O	t	nn	15	SENT_13	[p1l1992t2329r2046b2385],
13	and	CC	O	and	_	0	SENT_13	[p1l117t2413r264b2470],
14	C	NN	O	c	nn	15	SENT_13	[p1l285t2413r338b2471],
15	alleles	NNS	O	allele	prep_of	10	SENT_13	[p1l363t2413r611b2471],
16	in	IN	O	in	_	0	SENT_13	[p1l633t2413r711b2469],
17	subjects	NNS	O	subject	prep_in	8	SENT_13	[p1l734t2413r1052b2485],
18	grouped	VBN	O	group	partmod	17	SENT_13	[p1l1074t2413r1401b2485],
19	as	IN	O	as	_	0	SENT_13	[p1l1423t2431r1504b2471],
20	gaining	VBG	O	gain	prepc_as	18	SENT_13	[p1l1526t2413r1827b2485],
21	more	JJR	O	more	advmod	20	SENT_13	[p1l1844t2431r2044b2470],
22	or	CC	O	or	_	0	SENT_13	[p1l117t2515r201b2554],
23	less	JJR	O	less	conj_or	21	SENT_13	[p1l223t2496r368b2554],
24	than	IN	O	than	_	0	SENT_13	[p1l391t2496r573b2554],
25	5	CD	NUMBER	5	prep_than	20	SENT_13	[p1l598t2499r657b2566],
26	,	,	O	,	_	0	SENT_13	[p1l598t2499r657b2566],
27	7	CD	NUMBER	7	conj_and	25	SENT_13	[p1l685t2499r743b2566],
28	,	,	O	,	_	0	SENT_13	[p1l685t2499r743b2566],
29	and	CC	PERCENT	and	_	0	SENT_13	[p1l770t2496r917b2554],
30	10	CD	PERCENT	10	num	31	SENT_13	[p1l946t2499r1086b2554],
31	%	NN	PERCENT	%	conj_and	25	SENT_13	[p1l946t2499r1086b2554],
32	of	IN	O	of	_	0	SENT_13	[p1l1113t2496r1190b2554],
33	their	PRP$	O	they	poss	35	SENT_13	[p1l1209t2496r1404b2554],
34	baseline	NN	O	baseline	nn	35	SENT_13	[p1l1424t2496r1752b2554],
35	weight	NN	O	weight	prep_of	31	SENT_13	[p1l1775t2496r2044b2569],
36	during	IN	O	during	_	0	SENT_13	[p1l117t2580r386b2652],
37	treatment	NN	O	treatment	prep_during	20	SENT_13	[p1l404t2585r796b2638],
38	with	IN	O	with	_	0	SENT_13	[p1l817t2580r997b2638],
39	olanzapine	NN	O	olanzapine	prep_with	37	SENT_13	[p1l1019t2580r1470b2652],
40	.	.	O	.	_	0	SENT_13	[p1l1019t2580r1470b2652],

1	A	DT	O	a	det	2	SENT_14	[p1l1491t2581r1551b2637],
2	threshold	NN	O	threshold	nsubjpass	7	SENT_14	[p1l1570t2580r1951b2638],
3	of	IN	O	of	_	0	SENT_14	[p1l1972t2580r2050b2638],
4	10	CD	PERCENT	10	num	5	SENT_14	[p1l122t2667r262b2722],
5	%	NN	PERCENT	%	prep_of	2	SENT_14	[p1l122t2667r262b2722],
6	was	VBD	O	be	auxpass	7	SENT_14	[p1l287t2683r438b2722],
7	found	VBN	O	find	_	0	SENT_14	[p1l462t2664r692b2722],
8	to	TO	O	to	aux	10	SENT_14	[p1l716t2669r792b2722],
9	be	VB	O	be	cop	10	SENT_14	[p1l815t2664r907b2722],
10	signiﬁcant	JJ	O	signiﬁcant	xcomp	7	SENT_14	[p1l934t2664r1369b2736],
11	.	.	O	.	_	0	SENT_14	[p1l934t2664r1369b2736],

1	The	DT	O	the	det	2	SENT_15	[p1l1396t2664r1544b2722],
2	distribution	NN	O	distribution	nsubj	7	SENT_15	[p1l1570t2664r2045b2722],
3	of	IN	O	of	_	0	SENT_15	[p1l117t2748r194b2806],
4	T	NN	O	t	nn	5	SENT_15	[p1l207t2749r260b2805],
5	alleles	NNS	O	allele	prep_of	2	SENT_15	[p1l280t2748r529b2806],
6	was	VBD	O	be	cop	7	SENT_15	[p1l546t2767r697b2806],
7	higher	JJR	O	higher	_	0	SENT_15	[p1l716t2748r978b2820],
8	in	IN	O	in	_	0	SENT_15	[p1l996t2748r1075b2805],
9	subjects	NNS	O	subject	prep_in	7	SENT_15	[p1l1094t2748r1412b2820],
10	not	RB	O	not	neg	11	SENT_15	[p1l1431t2753r1559b2806],
11	gaining	VBG	O	gain	dep	9	SENT_15	[p1l1581t2748r1881b2820],
12	10	CD	PERCENT	10	num	13	SENT_15	[p1l1903t2750r2043b2806],
13	%	NN	PERCENT	%	dobj	11	SENT_15	[p1l1903t2750r2043b2806],
14	of	IN	O	of	_	0	SENT_15	[p1l117t2833r194b2890],
15	more	JJR	O	more	prep_of	13	SENT_15	[p1l220t2851r420b2890],
16	of	IN	O	of	_	0	SENT_15	[p1l453t2833r530b2890],
17	their	PRP$	O	they	poss	19	SENT_15	[p1l556t2833r750b2891],
18	body	NN	O	body	nn	19	SENT_15	[p1l778t2833r973b2905],
19	weight	NN	O	weight	prep_of	15	SENT_15	[p1l1001t2833r1270b2905],
20	compared	VBN	O	compare	prep	11	SENT_15	[p1l1302t2833r1693b2905],
21	who	WP	O	who	nsubj	23	SENT_15	[p1l1721t2833r1885b2890],
22	did	VBD	O	do	aux	23	SENT_15	[p1l1918t2833r2046b2890],
23	gain	VB	O	gain	pcomp	20	SENT_15	[p1l118t2917r288b2989],
24	signiﬁcant	JJ	O	signiﬁcant	amod	26	SENT_15	[p1l343t2917r758b2989],
25	weight	NN	O	weight	nn	26	SENT_15	[p1l811t2917r1080b2989],
26	(	NN	O	(	dobj	23	SENT_15	[p1l1138t2917r1357b2982],
27	11/27	CD	PERCENT	11/27	number	28	SENT_15	[p1l1138t2917r1357b2982],
28	(	CD	PERCENT	(	amod	26	SENT_15	[p1l1415t2917r1680b2982],
29	40.7	CD	PERCENT	40.7	num	30	SENT_15	[p1l1415t2917r1680b2982],
30	%	NN	PERCENT	%	dep	28	SENT_15	[p1l1415t2917r1680b2982],
31	)	CD	NUMBER	)	dep	43	SENT_15	[p1l1415t2917r1680b2982],
32	vs.	CC	O	vs.	prep	31	SENT_15	[p1l1736t2935r1839b2975],
33	0/15	CD	NUMBER	0/15	num	34	SENT_15	[p1l1896t2918r2044b2980],
34	(	NN	O	(	dep	32	SENT_15	[p1l119t3002r385b3071],
35	100	CD	PERCENT	100	number	36	SENT_15	[p1l119t3002r385b3071],
36	%	NN	PERCENT	%	amod	34	SENT_15	[p1l119t3002r385b3071],
37	)	CD	NUMBER	)	dep	43	SENT_15	[p1l119t3002r385b3071],
38	,	,	O	,	_	0	SENT_15	[p1l119t3002r385b3071],
39	X2	NN	O	x2	appos	37	SENT_15	[p1l421t2989r496b3074],
40	=	JJ	O	=	amod	39	SENT_15	[p1l515t3030r566b3048],
41	11.805	CD	NUMBER	11.805	tmod	40	SENT_15	[p1l589t3004r839b3071],
42	,	,	O	,	_	0	SENT_15	[p1l589t3004r839b3071],
43	P	NN	O	p	rcmod	26	SENT_15	[p1l870t3003r930b3058],
44	=	JJ	O	=	amod	43	SENT_15	[p1l946t3030r998b3048],
45	0.0035	CD	NUMBER	0.0035	num	46	SENT_15	[p1l1015t3002r1299b3067],
46	)	NN	O	)	dep	44	SENT_15	[p1l1015t3002r1299b3067],
47	.	.	O	.	_	0	SENT_15	[p1l1015t3002r1299b3067],

1	Conclusions	NNS	O	conclusion	_	0	SENT_16	[p1l1337t3001r1834b3060],
2	:	:	O	:	_	0	SENT_16	[p1l1337t3001r1834b3060],
3	Subjects	NNS	O	subject	dep	1	SENT_16	[p1l1874t3001r2043b3060, p1l108t3086r296b3158],
4	with	IN	O	with	_	0	SENT_16	[p1l310t3086r490b3143],
5	a	DT	O	a	det	7	SENT_16	[p1l507t3104r551b3143],
6	T	NN	O	t	nn	7	SENT_16	[p1l565t3087r618b3142],
7	allele	NN	O	allele	prep_with	3	SENT_16	[p1l634t3086r844b3143],
8	of	IN	O	of	_	0	SENT_16	[p1l862t3086r939b3143],
9	the	DT	O	the	det	11	SENT_16	[p1l949t3086r1074b3143],
10	5HT2C	NN	O	5ht2c	nn	11	SENT_16	[p1l1092t3086r1353b3143],
11	receptor	NN	O	receptor	prep_of	7	SENT_16	[p1l1371t3090r1708b3158],
12	-7	CD	NUMBER	-7	num	14	SENT_16	[p1l1728t3088r1823b3143],
13	59C/T	NN	O	59c/t	nn	14	SENT_16	[p1l1827t3086r2046b3149],
14	polymorphism	NN	O	polymorphism	nsubj	16	SENT_16	[p1l115t3170r686b3242],
15	may	MD	O	may	aux	16	SENT_16	[p1l734t3188r900b3242],
16	have	VB	O	have	rcmod	11	SENT_16	[p1l945t3170r1131b3227],
17	a	DT	O	a	det	19	SENT_16	[p1l1182t3188r1226b3227],
18	lower	JJR	O	lower	amod	19	SENT_16	[p1l1273t3170r1495b3227],
19	incidence	NN	O	incidence	dobj	16	SENT_16	[p1l1543t3170r1923b3227],
20	of	IN	O	of	_	0	SENT_16	[p1l1972t3170r2050b3227],
21	weight	NN	O	weight	nn	22	SENT_16	[p1l114t3253r383b3326],
22	gain	NN	O	gain	prep_of	19	SENT_16	[p1l404t3254r575b3326],
23	from	IN	O	from	_	0	SENT_16	[p1l593t3253r780b3311],
24	olanzapine	NN	O	olanzapine	prep_from	22	SENT_16	[p1l799t3253r1230b3326],
25	over	IN	O	over	_	0	SENT_16	[p1l1251t3272r1425b3311],
26	a	DT	O	a	det	29	SENT_16	[p1l1445t3272r1489b3311],
27	6	CD	DURATION	6	num	29	SENT_16	[p1l1508t3256r1548b3311],
28	week	NN	NUMBER	week	nn	29	SENT_16	[p1l1565t3253r1771b3311],
29	period	NN	O	period	prep_over	24	SENT_16	[p1l1787t3253r2046b3326],
30	compared	VBN	O	compare	_	0	SENT_16	[p1l117t3337r507b3410],
31	to	TO	O	to	prepc_compared_to	19	SENT_16	[p1l526t3342r601b3395],
32	those	DT	O	those	pobj	19	SENT_16	[p1l622t3337r832b3395],
33	with	IN	O	with	_	0	SENT_16	[p1l851t3337r1031b3395],
34	the	DT	O	the	det	36	SENT_16	[p1l1051t3337r1176b3395],
35	C	NN	O	c	nn	36	SENT_16	[p1l1198t3338r1251b3395],
36	allele	NN	O	allele	prep_with	32	SENT_16	[p1l1275t3337r1505b3395],
37	.	.	O	.	_	0	SENT_16	[p1l1275t3337r1505b3395],

1	These	DT	O	these	det	2	SENT_17	[p1l1527t3337r1756b3395],
2	results	NNS	O	result	nsubj	3	SENT_17	[p1l1776t3337r2044b3395],
3	need	VBP	O	need	_	0	SENT_17	[p1l116t3421r304b3479],
4	to	TO	O	to	aux	6	SENT_17	[p1l325t3426r400b3479],
5	be	VB	O	be	auxpass	6	SENT_17	[p1l420t3421r512b3479],
6	replicated	VBN	O	replicate	xcomp	3	SENT_17	[p1l534t3421r955b3493],
7	.	.	O	.	_	0	SENT_17	[p1l534t3421r955b3493],

1	©	RB	O	©	advmod	2	SENT_18	[p1l1002t3433r1048b3478],
2	2005	CD	DATE	2005	_	0	SENT_18	[p1l1071t3430r1222b3479],
3	Wiley-Liss	NNP	O	Wiley-Liss	dep	2	SENT_18	[p1l1240t3428r1614b3492],
4	,	,	O	,	_	0	SENT_18	[p1l1240t3428r1614b3492],
5	Inc.	NNP	ORGANIZATION	Inc.	appos	3	SENT_18	[p1l1635t3429r1763b3479],
6	.	.	O	.	_	0	SENT_18	[p1l1635t3429r1763b3479],

1	KEY	JJ	O	key	amod	2	SENT_19	[p1l116t3553r290b3608],
2	WORDS	NNS	O	word	_	0	SENT_19	[p1l313t3552r645b3609],
3	:	:	O	:	_	0	SENT_19	[p1l313t3552r645b3609],
4	schizophrenia	NN	O	schizophrenia	dep	2	SENT_19	[p1l727t3552r1305b3624],
5	;	:	O	;	_	0	SENT_19	[p1l727t3552r1305b3624],
6	serotonin	NN	O	serotonin	dep	4	SENT_19	[p1l1343t3552r1739b3621],
7	;	:	O	;	_	0	SENT_19	[p1l1343t3552r1739b3621],
8	weight	NN	O	weight	nn	9	SENT_19	[p1l1775t3552r2044b3624],
9	gain	NN	O	gain	dep	4	SENT_19	[p1l728t3636r917b3708],
10	;	:	O	;	_	0	SENT_19	[p1l728t3636r917b3708],
11	olanzapine	NN	O	olanzapine	dep	9	SENT_19	[p1l941t3636r1392b3708],
12	;	:	O	;	_	0	SENT_19	[p1l941t3636r1392b3708],
13	polymorphisms	NNS	O	polymorphism	dep	4	SENT_19	[p1l1415t3636r2042b3708],
14	;	:	O	;	_	0	SENT_19	[p1l1415t3636r2042b3708],
15	antipsychotics	NNS	O	antipsychotic	dep	13	SENT_19	[p1l727t3719r1300b3792],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_20	[p2l743t148r1419b206],

1	Atypical	JJ	O	atypical	amod	3	SENT_21	[p2l82t273r374b345],
2	antipsychotic	JJ	O	antipsychotic	amod	3	SENT_21	[p2l427t273r888b345],
3	(	NN	O	(	nsubj	6	SENT_21	[p2l942t273r1144b338],
4	AAP	NN	O	aap	nn	5	SENT_21	[p2l942t273r1144b338],
5	)	NN	O	)	dep	3	SENT_21	[p2l942t273r1144b338],
6	induced	VBD	O	induce	_	0	SENT_21	[p2l1197t273r1471b331],
7	Weight	NNP	O	Weight	nn	8	SENT_21	[p2l1520t273r1756b345],
8	gain	NN	O	gain	nsubj	13	SENT_21	[p2l1807t274r1957b345],
9	is	VBZ	O	be	cop	13	SENT_21	[p2l2008t274r2063b331],
10	a	DT	O	a	det	13	SENT_21	[p2l2115t293r2153b331],
11	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_21	[p2l10t357r374b429],
12	adverse	JJ	O	adverse	amod	13	SENT_21	[p2l407t357r673b415],
13	effect	NN	O	effect	ccomp	6	SENT_21	[p2l705t357r891b414],
14	facing	VBG	O	face	partmod	13	SENT_21	[p2l921t357r1134b429],
15	clinicians	NNS	O	clinician	dobj	14	SENT_21	[p2l1162t357r1491b415],
16	and	CC	O	and	_	0	SENT_21	[p2l1524t357r1652b414],
17	patients	NNS	O	patient	dobj	14	SENT_21	[p2l1681t358r1965b429],
18	with	IN	O	with	prep	14	SENT_21	[p2l1996t357r2152b415],

1	Grant	NNP	PERSON	Grant	nn	2	SENT_22	[p2l91t646r285b701],
2	sponsor	NN	O	sponsor	_	0	SENT_22	[p2l310t664r576b714],
3	:	:	O	:	_	0	SENT_22	[p2l310t664r576b714],
4	Eli	NNP	ORGANIZATION	Eli	nn	5	SENT_22	[p2l604t646r697b699],
5	Lilly	NNP	ORGANIZATION	Lilly	dep	2	SENT_22	[p2l722t646r872b714],
6	and	CC	ORGANIZATION	and	_	0	SENT_22	[p2l897t646r1017b700],
7	Co.	NNP	ORGANIZATION	Co.	conj_and	5	SENT_22	[p2l1043t646r1141b700],
8	.	.	O	.	_	0	SENT_22	[p2l1043t646r1141b700],

1	*	NN	O	*	nn	2	SENT_23	[p2l92t739r649b807],
2	Correspondence	NN	O	correspondence	_	0	SENT_23	[p2l92t739r649b807],
3	to	TO	O	to	dep	2	SENT_23	[p2l670t744r748b794],
4	:	:	O	:	_	0	SENT_23	[p2l670t744r748b794],
5	Vicki	NNP	PERSON	Vicki	nn	7	SENT_23	[p2l770t739r941b794],
6	L.	NNP	PERSON	L.	nn	7	SENT_23	[p2l962t740r1022b793],
7	Ellingrod	NNP	PERSON	Ellingrod	dep	2	SENT_23	[p2l1048t739r1370b807],
8	,	,	O	,	_	0	SENT_23	[p2l1048t739r1370b807],
9	Pharm	NNP	O	Pharm	appos	7	SENT_23	[p2l1397t739r1731b806],
10	.	.	O	.	_	0	SENT_23	[p2l1397t739r1731b806],

1	D.	NNP	O	D.	nn	3	SENT_24	[p2l1397t739r1731b806],
2	,	,	O	,	_	0	SENT_24	[p2l1397t739r1731b806],
3	BCPP	NNP	O	BCPP	_	0	SENT_24	[p2l1755t739r1968b806],
4	,	,	O	,	_	0	SENT_24	[p2l1755t739r1968b806],
5	S413	NN	O	s413	appos	3	SENT_24	[p2l1995t739r2151b794],

1	Pharmacy	NN	O	pharmacy	nn	2	SENT_25	[p2l9t819r343b887],
2	Building	NN	O	building	_	0	SENT_25	[p2l364t819r665b887],
3	,	,	O	,	_	0	SENT_25	[p2l364t819r665b887],
4	Iowa	NNP	LOCATION	Iowa	nn	5	SENT_25	[p2l693t820r851b873],
5	City	NNP	LOCATION	City	appos	2	SENT_25	[p2l876t819r1028b887],
6	,	,	O	,	_	0	SENT_25	[p2l876t819r1028b887],
7	Iowa	NNP	LOCATION	Iowa	appos	5	SENT_25	[p2l1056t820r1213b873],
8	52242	CD	NUMBER	52242	num	7	SENT_25	[p2l1238t821r1447b873],
9	.	.	O	.	_	0	SENT_25	[p2l1238t821r1447b873],

1	E-mail	NN	O	e-mail	_	0	SENT_26	[p2l9t899r244b953],
2	:	:	O	:	_	0	SENT_26	[p2l9t899r244b953],
3	Vicki-ellingrod@uioWa.edu	NN	O	vicki-ellingrod@uiowa.edu	dep	1	SENT_26	[p2l271t898r1134b967],

1	Received	VBN	O	receive	_	0	SENT_27	[p2l90t992r380b1047],
2	17	CD	DATE	17	dobj	1	SENT_27	[p2l408t994r477b1047],
3	March	NNP	DATE	March	tmod	2	SENT_27	[p2l502t992r715b1047],
4	2003	CD	DATE	2003	num	3	SENT_27	[p2l740t994r911b1059],
5	;	:	O	;	_	0	SENT_27	[p2l740t994r911b1059],
6	Accepted	JJ	O	accepted	amod	7	SENT_27	[p2l935t992r1232b1060],
7	14	CD	DATE	14	dep	2	SENT_27	[p2l1260t994r1331b1046],
8	October	NNP	DATE	October	tmod	1	SENT_27	[p2l1357t992r1611b1047],
9	2003	CD	DATE	2003	num	8	SENT_27	[p2l1636t994r1788b1047],

1	DOI	NNP	O	DOI	_	0	SENT_28	[p2l90t1086r226b1141],
2	10.1002	CD	NUMBER	10.1002	num	1	SENT_28	[p2l257t1086r962b1154],
3	/	:	O	/	punct	4	SENT_28	[p2l257t1086r962b1154],
4	ajmg	NN	O	ajmg	dep	1	SENT_28	[p2l257t1086r962b1154],
5	.	.	O	.	_	0	SENT_28	[p2l257t1086r962b1154],

1	b.	NN	O	b.	_	0	SENT_29	[p2l257t1086r962b1154],
2	20169	CD	NUMBER	20169	num	1	SENT_29	[p2l257t1086r962b1154],

1	©	RB	O	©	advmod	2	SENT_30	[p2l13t1250r65b1302],
2	2005	CD	DATE	2005	_	0	SENT_30	[p2l97t1247r269b1302],
3	Wiley-Liss	NNP	O	Wiley-Liss	dep	2	SENT_30	[p2l295t1244r719b1317],
4	,	,	O	,	_	0	SENT_30	[p2l295t1244r719b1317],
5	Inc.	NNP	O	Inc.	nn	6	SENT_30	[p2l749t1246r893b1302],
6	schizophrenia	NN	O	schizophrenia	appos	3	SENT_30	[p2l11t1328r511b1401],
7	.	.	O	.	_	0	SENT_30	[p2l11t1328r511b1401],

1	Estimates	NNS	O	estimate	nsubj	2	SENT_31	[p2l537t1330r886b1386],
2	suggest	VBP	O	suggest	_	0	SENT_31	[p2l909t1334r1170b1401],
3	that	IN	O	that	complm	13	SENT_31	[p2l1189t1328r1335b1386],
4	more	JJR	O	more	quantmod	6	SENT_31	[p2l1355t1348r1528b1386],
5	than	IN	O	than	quantmod	6	SENT_31	[p2l1549t1328r1710b1386],
6	half	NN	O	half	nsubj	13	SENT_31	[p2l1731t1328r1874b1386],
7	of	IN	O	of	_	0	SENT_31	[p2l1886t1329r1954b1386],
8	those	DT	O	those	prep_of	6	SENT_31	[p2l1966t1328r2150b1386],
9	treated	VBN	O	treat	partmod	8	SENT_31	[p2l9t1412r261b1470],
10	with	IN	O	with	_	0	SENT_31	[p2l286t1412r442b1470],
11	AAPs	NNS	O	aap	prep_with	9	SENT_31	[p2l466t1413r660b1470],
12	will	MD	O	will	aux	13	SENT_31	[p2l685t1412r814b1470],
13	gain	VB	O	gain	ccomp	2	SENT_31	[p2l840t1414r991b1485],
14	at	IN	O	at	quantmod	16	SENT_31	[p2l1019t1418r1085b1470],
15	least	JJS	O	least	mwe	14	SENT_31	[p2l1111t1412r1276b1470],
16	10	CD	PERCENT	10	num	17	SENT_31	[p2l1308t1415r1444b1470],
17	%	NN	PERCENT	%	dobj	13	SENT_31	[p2l1308t1415r1444b1470],
18	of	IN	O	of	_	0	SENT_31	[p2l1472t1413r1540b1470],
19	their	PRP$	O	they	poss	22	SENT_31	[p2l1558t1412r1727b1470],
20	initial	JJ	O	initial	amod	22	SENT_31	[p2l1753t1412r1963b1470],
21	body	NN	O	body	nn	22	SENT_31	[p2l1987t1412r2151b1485],
22	weight	NN	O	weight	prep_of	17	SENT_31	[p2l9t1497r245b1569],
23	over	IN	O	over	_	0	SENT_31	[p2l275t1516r422b1554],
24	the	DT	O	the	det	25	SENT_31	[p2l450t1497r561b1554],
25	course	NN	O	course	prep_over	13	SENT_31	[p2l591t1516r812b1555],
26	of	IN	O	of	_	0	SENT_31	[p2l842t1497r909b1554],
27	therapy	NN	O	therapy	prep_of	25	SENT_31	[p2l930t1497r1219b1569],
28	,	,	O	,	_	0	SENT_31	[p2l930t1497r1219b1569],
29	although	IN	O	although	mark	33	SENT_31	[p2l1254t1497r1563b1569],
30	some	DT	O	some	nsubjpass	33	SENT_31	[p2l1593t1516r1766b1555],
31	have	VBP	O	have	aux	33	SENT_31	[p2l1795t1497r1959b1554],
32	been	VBN	O	be	auxpass	33	SENT_31	[p2l1987t1497r2150b1554],
33	reported	VBN	O	report	advcl	13	SENT_31	[p2l9t1581r305b1653],
34	to	TO	O	to	aux	35	SENT_31	[p2l322t1586r386b1638],
35	gain	VB	O	gain	xcomp	33	SENT_31	[p2l404t1582r553b1653],
36	more	JJR	O	more	mwe	37	SENT_31	[p2l571t1600r745b1638],
37	than	IN	O	than	quantmod	38	SENT_31	[p2l761t1581r923b1638],
38	40	CD	PERCENT	40	num	39	SENT_31	[p2l941t1583r1083b1638],
39	%	NN	PERCENT	%	dobj	35	SENT_31	[p2l941t1583r1083b1638],
40	[	CD	NUMBER	[	num	41	SENT_31	[p2l1106t1581r1462b1646],
41	Umbricht	NNP	O	Umbricht	dep	39	SENT_31	[p2l1106t1581r1462b1646],
42	and	CC	O	and	_	0	SENT_31	[p2l1482t1581r1609b1638],
43	Kane	NNP	PERSON	Kane	dobj	35	SENT_31	[p2l1627t1582r1826b1651],
44	,	,	O	,	_	0	SENT_31	[p2l1627t1582r1826b1651],
45	1996	CD	DATE	1996	num	46	SENT_31	[p2l1853t1582r2054b1646],
46	]	NN	O	]	appos	43	SENT_31	[p2l1853t1582r2054b1646],
47	.	.	O	.	_	0	SENT_31	[p2l1853t1582r2054b1646],

1	In	IN	O	in	_	0	SENT_32	[p2l2076t1582r2150b1637],
2	general	JJ	O	general	prep_in	52	SENT_32	[p2l10t1665r270b1737],
3	a	DT	O	a	det	5	SENT_32	[p2l303t1684r341b1722],
4	Weight	NNP	O	Weight	nn	5	SENT_32	[p2l370t1665r605b1737],
5	gain	NN	O	gain	nsubj	18	SENT_32	[p2l636t1666r786b1737],
6	of	IN	O	of	_	0	SENT_32	[p2l818t1665r886b1722],
7	5	CD	PERCENT	5	number	8	SENT_32	[p2l910t1667r1009b1722],
8	%	NN	PERCENT	%	prep_of	5	SENT_32	[p2l910t1667r1009b1722],
9	or	CC	O	or	_	0	SENT_32	[p2l1042t1684r1111b1722],
10	more	JJR	O	more	prep_of	5	SENT_32	[p2l1141t1684r1315b1722],
11	over	IN	O	over	_	0	SENT_32	[p2l1346t1684r1494b1722],
12	ideal	JJ	O	ideal	amod	14	SENT_32	[p2l1525t1665r1692b1722],
13	body	NN	O	body	nn	14	SENT_32	[p2l1721t1665r1885b1737],
14	Weight	NNP	O	Weight	prep_over	8	SENT_32	[p2l1914t1665r2150b1737],
15	Within	IN	O	within	_	0	SENT_32	[p2l9t1748r236b1806],
16	1-2	CD	NUMBER	1-2	num	17	SENT_32	[p2l274t1751r401b1805],
17	months	NNS	NUMBER	month	prep_within	18	SENT_32	[p2l435t1748r694b1806],
18	places	VBZ	O	place	rcmod	2	SENT_32	[p2l726t1748r939b1821],
19	individuals	NNS	O	individual	dobj	18	SENT_32	[p2l971t1748r1360b1806],
20	at	IN	O	at	_	0	SENT_32	[p2l1394t1754r1461b1806],
21	risk	NN	O	risk	prep_at	18	SENT_32	[p2l1492t1748r1628b1806],
22	for	IN	O	for	_	0	SENT_32	[p2l1659t1749r1753b1806],
23	signiﬁcant	JJ	O	signiﬁcant	amod	25	SENT_32	[p2l1787t1749r2150b1821],
24	health	NN	O	health	nn	25	SENT_32	[p2l9t1832r233b1890],
25	complications	NNS	O	complication	prep_for	21	SENT_32	[p2l267t1833r741b1905],
26	such	JJ	O	such	_	0	SENT_32	[p2l778t1832r934b1890],
27	as	IN	O	as	_	0	SENT_32	[p2l970t1852r1042b1890],
28	hypertension	NN	O	hypertension	prep_such_as	25	SENT_32	[p2l1075t1832r1550b1905],
29	,	,	O	,	_	0	SENT_32	[p2l1075t1832r1550b1905],
30	type	NN	O	type	nsubj	52	SENT_32	[p2l1586t1838r1736b1905],
31	II	CD	NUMBER	ii	num	32	SENT_32	[p2l1770t1834r1827b1889],
32	diabetes	NNS	O	diabetes	dep	30	SENT_32	[p2l1863t1832r2150b1890],
33	mellitus	NN	O	mellitus	dep	30	SENT_32	[p2l10t1916r311b1987],
34	,	,	O	,	_	0	SENT_32	[p2l10t1916r311b1987],
35	coronary	JJ	O	coronary	amod	37	SENT_32	[p2l343t1936r648b1988],
36	heart	NN	O	heart	nn	37	SENT_32	[p2l675t1916r862b1974],
37	disease	NN	O	disease	dep	30	SENT_32	[p2l891t1916r1159b1987],
38	,	,	O	,	_	0	SENT_32	[p2l891t1916r1159b1987],
39	stroke	NN	O	stroke	dep	30	SENT_32	[p2l1193t1916r1424b1987],
40	,	,	O	,	_	0	SENT_32	[p2l1193t1916r1424b1987],
41	gallbladder	NN	O	gallbladder	nn	42	SENT_32	[p2l1456t1916r1850b1988],
42	disease	NN	O	disease	dep	30	SENT_32	[p2l1878t1916r2147b1987],
43	,	,	O	,	_	0	SENT_32	[p2l1878t1916r2147b1987],
44	osteoarthritis	NN	O	osteoarthritis	dep	30	SENT_32	[p2l10t2000r499b2071],
45	,	,	O	,	_	0	SENT_32	[p2l10t2000r499b2071],
46	sleep	NN	O	sleep	nn	47	SENT_32	[p2l528t2000r701b2072],
47	apnea	NN	O	apnea	dep	30	SENT_32	[p2l726t2020r951b2072],
48	,	,	O	,	_	0	SENT_32	[p2l726t2020r951b2072],
49	and	CC	O	and	_	0	SENT_32	[p2l980t2000r1107b2058],
50	respiratory	JJ	O	respiratory	amod	51	SENT_32	[p2l1129t2001r1519b2072],
51	problems	NNS	O	problem	dep	30	SENT_32	[p2l1541t2000r1859b2072],
52	[	VBP	O	[	_	0	SENT_32	[p2l1887t2000r2150b2065],
53	Allison	NNP	PERSON	Allison	dobj	52	SENT_32	[p2l1887t2000r2150b2065],
54	et	FW	O	et	nn	58	SENT_32	[p2l11t2089r74b2142],
55	al.	FW	O	al.	nn	58	SENT_32	[p2l98t2084r197b2154],
56	,	,	O	,	_	0	SENT_32	[p2l98t2084r197b2154],
57	1999a	FW	O	1999a	dep	58	SENT_32	[p2l229t2085r472b2149],
58	]	FW	O	]	dep	53	SENT_32	[p2l229t2085r472b2149],
59	.	.	O	.	_	0	SENT_32	[p2l229t2085r472b2149],

1	The	DT	O	the	det	5	SENT_33	[p2l85t2168r218b2226],
2	5H	NN	O	5h	nn	5	SENT_33	[p2l236t2169r343b2226],
3	T2C	NN	O	t2c	nn	5	SENT_33	[p2l345t2168r490b2226],
4	receptor	NN	O	receptor	nn	5	SENT_33	[p2l507t2173r793b2240],
5	gene	NN	O	gene	nsubj	22	SENT_33	[p2l812t2186r972b2240],
6	is	VBZ	O	be	cop	7	SENT_33	[p2l992t2169r1047b2226],
7	located	JJ	O	located	_	0	SENT_33	[p2l1066t2168r1311b2226],
8	on	IN	O	on	_	0	SENT_33	[p2l1331t2188r1412b2226],
9	the	DT	O	the	det	11	SENT_33	[p2l1430t2168r1541b2226],
10	X	NN	O	x	nn	11	SENT_33	[p2l1558t2169r1613b2225],
11	chromosome	NN	O	chromosome	prep_on	7	SENT_33	[p2l1631t2168r2063b2226],
12	at	IN	O	at	_	0	SENT_33	[p2l2084t2173r2151b2226],
13	q24	NN	O	q24	nn	15	SENT_33	[p2l12t2255r132b2325],
14	[	CD	NUMBER	[	num	15	SENT_33	[p2l156t2253r616b2325],
15	Lappalainen	NNP	O	Lappalainen	prep_at	7	SENT_33	[p2l156t2253r616b2325],
16	et	FW	O	et	nn	17	SENT_33	[p2l636t2258r700b2310],
17	al.	FW	O	al.	dep	15	SENT_33	[p2l721t2253r820b2323],
18	,	,	O	,	_	0	SENT_33	[p2l721t2253r820b2323],
19	1995	CD	DATE	1995	num	20	SENT_33	[p2l849t2254r1029b2318],
20	]	NN	O	]	appos	15	SENT_33	[p2l849t2254r1029b2318],
21	and	CC	O	and	_	0	SENT_33	[p2l1054t2253r1182b2310],
22	has	VBZ	O	have	conj_and	7	SENT_33	[p2l1200t2253r1321b2311],
23	a	DT	O	a	det	24	SENT_33	[p2l1342t2272r1380b2310],
24	polymorphism	NN	O	polymorphism	dobj	22	SENT_33	[p2l1398t2253r1896b2325],
25	consisting	VBG	O	consist	partmod	24	SENT_33	[p2l1917t2254r2148b2310, p2l9t2338r150b2409],
26	of	IN	O	of	_	0	SENT_33	[p2l168t2337r235b2394],
27	a	DT	O	a	det	28	SENT_33	[p2l249t2356r287b2394],
28	C	NN	O	c	prep_of	25	SENT_33	[p2l307t2337r356b2394],
29	to	TO	O	to	_	0	SENT_33	[p2l375t2342r439b2394],
30	T	NN	O	t	nn	31	SENT_33	[p2l459t2338r507b2393],
31	transversion	NN	O	transversion	prep_to	28	SENT_33	[p2l526t2338r965b2394],
32	at	IN	O	at	_	0	SENT_33	[p2l987t2342r1054b2394],
33	position	NN	O	position	prep_at	25	SENT_33	[p2l1072t2338r1347b2409],
34	-759	CD	NUMBER	-759	num	33	SENT_33	[p2l1372t2339r1547b2394],
35	in	IN	O	in	_	0	SENT_33	[p2l1568t2338r1635b2393],
36	the	DT	O	the	det	40	SENT_33	[p2l1653t2337r1765b2394],
37	5	CD	NUMBER	5	num	40	SENT_33	[p2l1786t2336r1839b2394],
38	’	NN	O	’	nn	40	SENT_33	[p2l1786t2336r1839b2394],
39	ﬂanking	NN	O	ﬂanking	nn	40	SENT_33	[p2l1862t2337r2153b2409],
40	region	NN	O	region	prep_in	33	SENT_33	[p2l9t2422r245b2493],
41	.	.	O	.	_	0	SENT_33	[p2l9t2422r245b2493],

1	The	DT	O	the	det	2	SENT_34	[p2l270t2421r403b2478],
2	site	NN	O	site	nsubj	6	SENT_34	[p2l426t2422r547b2478],
3	of	IN	O	of	_	0	SENT_34	[p2l569t2421r637b2478],
4	this	DT	O	this	det	5	SENT_34	[p2l649t2421r781b2478],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_34	[p2l802t2421r1301b2493],
6	contains	VBZ	O	contain	dep	14	SENT_34	[p2l1323t2422r1613b2478],
7	regulatory	JJ	O	regulatory	amod	13	SENT_34	[p2l1635t2421r2000b2493],
8	and	CC	O	and	_	0	SENT_34	[p2l2023t2421r2151b2478],
9	putative	JJ	O	putative	amod	13	SENT_34	[p2l9t2506r300b2577],
10	transcription	NN	O	transcription	nn	13	SENT_34	[p2l316t2506r772b2577],
11	factor	NN	O	factor	nn	13	SENT_34	[p2l790t2505r989b2562],
12	binding	NN	O	binding	nn	13	SENT_34	[p2l1003t2505r1272b2577],
13	regions	NNS	O	region	dobj	6	SENT_34	[p2l1285t2506r1538b2577],
14	[	VBP	O	[	_	0	SENT_34	[p2l1559t2505r1741b2570],
15	Shih	NNP	O	Shih	dobj	14	SENT_34	[p2l1559t2505r1741b2570],
16	et	FW	O	et	nn	17	SENT_34	[p2l1759t2510r1823b2562],
17	al.	FW	O	al.	nsubj	14	SENT_34	[p2l1841t2505r1940b2575],
18	,	,	O	,	_	0	SENT_34	[p2l1841t2505r1940b2575],
19	1996	CD	DATE	1996	num	20	SENT_34	[p2l1966t2506r2146b2570],
20	]	CD	NUMBER	]	appos	17	SENT_34	[p2l1966t2506r2146b2570],
21	Which	WDT	O	which	nsubj	23	SENT_34	[p2l9t2588r217b2646],
22	may	MD	O	may	aux	23	SENT_34	[p2l241t2608r389b2661],
23	result	VB	O	result	rcmod	20	SENT_34	[p2l411t2588r615b2646],
24	in	IN	O	in	_	0	SENT_34	[p2l639t2590r706b2645],
25	alterations	NNS	O	alteration	prep_in	23	SENT_34	[p2l732t2589r1107b2646],
26	in	IN	O	in	_	0	SENT_34	[p2l1131t2590r1198b2645],
27	the	DT	O	the	det	28	SENT_34	[p2l1222t2588r1333b2646],
28	expression	NN	O	expression	prep_in	25	SENT_34	[p2l1357t2590r1725b2661],
29	of	IN	O	of	_	0	SENT_34	[p2l1751t2589r1818b2646],
30	the	DT	O	the	det	31	SENT_34	[p2l1833t2588r1944b2646],
31	gene	NN	O	gene	prep_of	28	SENT_34	[p2l1969t2607r2146b2661],
32	.	.	O	.	_	0	SENT_34	[p2l1969t2607r2146b2661],

1	Other	JJ	O	other	amod	2	SENT_35	[p2l11t2672r214b2730],
2	investigators	NNS	O	investigator	nsubj	4	SENT_35	[p2l239t2674r692b2745],
3	have	VBP	O	have	aux	4	SENT_35	[p2l718t2672r882b2730],
4	found	VBN	O	find	dep	23	SENT_35	[p2l908t2672r1106b2730],
5	that	IN	O	that	complm	12	SENT_35	[p2l1130t2672r1275b2730],
6	mice	NNS	O	mouse	nsubj	12	SENT_35	[p2l1300t2674r1460b2730],
7	lacking	VBG	O	lack	partmod	6	SENT_35	[p2l1486t2672r1742b2745],
8	the	DT	O	the	det	10	SENT_35	[p2l1764t2672r1875b2730],
9	5HT2C	NN	O	5ht2c	nn	10	SENT_35	[p2l1902t2673r2149b2730],
10	receptor	NN	O	receptor	dobj	7	SENT_35	[p2l9t2761r295b2828],
11	are	VBP	O	be	cop	12	SENT_35	[p2l337t2776r445b2814],
12	obese	JJ	O	obese	ccomp	4	SENT_35	[p2l486t2756r672b2814],
13	and	CC	O	and	_	0	SENT_35	[p2l714t2756r842b2814],
14	the	DT	O	the	det	15	SENT_35	[p2l880t2756r991b2814],
15	activation	NN	O	activation	nsubj	18	SENT_35	[p2l1033t2757r1377b2814],
16	of	IN	O	of	_	0	SENT_35	[p2l1417t2756r1485b2814],
17	5HT2C	NN	O	5ht2c	prep_of	15	SENT_35	[p2l1518t2756r1765b2814],
18	results	VBZ	O	result	conj_and	4	SENT_35	[p2l1805t2756r2043b2814],
19	in	IN	O	in	_	0	SENT_35	[p2l2083t2757r2150b2813],
20	decreased	VBN	O	decrease	amod	22	SENT_35	[p2l10t2840r352b2898],
21	eating	NN	O	eating	nn	22	SENT_35	[p2l382t2841r602b2912],
22	behaviors	NNS	O	behavior	prep_in	18	SENT_35	[p2l625t2840r963b2898],
23	[	VBP	O	[	_	0	SENT_35	[p2l997t2841r1234b2905],
24	Tecott	NNP	O	Tecott	dobj	23	SENT_35	[p2l997t2841r1234b2905],
25	et	FW	O	et	nn	26	SENT_35	[p2l1263t2845r1327b2898],
26	al.	FW	O	al.	nsubj	23	SENT_35	[p2l1357t2840r1456b2911],
27	,	,	O	,	_	0	SENT_35	[p2l1357t2840r1456b2911],
28	1995	CD	DATE	1995	appos	26	SENT_35	[p2l1495t2842r1672b2911],
29	;	:	O	;	_	0	SENT_35	[p2l1495t2842r1672b2911],
30	Stahl	NNP	PERSON	Stahl	dep	28	SENT_35	[p2l1706t2840r1907b2911],
31	,	,	O	,	_	0	SENT_35	[p2l1706t2840r1907b2911],
32	1998	CD	DATE	1998	num	33	SENT_35	[p2l1945t2841r2146b2905],
33	]	NN	O	]	appos	30	SENT_35	[p2l1945t2841r2146b2905],
34	.	.	O	.	_	0	SENT_35	[p2l1945t2841r2146b2905],

1	Recently	RB	DATE	recently	advmod	7	SENT_36	[p2l10t2924r329b2996],
2	,	,	O	,	_	0	SENT_36	[p2l10t2924r329b2996],
3	this	DT	O	this	det	4	SENT_36	[p2l353t2924r484b2982],
4	polymorphism	NN	O	polymorphism	nsubjpass	7	SENT_36	[p2l503t2924r1002b2996],
5	has	VBZ	O	have	aux	7	SENT_36	[p2l1022t2924r1142b2982],
6	been	VBN	O	be	auxpass	7	SENT_36	[p2l1160t2924r1323b2982],
7	hypothesized	VBN	O	hypothesize	_	0	SENT_36	[p2l1343t2924r1799b2996],
8	as	IN	O	as	_	0	SENT_36	[p2l1821t2944r1892b2982],
9	having	VBG	O	have	prepc_as	7	SENT_36	[p2l1912t2924r2153b2996],
10	a	DT	O	a	det	11	SENT_36	[p2l12t3028r50b3066],
11	relationship	NN	O	relationship	nsubj	27	SENT_36	[p2l80t3008r500b3080],
12	with	IN	O	with	_	0	SENT_36	[p2l532t3008r689b3066],
13	the	DT	O	the	det	14	SENT_36	[p2l720t3008r831b3066],
14	development	NN	O	development	prep_with	11	SENT_36	[p2l864t3008r1307b3080],
15	of	IN	O	of	_	0	SENT_36	[p2l1339t3008r1407b3066],
16	type	NN	O	type	nn	18	SENT_36	[p2l1430t3013r1579b3080],
17	II	CD	NUMBER	ii	num	18	SENT_36	[p2l1612t3009r1669b3065],
18	diabetes	NNS	O	diabetes	prep_of	14	SENT_36	[p2l1702t3008r1989b3066],
19	and	CC	O	and	_	0	SENT_36	[p2l2023t3008r2151b3066],
20	obesity	NN	O	obesity	prep_with	11	SENT_36	[p2l10t3092r254b3165],
21	in	IN	O	in	_	0	SENT_36	[p2l291t3094r359b3149],
22	a	DT	O	a	det	24	SENT_36	[p2l398t3112r436b3150],
23	normal	JJ	O	normal	amod	24	SENT_36	[p2l473t3092r721b3150],
24	control	NN	O	control	prep_in	20	SENT_36	[p2l759t3092r999b3150],
25	population	NN	O	population	nn	27	SENT_36	[p2l1036t3092r1408b3165],
26	[	CD	MONEY	[	num	27	SENT_36	[p2l1450t3094r1656b3158],
27	Yuan	NNP	MONEY	Yuan	xcomp	9	SENT_36	[p2l1450t3094r1656b3158],
28	et	FW	O	et	nn	29	SENT_36	[p2l1695t3098r1759b3150],
29	al.	FW	O	al.	dep	27	SENT_36	[p2l1798t3092r1897b3163],
30	,	,	O	,	_	0	SENT_36	[p2l1798t3092r1897b3163],
31	2000	CD	DATE	2000	num	32	SENT_36	[p2l1940t3094r2146b3163],
32	]	NN	O	]	appos	27	SENT_36	[p2l1940t3094r2146b3163],
33	,	,	O	,	_	0	SENT_36	[p2l1940t3094r2146b3163],
34	Where	WRB	O	where	advmod	42	SENT_36	[p2l9t3176r222b3234],
35	an	DT	O	a	det	36	SENT_36	[p2l241t3196r324b3234],
36	excess	NN	O	excess	nsubjpass	42	SENT_36	[p2l342t3196r558b3234],
37	of	IN	O	of	_	0	SENT_36	[p2l575t3176r643b3234],
38	the	DT	O	the	det	40	SENT_36	[p2l651t3176r762b3234],
39	T	NN	O	t	nn	40	SENT_36	[p2l778t3177r826b3233],
40	allele	NN	O	allele	prep_of	36	SENT_36	[p2l844t3176r1027b3234],
41	was	VBD	O	be	auxpass	42	SENT_36	[p2l1043t3196r1176b3234],
42	found	VBN	O	find	rcmod	27	SENT_36	[p2l1193t3176r1391b3234],
43	in	IN	O	in	_	0	SENT_36	[p2l1407t3177r1474b3233],
44	non-obese	JJ	O	non-obese	amod	45	SENT_36	[p2l1491t3176r1834b3234],
45	subjects	NNS	O	subject	prep_in	42	SENT_36	[p2l1852t3176r2146b3248],
46	.	.	O	.	_	0	SENT_36	[p2l1852t3176r2146b3248],

1	Additionally	RB	O	additionally	advmod	11	SENT_37	[p2l7t3260r457b3332],
2	,	,	O	,	_	0	SENT_37	[p2l7t3260r457b3332],
3	an	DT	O	a	det	4	SENT_37	[p2l507t3280r591b3318],
4	excess	NN	O	excess	nsubjpass	11	SENT_37	[p2l635t3280r851b3318],
5	of	IN	O	of	_	0	SENT_37	[p2l896t3260r963b3318],
6	the	DT	O	the	det	8	SENT_37	[p2l998t3260r1109b3318],
7	T	NN	O	t	nn	8	SENT_37	[p2l1153t3261r1201b3317],
8	allele	NN	O	allele	prep_of	4	SENT_37	[p2l1246t3260r1430b3318],
9	has	VBZ	O	have	aux	11	SENT_37	[p2l1473t3260r1594b3318],
10	been	VBN	O	be	auxpass	11	SENT_37	[p2l1636t3260r1798b3318],
11	found	VBN	O	find	_	0	SENT_37	[p2l1842t3260r2040b3318],
12	in	IN	O	in	_	0	SENT_37	[p2l2083t3261r2150b3317],
13	patients	NNS	O	patient	nsubj	16	SENT_37	[p2l9t3345r293b3416],
14	With	IN	O	with	_	0	SENT_37	[p2l314t3344r471b3402],
15	schizophrenia	NN	O	schizophrenia	prep_with	16	SENT_37	[p2l494t3344r977b3416],
16	receiving	VBG	O	receive	prepc_in	11	SENT_37	[p2l997t3345r1317b3416],
17	chlorpromazine	NN	O	chlorpromazine	dobj	16	SENT_37	[p2l1336t3344r1895b3416],
18	,	,	O	,	_	0	SENT_37	[p2l1336t3344r1895b3416],
19	risperidone	NN	O	risperidone	dobj	16	SENT_37	[p2l1920t3345r2148b3416, p2l10t3428r214b3498],
20	,	,	O	,	_	0	SENT_37	[p2l1920t3345r2148b3416, p2l10t3428r214b3498],
21	and	CC	O	and	_	0	SENT_37	[p2l265t3428r392b3486],
22	clozapine	NN	O	clozapine	dobj	16	SENT_37	[p2l437t3428r759b3500],
23	who	WP	O	who	nsubj	24	SENT_37	[p2l803t3428r944b3486],
24	did	VBD	O	do	rcmod	17	SENT_37	[p2l990t3428r1097b3485],
25	not	RB	O	not	neg	28	SENT_37	[p2l1141t3433r1252b3486],
26	development	NN	O	development	nn	28	SENT_37	[p2l1297t3428r1740b3500],
27	signiﬁcant	JJ	O	signiﬁcant	amod	28	SENT_37	[p2l1787t3428r2150b3500],
28	weight	NN	O	weight	dobj	24	SENT_37	[p2l9t3513r245b3585],
29	gain	NN	O	gain	npadvmod	31	SENT_37	[p2l267t3514r416b3585],
30	(	CD	NUMBER	(	num	29	SENT_37	[p2l441t3513r515b3578],
31	>	JJR	O	>	amod	28	SENT_37	[p2l441t3513r515b3578],
32	7	CD	PERCENT	7	num	33	SENT_37	[p2l526t3513r647b3578],
33	%	NN	PERCENT	%	dep	31	SENT_37	[p2l526t3513r647b3578],
34	)	CD	NUMBER	)	advmod	28	SENT_37	[p2l526t3513r647b3578],
35	over	IN	O	over	_	0	SENT_37	[p2l672t3532r820b3570],
36	their	PRP$	O	they	poss	37	SENT_37	[p2l841t3513r1010b3570],
37	baseline	NN	O	baseline	prep_over	34	SENT_37	[p2l1029t3513r1316b3571],
38	weight	NN	O	weight	nn	40	SENT_37	[p2l1338t3513r1574b3585],
39	[	CD	NUMBER	[	num	40	SENT_37	[p2l1599t3513r1937b3585],
40	Reynolds	NNP	O	Reynolds	dep	28	SENT_37	[p2l1599t3513r1937b3585],
41	et	FW	O	et	nn	42	SENT_37	[p2l1960t3518r2024b3571],
42	al.	FW	O	al.	dep	40	SENT_37	[p2l2047t3513r2147b3583],
43	,	,	O	,	_	0	SENT_37	[p2l2047t3513r2147b3583],
44	2002	CD	DATE	2002	appos	28	SENT_37	[p2l11t3599r192b3667],
45	,	,	DATE	,	_	0	SENT_37	[p2l11t3599r192b3667],
46	2003	CD	DATE	2003	num	47	SENT_37	[p2l224t3598r429b3662],
47	]	NN	O	]	appos	28	SENT_37	[p2l224t3598r429b3662],
48	.	.	O	.	_	0	SENT_37	[p2l224t3598r429b3662],

1	Although	IN	O	although	mark	5	SENT_38	[p2l458t3597r784b3669],
2	others	NNS	O	other	nsubj	5	SENT_38	[p2l812t3597r1028b3655],
3	have	VBP	O	have	aux	5	SENT_38	[p2l1055t3597r1220b3654],
4	not	RB	O	not	neg	5	SENT_38	[p2l1247t3602r1358b3654],
5	found	VBN	O	find	_	0	SENT_38	[p2l1385t3597r1582b3654],
6	this	DT	O	this	det	9	SENT_38	[p2l1608t3597r1739b3655],
7	association	NN	O	association	nn	9	SENT_38	[p2l1769t3598r2150b3654],
8	[	CD	NUMBER	[	num	9	SENT_38	[p2l14t3681r248b3746],
9	Basile	NNP	PERSON	Basile	dobj	5	SENT_38	[p2l14t3681r248b3746],
10	et	FW	O	et	nn	11	SENT_38	[p2l268t3686r332b3738],
11	al.	FW	O	al.	dep	9	SENT_38	[p2l352t3681r451b3751],
12	,	,	O	,	_	0	SENT_38	[p2l352t3681r451b3751],
13	2002	CD	DATE	2002	appos	9	SENT_38	[p2l475t3683r656b3751],
14	;	:	O	;	_	0	SENT_38	[p2l475t3683r656b3751],
15	Tsai	NNP	PERSON	Tsai	dep	9	SENT_38	[p2l677t3682r826b3738],
16	et	FW	O	et	nn	17	SENT_38	[p2l844t3686r908b3738],
17	al.	FW	O	al.	dep	15	SENT_38	[p2l928t3681r1028b3751],
18	,	,	O	,	_	0	SENT_38	[p2l928t3681r1028b3751],
19	2002	CD	DATE	2002	num	20	SENT_38	[p2l1051t3682r1257b3746],
20	]	NN	O	]	appos	17	SENT_38	[p2l1051t3682r1257b3746],
21	.	.	O	.	_	0	SENT_38	[p2l1051t3682r1257b3746],

1	The	DT	O	the	det	2	SENT_39	[p2l1279t3681r1411b3738],
2	aim	NN	O	aim	nsubj	6	SENT_39	[p2l1432t3682r1560b3738],
3	of	IN	O	of	_	0	SENT_39	[p2l1579t3681r1647b3738],
4	this	DT	O	this	det	5	SENT_39	[p2l1656t3681r1788b3738],
5	study	NN	O	study	prep_of	2	SENT_39	[p2l1809t3681r2000b3753],
6	Was	VBD	O	be	_	0	SENT_39	[p2l2016t3700r2150b3738],
7	to	TO	O	to	aux	8	SENT_39	[p3l9t18r73b70],
8	examine	VB	O	examine	xcomp	6	SENT_39	[p3l96t14r388b70],
9	the	DT	O	the	det	10	SENT_39	[p3l409t13r520b70],
10	relationship	NN	O	relationship	dobj	8	SENT_39	[p3l541t13r961b85],
11	between	IN	O	between	_	0	SENT_39	[p3l981t13r1271b70],
12	the	DT	O	the	det	15	SENT_39	[p3l1291t13r1402b70],
13	—	NN	O	—	nn	15	SENT_39	[p3l1428t13r1732b76],
14	759C/T	NN	O	759c/t	nn	15	SENT_39	[p3l1428t13r1732b76],
15	polymorphism	NN	O	polymorphism	prep_between	10	SENT_39	[p3l1752t13r2148b85, p3l10t98r133b154],
16	of	IN	O	of	_	0	SENT_39	[p3l157t97r225b154],
17	the	DT	O	the	det	19	SENT_39	[p3l240t96r351b154],
18	5HT2C	NN	O	5ht2c	nn	19	SENT_39	[p3l377t97r623b154],
19	receptor	NN	O	receptor	prep_of	15	SENT_39	[p3l648t102r934b169],
20	and	CC	O	and	_	0	SENT_39	[p3l960t96r1087b154],
21	weight	NN	O	weight	nn	22	SENT_39	[p3l1110t96r1346b169],
22	gain	NN	O	gain	conj_and	19	SENT_39	[p3l1369t98r1519b169],
23	during	IN	O	during	_	0	SENT_39	[p3l1544t96r1779b169],
24	treatment	NN	O	treatment	prep_during	8	SENT_39	[p3l1799t102r2150b154],
25	with	IN	O	with	_	0	SENT_39	[p3l9t180r165b238],
26	olanzapine	NN	O	olanzapine	prep_with	8	SENT_39	[p3l188t180r581b252],
27	.	.	O	.	_	0	SENT_39	[p3l188t180r581b252],

1	SUBJECTS	NNS	O	subject	_	0	SENT_40	[p3l532t413r968b470],
2	AND	CC	O	and	_	0	SENT_40	[p3l994t413r1177b470],
3	METHODS	NNS	O	method	conj_and	1	SENT_40	[p3l1202t413r1629b470],

1	Subjects	NNS	O	subject	_	0	SENT_41	[p3l465t539r793b611],
2	and	CC	O	and	_	0	SENT_41	[p3l820t539r967b596],
3	Clinical	JJ	O	clinical	amod	4	SENT_41	[p3l993t539r1299b596],
4	Measures	NNS	O	measure	conj_and	1	SENT_41	[p3l1324t540r1697b596],

1	All	DT	O	all	det	2	SENT_42	[p3l83t663r187b720],
2	subjects	NNS	O	subject	nsubjpass	19	SENT_42	[p3l214t663r497b735],
3	were	VBD	O	be	auxpass	4	SENT_42	[p3l523t683r692b721],
4	recruited	VBN	O	recruit	_	0	SENT_42	[p3l718t663r1044b721],
5	through	IN	O	through	_	0	SENT_42	[p3l1069t663r1353b736],
6	Iowa	NNP	LOCATION	Iowa	poss	9	SENT_42	[p3l1381t663r1601b721],
7	’s	POS	O	’s	_	0	SENT_42	[p3l1381t663r1601b721],
8	Mental	NNP	ORGANIZATION	Mental	nn	9	SENT_42	[p3l1626t663r1880b721],
9	Health	NNP	ORGANIZATION	Health	prep_through	4	SENT_42	[p3l1907t663r2150b721],
10	Clinical	JJ	ORGANIZATION	clinical	amod	14	SENT_42	[p3l11t747r285b805],
11	Research	NNP	ORGANIZATION	Research	nn	14	SENT_42	[p3l338t747r662b805],
12	Center	NNP	ORGANIZATION	Center	nn	14	SENT_42	[p3l717t747r957b805],
13	(	CD	NUMBER	(	num	14	SENT_42	[p3l1013t747r1359b813],
14	MHCRC	NNP	O	MHCRC	tmod	4	SENT_42	[p3l1013t747r1359b813],
15	)	CD	NUMBER	)	num	17	SENT_42	[p3l1013t747r1359b813],
16	in-patient	JJ	O	in-patient	amod	17	SENT_42	[p3l1415t748r1767b819],
17	unit	NN	O	unit	dep	14	SENT_42	[p3l1819t748r1966b805],
18	and	CC	O	and	_	0	SENT_42	[p3l2021t747r2151b805],
19	consisted	VBD	O	consist	conj_and	4	SENT_42	[p3l10t831r336b889],
20	of	IN	O	of	_	0	SENT_42	[p3l394t831r463b889],
21	42	CD	NUMBER	42	num	22	SENT_42	[p3l513t834r593b888],
22	subjects	NNS	O	subject	prep_of	19	SENT_42	[p3l654t831r937b903],
23	who	WP	O	who	nsubj	24	SENT_42	[p3l995t831r1137b889],
24	met	VBD	O	meet	rcmod	22	SENT_42	[p3l1196t837r1329b889],
25	DSM-IV	NN	O	dsm-iv	nn	26	SENT_42	[p3l1387t831r1680b889],
26	criteria	NNS	O	criterion	dobj	24	SENT_42	[p3l1736t832r1997b889],
27	for	IN	O	for	_	0	SENT_42	[p3l2054t831r2151b889],
28	schizophrenia	NN	O	schizophrenia	prep_for	24	SENT_42	[p3l12t915r522b987],
29	.	.	O	.	_	0	SENT_42	[p3l12t915r522b987],

1	Ratings	NNS	O	rating	nn	2	SENT_43	[p3l569t916r841b987],
2	scales	NNS	O	scale	nsubj	3	SENT_43	[p3l885t915r1092b973],
3	included	VBD	O	include	dep	27	SENT_43	[p3l1134t915r1437b973],
4	the	DT	O	the	det	10	SENT_43	[p3l1477t915r1590b973],
5	Brief	JJ	O	brief	amod	10	SENT_43	[p3l1631t915r1816b973],
6	Psychiatric	JJ	O	psychiatric	amod	10	SENT_43	[p3l1850t915r2149b987, p3l9t1001r131b1057],
7	Rating	NNP	O	Rating	nn	10	SENT_43	[p3l166t1001r407b1072],
8	Scale	NNP	O	Scale	nn	10	SENT_43	[p3l442t1000r624b1057],
9	(	CD	NUMBER	(	num	10	SENT_43	[p3l663t1000r916b1065],
10	BPRS	NNP	O	BPRS	dobj	3	SENT_43	[p3l663t1000r916b1065],
11	)	CD	NUMBER	)	number	12	SENT_43	[p3l663t1000r916b1065],
12	[	CD	NUMBER	[	dep	10	SENT_43	[p3l958t1000r1245b1065],
13	Overall	JJ	O	overall	advmod	12	SENT_43	[p3l958t1000r1245b1065],
14	and	CC	O	and	_	0	SENT_43	[p3l1281t1000r1410b1057],
15	Gorham	NNP	PERSON	Gorham	conj_and	10	SENT_43	[p3l1448t1000r1752b1070],
16	,	,	O	,	_	0	SENT_43	[p3l1448t1000r1752b1070],
17	1962	CD	DATE	1962	num	18	SENT_43	[p3l1797t1001r1979b1065],
18	]	NN	O	]	conj_and	10	SENT_43	[p3l1797t1001r1979b1065],
19	and	CC	O	and	_	0	SENT_43	[p3l2022t1000r2151b1057],
20	the	DT	O	the	det	21	SENT_43	[p3l9t1084r122b1141],
21	Scale	NNP	O	Scale	conj_and	10	SENT_43	[p3l170t1084r352b1141],
22	for	IN	O	for	_	0	SENT_43	[p3l398t1084r494b1141],
23	Assessment	NNP	O	Assessment	prep_for	3	SENT_43	[p3l537t1084r957b1142],
24	of	IN	O	of	_	0	SENT_43	[p3l1002t1084r1071b1141],
25	Negative	JJ	O	negative	amod	26	SENT_43	[p3l1109t1085r1425b1156],
26	Symptoms	NNS	O	symptom	prep_of	23	SENT_43	[p3l1473t1084r1842b1156],
27	(	VBP	O	(	_	0	SENT_43	[p3l1891t1084r2148b1149],
28	SANS	NNS	O	san	dobj	27	SENT_43	[p3l1891t1084r2148b1149],
29	)	CD	NUMBER	)	number	30	SENT_43	[p3l1891t1084r2148b1149],
30	[	CD	NUMBER	[	num	31	SENT_43	[p3l14t1168r435b1238],
31	Andreasen	NNP	PERSON	Andreasen	nsubj	27	SENT_43	[p3l14t1168r435b1238],
32	,	,	O	,	_	0	SENT_43	[p3l14t1168r435b1238],
33	1983	CD	DATE	1983	num	34	SENT_43	[p3l483t1169r688b1233],
34	]	NN	O	]	appos	31	SENT_43	[p3l483t1169r688b1233],
35	.	.	O	.	_	0	SENT_43	[p3l483t1169r688b1233],

1	These	DT	O	these	nsubjpass	3	SENT_44	[p3l730t1168r938b1225],
2	were	VBD	O	be	auxpass	3	SENT_44	[p3l977t1187r1146b1225],
3	completed	VBN	O	complete	_	0	SENT_44	[p3l1185t1168r1545b1240],
4	at	IN	O	at	_	0	SENT_44	[p3l1584t1173r1651b1225],
5	baseline	NN	O	baseline	prep_at	3	SENT_44	[p3l1688t1168r1980b1225],
6	and	CC	O	and	_	0	SENT_44	[p3l2021t1168r2151b1225],
7	then	RB	O	then	advmod	8	SENT_44	[p3l9t1252r169b1309],
8	weekly	JJ	SET	weekly	prep_at	3	SENT_44	[p3l197t1252r446b1324],
9	to	TO	O	to	aux	10	SENT_44	[p3l472t1257r537b1309],
10	assess	VB	O	assess	xcomp	3	SENT_44	[p3l569t1271r787b1309],
11	psychopathology	NN	O	psychopathology	nn	15	SENT_44	[p3l815t1252r1406b1324],
12	and	CC	O	and	_	0	SENT_44	[p3l1435t1252r1564b1309],
13	medication	NN	O	medication	nn	15	SENT_44	[p3l1592t1252r1981b1309],
14	side	JJ	O	side	amod	15	SENT_44	[p3l2012t1252r2149b1309],
15	effects	NNS	O	effect	dobj	10	SENT_44	[p3l11t1336r254b1393],
16	.	.	O	.	_	0	SENT_44	[p3l11t1336r254b1393],

1	Additionally	RB	O	additionally	advmod	11	SENT_45	[p3l293t1335r753b1408],
2	,	,	O	,	_	0	SENT_45	[p3l293t1335r753b1408],
3	each	DT	O	each	det	4	SENT_45	[p3l795t1335r954b1393],
4	subject	JJ	O	subject	poss	6	SENT_45	[p3l993t1335r1292b1407],
5	’s	POS	O	’s	_	0	SENT_45	[p3l993t1335r1292b1407],
6	weight	NN	O	weight	nsubjpass	11	SENT_45	[p3l1329t1335r1569b1408],
7	and	CC	O	and	_	0	SENT_45	[p3l1608t1335r1736b1393],
8	vital	JJ	O	vital	amod	9	SENT_45	[p3l1771t1335r1933b1393],
9	signs	NNS	O	sign	conj_and	6	SENT_45	[p3l1971t1337r2150b1408],
10	were	VBD	O	be	auxpass	11	SENT_45	[p3l9t1439r178b1477],
11	obtained	VBN	O	obtain	_	0	SENT_45	[p3l225t1419r531b1477],
12	at	IN	O	at	_	0	SENT_45	[p3l578t1425r646b1477],
13	each	DT	O	each	det	15	SENT_45	[p3l692t1419r851b1477],
14	study	NN	O	study	nn	15	SENT_45	[p3l899t1419r1094b1492],
15	visit	NN	O	visit	prep_at	11	SENT_45	[p3l1138t1421r1309b1477],
16	.	.	O	.	_	0	SENT_45	[p3l1138t1421r1309b1477],

1	Prior	RB	O	prior	advcl	7	SENT_46	[p3l1360t1421r1540b1477],
2	to	TO	O	to	aux	3	SENT_46	[p3l1586t1425r1651b1477],
3	study	VB	O	study	dep	1	SENT_46	[p3l1699t1419r1893b1492],
4	entry	NN	O	entry	dobj	3	SENT_46	[p3l1939t1425r2147b1492],
5	,	,	O	,	_	0	SENT_46	[p3l1939t1425r2147b1492],
6	subjects	NNS	O	subject	nsubj	7	SENT_46	[p3l11t1503r293b1575],
7	underwent	VBD	O	undergo	_	0	SENT_46	[p3l334t1503r721b1561],
8	a	DT	O	a	det	10	SENT_46	[p3l765t1523r803b1561],
9	physical	JJ	O	physical	amod	10	SENT_46	[p3l843t1503r1136b1575],
10	exam	NN	O	exam	dobj	7	SENT_46	[p3l1178t1523r1365b1561],
11	to	TO	O	to	aux	12	SENT_46	[p3l1406t1509r1470b1561],
12	assure	VB	O	assure	xcomp	7	SENT_46	[p3l1515t1523r1744b1561],
13	they	PRP	O	they	nsubj	16	SENT_46	[p3l1785t1503r1941b1575],
14	were	VBD	O	be	cop	16	SENT_46	[p3l1981t1523r2150b1561],
15	physically	RB	O	physically	advmod	16	SENT_46	[p3l9t1587r370b1659],
16	healthy	JJ	O	healthy	ccomp	12	SENT_46	[p3l391t1587r678b1659],
17	.	.	O	.	_	0	SENT_46	[p3l391t1587r678b1659],

1	All	DT	O	all	det	2	SENT_47	[p3l83t1671r185b1728],
2	subjects	NNS	O	subject	nsubj	3	SENT_47	[p3l218t1671r493b1743],
3	gave	VBD	O	give	_	0	SENT_47	[p3l525t1689r683b1743],
4	written	VBN	O	write	amod	6	SENT_47	[p3l713t1672r970b1729],
5	informed	VBN	O	inform	amod	6	SENT_47	[p3l1001t1671r1315b1729],
6	consent	NN	O	consent	dobj	3	SENT_47	[p3l1345t1676r1609b1729],
7	to	TO	O	to	_	0	SENT_47	[p3l1639t1676r1703b1729],
8	the	DT	O	the	det	9	SENT_47	[p3l1733t1671r1844b1729],
9	protocol	NN	O	protocol	prep_to	3	SENT_47	[p3l1874t1671r2150b1743],
10	approved	VBN	O	approve	partmod	9	SENT_47	[p3l12t1755r331b1827],
11	by	IN	O	by	_	0	SENT_47	[p3l355t1755r438b1827],
12	the	DT	O	the	det	20	SENT_47	[p3l463t1755r574b1813],
13	University	NNP	ORGANIZATION	University	dep	20	SENT_47	[p3l601t1756r973b1827],
14	of	IN	ORGANIZATION	of	_	0	SENT_47	[p3l999t1755r1067b1813],
15	Iowa	NNP	ORGANIZATION	Iowa	nn	18	SENT_47	[p3l1087t1756r1254b1813],
16	Human	NNP	ORGANIZATION	Human	nn	18	SENT_47	[p3l1280t1756r1542b1813],
17	Subjects	NNPS	ORGANIZATION	Subjects	nn	18	SENT_47	[p3l1572t1755r1860b1827],
18	Institutional	NNP	ORGANIZATION	Institutional	prep_of	13	SENT_47	[p3l1887t1756r2148b1813, p3l9t1840r210b1897],
19	Review	NNP	ORGANIZATION	Review	nn	20	SENT_47	[p3l229t1841r480b1897],
20	Board	NNP	ORGANIZATION	Board	agent	10	SENT_47	[p3l497t1839r723b1897],
21	.	.	O	.	_	0	SENT_47	[p3l497t1839r723b1897],

1	The	DT	O	the	det	3	SENT_48	[p3l746t1839r878b1897],
2	consent	NN	O	consent	nn	3	SENT_48	[p3l897t1845r1161b1897],
3	process	NN	O	process	nsubj	5	SENT_48	[p3l1179t1859r1432b1912],
4	was	VBD	O	be	cop	5	SENT_48	[p3l1450t1859r1583b1897],
5	ongoing	JJ	O	ongoing	_	0	SENT_48	[p3l1603t1841r1877b1912],
6	and	CC	O	and	_	0	SENT_48	[p3l1894t1839r2022b1897],
7	the	DT	O	the	det	8	SENT_48	[p3l2039t1839r2150b1897],
8	subjects	NNS	O	subject	nsubjpass	11	SENT_48	[p3l11t1923r288b1995],
9	were	VBD	O	be	auxpass	11	SENT_48	[p3l308t1943r475b1981],
10	regularly	RB	O	regularly	advmod	11	SENT_48	[p3l495t1923r818b1995],
11	reminded	VBN	O	remind	conj_and	5	SENT_48	[p3l837t1923r1169b1981],
12	throughout	IN	O	throughout	_	0	SENT_48	[p3l1189t1923r1583b1995],
13	study	NN	O	study	prep_throughout	11	SENT_48	[p3l1606t1923r1797b1995],
14	that	IN	O	that	complm	18	SENT_48	[p3l1816t1923r1961b1981],
15	their	PRP$	O	they	poss	16	SENT_48	[p3l1981t1923r2151b1981],
16	participation	NN	O	participation	nsubj	18	SENT_48	[p3l9t2008r459b2079],
17	was	VBD	O	be	cop	18	SENT_48	[p3l481t2027r614b2065],
18	voluntary	JJ	O	voluntary	ccomp	11	SENT_48	[p3l635t2007r992b2079],
19	.	.	O	.	_	0	SENT_48	[p3l635t2007r992b2079],

1	5HT2CR	NN	O	5ht2cr	_	0	SENT_49	[p3l417t2154r563b2180],
2	—	CD	NUMBER	—	num	4	SENT_49	[p3l576t2154r718b2182],
3	759C/T	NNP	O	759C/T	nn	4	SENT_49	[p3l576t2154r718b2182],
4	Polymorphism	NN	O	polymorphism	dep	1	SENT_49	[p3l729t2154r989b2186],
5	and	CC	O	and	_	0	SENT_49	[p3l1000t2154r1066b2180],
6	Weight	NNP	O	Weight	nn	7	SENT_49	[p3l1076t2154r1200b2186],
7	Gain	NNP	O	Gain	conj_and	4	SENT_49	[p3l1213t2154r1296b2180],
8	With	IN	O	with	_	0	SENT_49	[p3l1307t2154r1391b2180],
9	Olanzapine	NNP	O	Olanzapine	prep_with	7	SENT_49	[p3l1402t2154r1604b2186],
10	77	CD	NUMBER	77	num	9	SENT_49	[p3l1706t2155r1743b2180],

1	Olanzapine	NNP	O	Olanzapine	nn	2	SENT_50	[p3l706t2292r1151b2364],
2	Dosing	NNP	O	Dosing	_	0	SENT_50	[p3l1177t2292r1452b2364],

1	Subjects	NNS	O	subject	nsubjpass	12	SENT_51	[p3l89t2416r376b2488],
2	were	VBD	O	be	auxpass	3	SENT_51	[p3l410t2436r575b2474],
3	started	VBN	O	start	_	0	SENT_51	[p3l611t2416r856b2474],
4	on	IN	O	on	_	0	SENT_51	[p3l890t2436r970b2474],
5	olanzapine	NN	O	olanzapine	prep_on	3	SENT_51	[p3l1004t2416r1379b2488],
6	at	IN	O	at	_	0	SENT_51	[p3l1415t2422r1481b2474],
7	the	DT	O	the	det	9	SENT_51	[p3l1513t2416r1624b2474],
8	ﬁrst	JJ	O	ﬁrst	amod	9	SENT_51	[p3l1658t2416r1799b2474],
9	visit	NN	O	visit	prep_at	3	SENT_51	[p3l1831t2417r1982b2474],
10	and	CC	O	and	_	0	SENT_51	[p3l2017t2416r2144b2474],
11	then	RB	O	then	advmod	12	SENT_51	[p3l10t2500r168b2558],
12	titrated	VBD	O	titrate	conj_and	3	SENT_51	[p3l188t2500r453b2558],
13	to	TO	O	to	_	0	SENT_51	[p3l472t2506r536b2558],
14	a	DT	O	a	det	16	SENT_51	[p3l559t2520r597b2558],
15	ﬁxed	JJ	O	ﬁxed	amod	16	SENT_51	[p3l616t2500r782b2558],
16	dose	NN	O	dose	prep_to	12	SENT_51	[p3l803t2500r952b2558],
17	ranging	VBG	O	range	xcomp	12	SENT_51	[p3l972t2501r1247b2572],
18	from	IN	O	from	_	0	SENT_51	[p3l1264t2500r1425b2558],
19	7.5	CD	NUMBER	7.5	number	21	SENT_51	[p3l1448t2502r1545b2558],
20	to	TO	NUMBER	to	dep	21	SENT_51	[p3l1566t2506r1630b2558],
21	20	CD	NUMBER	20	num	22	SENT_51	[p3l1653t2503r1730b2558],
22	mg/day	NN	O	mg/day	prep_from	17	SENT_51	[p3l1752t2500r2021b2572],
23	.	.	O	.	_	0	SENT_51	[p3l1752t2500r2021b2572],

1	An	DT	O	a	det	3	SENT_52	[p3l2043t2501r2143b2557],
2	olanzapine	NN	O	olanzapine	nn	3	SENT_52	[p3l11t2584r386b2656],
3	level	NN	O	level	nsubjpass	5	SENT_52	[p3l416t2584r577b2642],
4	was	VBD	O	be	auxpass	5	SENT_52	[p3l605t2604r738b2642],
5	obtained	VBN	O	obtain	conj_and	5	SENT_52	[p3l768t2584r1066b2642],
6	after	IN	O	after	_	0	SENT_52	[p3l1097t2584r1260b2642],
7	1	CD	DURATION	1	num	8	SENT_52	[p3l1295t2586r1324b2641],
8	week	NN	NUMBER	week	prep_after	5	SENT_52	[p3l1356t2584r1535b2642],
9	and	CC	O	and	_	0	SENT_52	[p3l1565t2584r1692b2642],
10	at	IN	O	at	_	0	SENT_52	[p3l1722t2589r1789b2642],
11	endpoint	NN	O	endpoint	prep_at	5	SENT_52	[p3l1818t2584r2139b2656],
12	.	.	O	.	_	0	SENT_52	[p3l1818t2584r2139b2656],

1	Dosage	NN	O	dosage	nn	2	SENT_53	[p3l11t2669r260b2740],
2	adjustments	NNS	O	adjustment	nsubjpass	4	SENT_53	[p3l306t2668r733b2740],
3	were	VBD	O	be	auxpass	4	SENT_53	[p3l777t2688r943b2726],
4	performed	VBN	O	perform	dep	13	SENT_53	[p3l987t2668r1345b2740],
5	to	TO	O	to	aux	6	SENT_53	[p3l1388t2673r1452b2726],
6	assure	VB	O	assure	xcomp	4	SENT_53	[p3l1499t2688r1723b2726],
7	olanzapine	NN	O	olanzapine	nn	9	SENT_53	[p3l1768t2668r2143b2740],
8	plasma	NN	O	plasma	nn	9	SENT_53	[p3l10t2753r261b2825],
9	concentrations	NNS	O	concentration	dobj	6	SENT_53	[p3l300t2754r808b2811],
10	were	VBD	O	be	cop	13	SENT_53	[p3l849t2772r1014b2810],
11	greater	JJR	O	greater	mwe	12	SENT_53	[p3l1054t2758r1307b2825],
12	than	IN	O	than	quantmod	13	SENT_53	[p3l1345t2753r1507b2810],
13	9.3	CD	NUMBER	9.3	_	0	SENT_53	[p3l1548t2755r1646b2811],
14	ng/ml	NN	O	ng/ml	nn	16	SENT_53	[p3l1689t2753r1885b2825],
15	[	CD	NUMBER	[	num	16	SENT_53	[p3l1929t2754r2144b2825],
16	Perry	NNP	PERSON	Perry	dep	13	SENT_53	[p3l1929t2754r2144b2825],
17	et	FW	O	et	nn	18	SENT_53	[p3l12t2842r75b2894],
18	al.	FW	O	al.	nsubj	13	SENT_53	[p3l93t2837r192b2907],
19	,	,	O	,	_	0	SENT_53	[p3l93t2837r192b2907],
20	1997	CD	DATE	1997	num	21	SENT_53	[p3l219t2838r419b2902],
21	]	NN	O	]	appos	18	SENT_53	[p3l219t2838r419b2902],
22	.	.	O	.	_	0	SENT_53	[p3l219t2838r419b2902],

1	Olanzapine	NNP	O	Olanzapine	nsubjpass	3	SENT_54	[p3l442t2837r836b2909],
2	was	VBD	O	be	auxpass	3	SENT_54	[p3l853t2856r986b2894],
3	continued	VBN	O	continue	_	0	SENT_54	[p3l1003t2837r1345b2895],
4	for	IN	O	for	_	0	SENT_54	[p3l1361t2837r1456b2894],
5	a	DT	O	a	det	6	SENT_54	[p3l1474t2856r1511b2894],
6	total	NN	O	total	prep_for	3	SENT_54	[p3l1527t2837r1686b2895],
7	of	IN	O	of	_	0	SENT_54	[p3l1703t2837r1771b2894],
8	6	CD	DURATION	6	num	9	SENT_54	[p3l1780t2839r1817b2894],
9	weeks	NNS	NUMBER	week	prep_of	6	SENT_54	[p3l1834t2837r2063b2907],
10	,	,	O	,	_	0	SENT_54	[p3l1834t2837r2063b2907],
11	of	IN	O	of	_	0	SENT_54	[p3l2084t2837r2152b2894],
12	which	WDT	O	which	rel	15	SENT_54	[p3l10t2921r217b2978],
13	4	CD	DURATION	4	num	14	SENT_54	[p3l239t2923r277b2977],
14	weeks	NNS	NUMBER	week	nsubj	15	SENT_54	[p3l299t2921r511b2978],
15	was	VBD	O	be	rcmod	9	SENT_54	[p3l532t2940r665b2978],
16	at	IN	O	at	_	0	SENT_54	[p3l689t2926r755b2978],
17	a	DT	O	a	det	19	SENT_54	[p3l779t2940r817b2978],
18	ﬁxed	JJ	O	ﬁxed	amod	19	SENT_54	[p3l838t2921r1004b2978],
19	dose	NN	O	dose	prep_at	15	SENT_54	[p3l1026t2921r1192b2978],
20	.	.	O	.	_	0	SENT_54	[p3l1026t2921r1192b2978],

1	Genotyping	VBG	O	genotype	_	0	SENT_55	[p3l849t3100r1309b3173],

1	DNA	NN	O	dna	nsubjpass	3	SENT_56	[p4l87t33r261b91],
2	was	VBD	O	be	auxpass	3	SENT_56	[p4l288t53r421b91],
3	analyzed	VBN	O	analyze	_	0	SENT_56	[p4l453t33r760b105],
4	for	IN	O	for	_	0	SENT_56	[p4l789t33r884b91],
5	the	DT	O	the	det	8	SENT_56	[p4l913t33r1023b91],
6	-759	CD	NUMBER	-759	num	8	SENT_56	[p4l1058t35r1233b91],
7	C/T	NN	O	c/t	nn	8	SENT_56	[p4l1266t33r1387b97],
8	polymorphism	NN	O	polymorphism	prep_for	3	SENT_56	[p4l1417t33r1913b105],
9	of	IN	O	of	_	0	SENT_56	[p4l1943t33r2011b91],
10	the	DT	O	the	det	12	SENT_56	[p4l2032t33r2143b91],
11	5HT2C	NN	O	5ht2c	nn	12	SENT_56	[p4l13t117r258b175],
12	receptor	NN	O	receptor	prep_of	8	SENT_56	[p4l288t122r573b189],
13	using	VBG	O	use	xcomp	3	SENT_56	[p4l601t118r795b189],
14	methods	NNS	O	method	iobj	13	SENT_56	[p4l821t117r1114b175],
15	by	IN	O	by	_	0	SENT_56	[p4l1142t117r1224b189],
16	Yuan	NNP	O	Yuan	prep_by	14	SENT_56	[p4l1250t118r1438b175],
17	et	FW	O	et	nn	19	SENT_56	[p4l1468t122r1532b175],
18	al.	FW	O	al.	nn	19	SENT_56	[p4l1563t117r1640b175],
19	[	FW	O	[	dobj	13	SENT_56	[p4l1678t118r1905b182],
20	2000	CD	DATE	2000	num	21	SENT_56	[p4l1678t118r1905b182],
21	]	CD	NUMBER	]	dobj	13	SENT_56	[p4l1678t118r1905b182],
22	.	.	O	.	_	0	SENT_56	[p4l1678t118r1905b182],

1	Using	VBG	O	use	partmod	16	SENT_57	[p4l1939t118r2146b189],
2	PCR	NN	O	pcr	dobj	1	SENT_57	[p4l11t202r184b272],
3	,	,	O	,	_	0	SENT_57	[p4l11t202r184b272],
4	a	DT	O	a	det	5	SENT_57	[p4l209t221r247b259],
5	fragment	NN	O	fragment	nsubjpass	16	SENT_57	[p4l265t202r585b274],
6	from	IN	O	from	_	0	SENT_57	[p4l604t202r765b259],
7	-855	CD	NUMBER	-855	num	9	SENT_57	[p4l788t204r962b260],
8	to	TO	NUMBER	to	dep	9	SENT_57	[p4l983t207r1047b259],
9	-634	CD	NUMBER	-634	prep_from	5	SENT_57	[p4l1071t204r1247b259],
10	of	IN	O	of	_	0	SENT_57	[p4l1267t202r1335b259],
11	the	DT	O	the	det	12	SENT_57	[p4l1345t202r1456b259],
12	receptor	NN	O	receptor	poss	14	SENT_57	[p4l1475t202r1810b274],
13	’s	POS	O	’s	_	0	SENT_57	[p4l1475t202r1810b274],
14	sequence	NN	O	sequence	prep_of	9	SENT_57	[p4l1832t221r2143b274],
15	was	VBD	O	be	auxpass	16	SENT_57	[p4l10t305r143b343],
16	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_57	[p4l170t286r508b358],
17	.	.	O	.	_	0	SENT_57	[p4l170t286r508b358],

1	This	DT	O	this	det	2	SENT_58	[p4l537t286r690b343],
2	fragment	NN	O	fragment	nsubjpass	5	SENT_58	[p4l714t286r1034b358],
3	was	VBD	O	be	auxpass	5	SENT_58	[p4l1058t305r1191b344],
4	then	RB	O	then	advmod	5	SENT_58	[p4l1215t286r1372b343],
5	digested	VBN	O	digest	_	0	SENT_58	[p4l1398t286r1685b358],
6	with	IN	O	with	_	0	SENT_58	[p4l1709t286r1865b344],
7	Aci	NN	O	acus	nn	8	SENT_58	[p4l1883t286r1997b344],
8	I	NN	O	i	prep_with	5	SENT_58	[p4l2020t287r2055b342],
9	in	IN	O	in	mark	12	SENT_58	[p4l2077t287r2144b342],
10	order	NN	O	order	dep	12	SENT_58	[p4l11t370r195b427],
11	to	TO	O	to	aux	12	SENT_58	[p4l217t375r280b427],
12	determine	VB	O	determine	purpcl	5	SENT_58	[p4l305t370r658b427],
13	each	DT	O	each	det	14	SENT_58	[p4l682t370r838b427],
14	subject	JJ	O	subject	poss	16	SENT_58	[p4l864t370r1155b442],
15	’s	POS	O	’s	_	0	SENT_58	[p4l864t370r1155b442],
16	genotype	NN	O	genotype	dobj	12	SENT_58	[p4l1178t375r1506b442],
17	.	.	O	.	_	0	SENT_58	[p4l1178t375r1506b442],

1	In	IN	O	in	_	0	SENT_59	[p4l1534t371r1607b426],
2	subjects	NNS	O	subject	prep_in	16	SENT_59	[p4l1633t370r1908b442],
3	where	WRB	O	where	advmod	5	SENT_59	[p4l1931t370r2143b427],
4	there	EX	O	there	expl	5	SENT_59	[p4l10t454r192b511],
5	was	VBD	O	be	rcmod	2	SENT_59	[p4l225t473r358b511],
6	a	DT	O	a	det	7	SENT_59	[p4l393t473r430b511],
7	question	NN	O	question	nsubj	5	SENT_59	[p4l464t455r757b526],
8	about	IN	O	about	_	0	SENT_59	[p4l792t454r984b511],
9	genotype	NN	O	genotype	prep_about	7	SENT_59	[p4l1016t459r1344b526],
10	,	,	O	,	_	0	SENT_59	[p4l1016t459r1344b526],
11	the	DT	O	the	det	13	SENT_59	[p4l1381t454r1492b511],
12	PCR	NN	O	pcr	nn	13	SENT_59	[p4l1525t454r1682b511],
13	product	NN	O	product	nsubjpass	16	SENT_59	[p4l1713t454r1979b526],
14	was	VBD	O	be	auxpass	16	SENT_59	[p4l2010t473r2143b511],
15	directly	RB	O	directly	advmod	16	SENT_59	[p4l12t537r275b610],
16	sequenced	VBN	O	sequence	_	0	SENT_59	[p4l303t537r675b610],
17	.	.	O	.	_	0	SENT_59	[p4l303t537r675b610],

1	The	DT	O	the	det	2	SENT_60	[p4l706t537r838b595],
2	results	NNS	O	result	nsubjpass	8	SENT_60	[p4l865t537r1102b595],
3	of	IN	O	of	_	0	SENT_60	[p4l1131t538r1199b595],
4	the	DT	O	the	det	5	SENT_60	[p4l1218t537r1328b595],
5	restriction	NN	O	restriction	prep_of	2	SENT_60	[p4l1355t539r1716b595],
6	digest	VB	O	digest	dep	5	SENT_60	[p4l1745t537r1951b610],
7	were	VBD	O	be	auxpass	8	SENT_60	[p4l1977t557r2143b595],
8	run	VBN	O	run	_	0	SENT_60	[p4l10t641r135b679],
9	on	IN	O	on	_	0	SENT_60	[p4l184t641r265b679],
10	a	DT	O	a	det	14	SENT_60	[p4l316t641r354b679],
11	10	CD	PERCENT	10	number	12	SENT_60	[p4l408t624r544b679],
12	%	NN	PERCENT	%	amod	14	SENT_60	[p4l408t624r544b679],
13	polyacrylamide	NN	O	polyacrylamide	nn	14	SENT_60	[p4l593t621r1123b694],
14	gel	NN	O	gel	prep_on	8	SENT_60	[p4l1174t622r1273b694],
15	stained	VBN	O	stain	partmod	14	SENT_60	[p4l1324t621r1576b679],
16	with	IN	O	with	_	0	SENT_60	[p4l1624t621r1779b679],
17	ethidium	NN	O	ethidium	nn	18	SENT_60	[p4l1830t621r2144b679],
18	bromide	NN	O	bromide	prep_with	15	SENT_60	[p4l9t705r309b763],
19	.	.	O	.	_	0	SENT_60	[p4l9t705r309b763],

1	All	DT	O	all	det	3	SENT_61	[p4l330t705r432b762],
2	genotyping	VBG	O	genotype	amod	3	SENT_61	[p4l450t706r837b777],
3	procedures	NNS	O	procedure	nsubjpass	5	SENT_61	[p4l852t705r1232b777],
4	were	VBD	O	be	auxpass	5	SENT_61	[p4l1251t725r1417b763],
5	conducted	VBN	O	conduct	_	0	SENT_61	[p4l1436t705r1785b763],
6	after	IN	O	after	_	0	SENT_61	[p4l1805t705r1969b763],
7	each	DT	O	each	det	8	SENT_61	[p4l1987t705r2143b763],
8	subject	JJ	O	subject	prep_after	5	SENT_61	[p4l13t789r254b861],
9	completed	VBN	O	complete	partmod	8	SENT_61	[p4l288t789r638b861],
10	the	DT	O	the	det	11	SENT_61	[p4l671t789r782b847],
11	study	NN	O	study	dobj	9	SENT_61	[p4l818t789r1008b861],
12	to	TO	O	to	_	0	SENT_61	[p4l1040t795r1104b847],
13	blind	JJ	O	blind	amod	15	SENT_61	[p4l1137t789r1315b847],
14	the	DT	O	the	det	15	SENT_61	[p4l1347t789r1458b847],
15	raters	NNS	O	rater	prep_to	9	SENT_61	[p4l1492t795r1700b847],
16	to	TO	O	to	_	0	SENT_61	[p4l1734t795r1798b847],
17	genotype	NN	O	genotype	nn	18	SENT_61	[p4l1832t795r2143b861],
18	status	NN	O	status	prep_to	15	SENT_61	[p4l13t878r240b931],
19	.	.	O	.	_	0	SENT_61	[p4l13t878r240b931],

1	Statistical	JJ	O	statistical	amod	2	SENT_62	[p4l701t1053r1099b1111],
2	Analysis	NN	O	analysis	_	0	SENT_62	[p4l1122t1053r1455b1125],

1	A	DT	O	a	det	3	SENT_63	[p4l84t1178r141b1234],
2	chi-square	JJ	O	chi-square	amod	3	SENT_63	[p4l173t1177r534b1250],
3	analysis	NN	O	analysis	nsubj	22	SENT_63	[p4l572t1177r854b1250],
4	(	CD	NUMBER	(	num	3	SENT_63	[p4l892t1177r1189b1243],
5	Fisher	NNP	PERSON	Fisher	poss	9	SENT_63	[p4l892t1177r1189b1243],
6	’s	POS	O	’s	_	0	SENT_63	[p4l892t1177r1189b1243],
7	exact	JJ	O	exact	amod	9	SENT_63	[p4l1224t1183r1404b1235],
8	test	NN	O	test	nn	9	SENT_63	[p4l1438t1178r1589b1243],
9	)	NN	O	)	nsubjpass	11	SENT_63	[p4l1438t1178r1589b1243],
10	was	VBD	O	be	auxpass	11	SENT_63	[p4l1627t1197r1759b1235],
11	conducted	VBN	O	conduct	rcmod	3	SENT_63	[p4l1795t1177r2144b1235],
12	comparing	VBG	O	compare	xcomp	11	SENT_63	[p4l11t1262r379b1333],
13	the	DT	O	the	det	14	SENT_63	[p4l420t1261r530b1319],
14	distribution	NN	O	distribution	dobj	12	SENT_63	[p4l575t1261r984b1319],
15	of	IN	O	of	_	0	SENT_63	[p4l1029t1261r1097b1319],
16	T	NN	O	t	nn	19	SENT_63	[p4l1132t1262r1180b1318],
17	and	CC	O	and	_	0	SENT_63	[p4l1226t1261r1353b1319],
18	C	NN	O	c	nn	19	SENT_63	[p4l1398t1261r1447b1319],
19	alleles	NNS	O	allele	prep_of	14	SENT_63	[p4l1493t1261r1711b1319],
20	in	IN	O	in	_	0	SENT_63	[p4l1755t1262r1822b1318],
21	subjects	NNS	O	subject	prep_in	12	SENT_63	[p4l1868t1261r2143b1333],
22	grouped	VBN	O	group	_	0	SENT_63	[p4l11t1345r292b1417],
23	as	IN	O	as	_	0	SENT_63	[p4l324t1365r395b1403],
24	gaining	VBG	O	gain	prepc_as	22	SENT_63	[p4l426t1346r690b1417],
25	more	JJR	O	more	advmod	24	SENT_63	[p4l717t1365r891b1403],
26	or	CC	O	or	_	0	SENT_63	[p4l922t1365r991b1403],
27	less	JJR	O	less	conj_or	25	SENT_63	[p4l1021t1345r1148b1403],
28	than	IN	O	than	_	0	SENT_63	[p4l1179t1345r1340b1403],
29	5	CD	NUMBER	5	prep_than	24	SENT_63	[p4l1372t1347r1427b1416],
30	,	,	O	,	_	0	SENT_63	[p4l1372t1347r1427b1416],
31	7	CD	NUMBER	7	prep_than	24	SENT_63	[p4l1464t1348r1517b1416],
32	,	,	O	,	_	0	SENT_63	[p4l1464t1348r1517b1416],
33	and	CC	PERCENT	and	_	0	SENT_63	[p4l1554t1345r1681b1403],
34	10	CD	PERCENT	10	num	35	SENT_63	[p4l1717t1348r1852b1403],
35	%	NN	PERCENT	%	conj_and	29	SENT_63	[p4l1717t1348r1852b1403],
36	of	IN	O	of	_	0	SENT_63	[p4l1885t1345r1953b1403],
37	their	PRP$	O	they	poss	39	SENT_63	[p4l1975t1345r2144b1403],
38	baseline	NN	O	baseline	nn	39	SENT_63	[p4l9t1429r295b1487],
39	weight	NN	O	weight	prep_of	35	SENT_63	[p4l319t1429r554b1501],
40	during	IN	O	during	_	0	SENT_63	[p4l578t1429r812b1501],
41	treatment	NN	O	treatment	prep_during	24	SENT_63	[p4l832t1434r1181b1487],
42	with	IN	O	with	_	0	SENT_63	[p4l1204t1429r1360b1487],
43	olanzapine	NN	O	olanzapine	prep_with	41	SENT_63	[p4l1385t1429r1776b1501],
44	.	.	O	.	_	0	SENT_63	[p4l1385t1429r1776b1501],

1	A	DT	O	a	det	5	SENT_64	[p4l1803t1429r1860b1486],
2	P-value	JJ	O	p-value	amod	5	SENT_64	[p4l1876t1429r2143b1487],
3	less	JJR	O	less	mwe	4	SENT_64	[p4l11t1513r138b1571],
4	than	IN	O	than	quantmod	5	SENT_64	[p4l177t1513r338b1571],
5	0.05	CD	NUMBER	0.05	nsubjpass	7	SENT_64	[p4l380t1515r520b1571],
6	was	VBD	O	be	auxpass	7	SENT_64	[p4l560t1533r693b1571],
7	considered	VBN	O	consider	_	0	SENT_64	[p4l734t1513r1103b1571],
8	statistically	RB	O	statistically	advmod	9	SENT_64	[p4l1144t1513r1549b1585],
9	signiﬁcant	JJ	O	signiﬁcant	acomp	7	SENT_64	[p4l1590t1513r1969b1585],
10	.	.	O	.	_	0	SENT_64	[p4l1590t1513r1969b1585],

1	Differences	NNS	O	difference	nsubjpass	8	SENT_65	[p4l2014t1513r2142b1570, p4l11t1598r295b1655],
2	between	IN	O	between	_	0	SENT_65	[p4l322t1598r610b1655],
3	group	NN	O	group	nn	4	SENT_65	[p4l639t1616r837b1670],
4	means	NNS	O	means	prep_between	1	SENT_65	[p4l866t1617r1090b1655],
5	and	CC	O	and	_	0	SENT_65	[p4l1121t1598r1248b1655],
6	socio-demographics	NNS	O	socio-demographic	prep_between	1	SENT_65	[p4l1277t1598r1949b1670],
7	were	VBD	O	be	auxpass	8	SENT_65	[p4l1977t1617r2143b1655],
8	determined	VBN	O	determine	_	0	SENT_65	[p4l12t1682r409b1739],
9	by	IN	O	by	_	0	SENT_65	[p4l425t1682r508b1754],
10	the	DT	O	the	det	11	SENT_65	[p4l525t1682r636b1739],
11	use	NN	O	use	agent	8	SENT_65	[p4l653t1701r770b1739],
12	of	IN	O	of	_	0	SENT_65	[p4l790t1682r858b1739],
13	the	DT	O	the	det	14	SENT_65	[p4l868t1682r979b1739],
14	Student	NN	O	student	poss	17	SENT_65	[p4l1000t1682r1324b1739],
15	’s	POS	O	’s	_	0	SENT_65	[p4l1000t1682r1324b1739],
16	unpaired	JJ	O	unpaired	amod	17	SENT_65	[p4l1343t1682r1658b1754],
17	t-tests	NNS	O	t-test	prep_of	11	SENT_65	[p4l1676t1687r1891b1739],
18	as	RB	O	as	_	0	SENT_65	[p4l1912t1701r1983b1739],
19	well	RB	O	well	_	0	SENT_65	[p4l2002t1682r2144b1739],
20	as	IN	O	as	_	0	SENT_65	[p4l13t1785r84b1823],
21	change	NN	O	change	nn	22	SENT_65	[p4l104t1766r348b1838],
22	scores	NNS	O	score	conj_and	11	SENT_65	[p4l370t1785r578b1823],
23	for	IN	O	for	_	0	SENT_65	[p4l598t1766r692b1823],
24	the	DT	O	the	det	25	SENT_65	[p4l712t1766r822b1823],
25	BPRS	NN	ORGANIZATION	bpr	prep_for	22	SENT_65	[p4l841t1766r1044b1823],
26	and	CC	O	and	_	0	SENT_65	[p4l1068t1766r1195b1823],
27	SANS	NN	O	san	conj_and	25	SENT_65	[p4l1217t1766r1439b1823],
28	.	.	O	.	_	0	SENT_65	[p4l1217t1766r1439b1823],

1	Change	NNP	O	Change	nn	2	SENT_66	[p4l1465t1766r1728b1838],
2	scores	NNS	O	score	nsubjpass	4	SENT_66	[p4l1750t1785r1957b1823],
3	were	VBD	O	be	auxpass	4	SENT_66	[p4l1977t1785r2143b1823],
4	based	VBN	O	base	_	0	SENT_66	[p4l9t1850r208b1907],
5	on	IN	O	on	_	0	SENT_66	[p4l230t1869r310b1907],
6	the	DT	O	the	det	8	SENT_66	[p4l332t1850r442b1907],
7	last	JJ	O	last	amod	8	SENT_66	[p4l464t1850r591b1907],
8	observation	NN	O	observation	prep_on	4	SENT_66	[p4l613t1850r1015b1907],
9	carried	VBD	O	carry	partmod	8	SENT_66	[p4l1038t1850r1282b1907],
10	forward	RB	O	forward	advmod	9	SENT_66	[p4l1304t1850r1577b1907],
11	method	NN	O	method	dobj	9	SENT_66	[p4l1598t1850r1873b1907],
12	.	.	O	.	_	0	SENT_66	[p4l1598t1850r1873b1907],

1	RESULTS	NNS	O	result	_	0	SENT_67	[p4l882t2062r1269b2120],

1	A	DT	O	a	det	2	SENT_68	[p4l84t2187r141b2243],
2	total	NN	O	total	nsubjpass	8	SENT_68	[p4l183t2187r342b2244],
3	of	IN	O	of	_	0	SENT_68	[p4l387t2187r455b2244],
4	42	CD	NUMBER	42	num	6	SENT_68	[p4l493t2189r571b2243],
5	Caucasian	JJ	MISC	caucasian	amod	6	SENT_68	[p4l620t2187r980b2244],
6	subjects	NNS	O	subject	prep_of	2	SENT_68	[p4l1027t2187r1303b2259],
7	were	VBD	O	be	auxpass	8	SENT_68	[p4l1347t2206r1513b2244],
8	included	VBN	O	include	_	0	SENT_68	[p4l1559t2187r1855b2244],
9	in	IN	O	in	_	0	SENT_68	[p4l1900t2188r1967b2243],
10	this	DT	O	this	det	11	SENT_68	[p4l2012t2187r2143b2244],
11	analysis	NN	O	analysis	prep_in	8	SENT_68	[p4l13t2271r313b2343],
12	,	,	O	,	_	0	SENT_68	[p4l13t2271r313b2343],
13	of	IN	O	of	_	0	SENT_68	[p4l333t2271r400b2328],
14	which	WDT	O	which	rel	17	SENT_68	[p4l407t2271r614b2328],
15	eight	CD	NUMBER	eight	nsubj	17	SENT_68	[p4l631t2271r805b2343],
16	were	VBD	O	be	cop	17	SENT_68	[p4l820t2290r986b2328],
17	female	JJ	O	female	rcmod	11	SENT_68	[p4l1002t2271r1249b2328],
18	.	.	O	.	_	0	SENT_68	[p4l1002t2271r1249b2328],

1	There	EX	O	there	expl	2	SENT_69	[p4l1269t2271r1472b2328],
2	were	VBD	O	be	_	0	SENT_69	[p4l1488t2290r1654b2328],
3	no	DT	O	no	det	4	SENT_69	[p4l1670t2290r1750b2328],
4	differences	NNS	O	difference	nsubj	2	SENT_69	[p4l1767t2271r2143b2328],
5	in	IN	O	in	_	0	SENT_69	[p4l11t2356r78b2411],
6	socio-demographics	NNS	O	socio-demographic	prep_in	4	SENT_69	[p4l99t2354r770b2427],
7	or	CC	O	or	_	0	SENT_69	[p4l791t2374r860b2412],
8	psychopathology	NN	O	psychopathology	prep_in	4	SENT_69	[p4l878t2354r1455b2427],
9	between	IN	O	between	_	0	SENT_69	[p4l1472t2354r1760b2412],
10	the	DT	O	the	det	11	SENT_69	[p4l1779t2354r1890b2412],
11	groups	NNS	O	group	prep_between	4	SENT_69	[p4l1910t2373r2143b2427],
12	of	IN	O	of	_	0	SENT_69	[p4l11t2439r79b2496],
13	subjects	NNS	O	subject	prep_of	11	SENT_69	[p4l107t2438r382b2510],
14	with	IN	O	with	_	0	SENT_69	[p4l416t2438r572b2496],
15	the	DT	O	the	det	17	SENT_69	[p4l606t2438r717b2496],
16	Various	JJ	O	various	amod	17	SENT_69	[p4l750t2440r1007b2496],
17	genotypes	NNS	O	genotype	prep_with	13	SENT_69	[p4l1042t2444r1387b2511],
18	at	IN	O	at	_	0	SENT_69	[p4l1424t2444r1490b2496],
19	baseline	NN	O	baseline	prep_at	17	SENT_69	[p4l1523t2438r1808b2496],
20	with	IN	O	with	_	0	SENT_69	[p4l1842t2438r1998b2496],
21	the	DT	O	the	det	22	SENT_69	[p4l2032t2438r2143b2496],
22	exception	NN	O	exception	nsubj	27	SENT_69	[p4l12t2523r338b2594],
23	of	IN	O	of	_	0	SENT_69	[p4l358t2522r425b2580],
24	the	DT	O	the	det	26	SENT_69	[p4l434t2522r545b2580],
25	less	JJR	O	less	amod	26	SENT_69	[p4l564t2522r692b2580],
26	women	NNS	O	woman	prep_of	22	SENT_69	[p4l710t2542r955b2580],
27	being	VBG	O	be	prepc_with	2	SENT_69	[p4l972t2522r1164b2594],
28	in	IN	O	in	_	0	SENT_69	[p4l1180t2523r1247b2579],
29	the	DT	O	the	det	32	SENT_69	[p4l1265t2522r1375b2580],
30	C	NN	O	c	nn	32	SENT_69	[p4l1395t2522r1444b2580],
31	allele	NN	O	allele	nn	32	SENT_69	[p4l1465t2522r1649b2580],
32	group	NN	O	group	prep_in	27	SENT_69	[p4l1667t2541r1866b2594],
33	(	CD	NUMBER	(	number	34	SENT_69	[p4l1888t2523r1947b2587],
34	3	CD	NUMBER	3	num	35	SENT_69	[p4l1888t2523r1947b2587],
35	Vs.	NN	O	v.	dep	32	SENT_69	[p4l1966t2542r2057b2580],
36	5	CD	NUMBER	5	num	37	SENT_69	[p4l2081t2523r2141b2588],
37	)	NN	O	)	dep	32	SENT_69	[p4l2081t2523r2141b2588],
38	(	CD	NUMBER	(	num	39	SENT_69	[p4l14t2607r152b2671],
39	P	NN	O	p	dep	37	SENT_69	[p4l14t2607r152b2671],
40	:	:	O	:	_	0	SENT_69	[p4l14t2607r152b2671],
41	0.01	CD	NUMBER	0.01	num	42	SENT_69	[p4l172t2607r355b2671],
42	)	NN	O	)	dep	32	SENT_69	[p4l172t2607r355b2671],
43	.	.	O	.	_	0	SENT_69	[p4l172t2607r355b2671],

1	The	DT	O	the	det	4	SENT_70	[p4l387t2606r519b2664],
2	mean	NN	O	mean	nn	4	SENT_70	[p4l548t2626r737b2664],
3	endpoint	NN	O	endpoint	nn	4	SENT_70	[p4l766t2606r1071b2678],
4	dose	NN	O	dose	nsubj	8	SENT_70	[p4l1099t2606r1248b2664],
5	of	IN	O	of	_	0	SENT_70	[p4l1277t2606r1345b2664],
6	olanzapine	NN	O	olanzapine	prep_of	4	SENT_70	[p4l1365t2606r1740b2678],
7	was	VBD	O	be	cop	8	SENT_70	[p4l1768t2626r1901b2664],
8	12.8	CD	NUMBER	12.8	_	0	SENT_70	[p4l1935t2609r2072b2664],
9	i	FW	O	i	nsubj	19	SENT_70	[p4l2091t2612r2141b2663],
10	3.12	CD	NUMBER	3.12	num	11	SENT_70	[p4l12t2692r152b2748],
11	mg/day	NN	O	mg/day	dep	9	SENT_70	[p4l176t2690r429b2762],
12	and	CC	O	and	_	0	SENT_70	[p4l453t2690r580b2748],
13	the	DT	O	the	det	14	SENT_70	[p4l601t2690r712b2748],
14	mean	NN	O	mean	nsubj	19	SENT_70	[p4l735t2710r924b2748],
15	endpoint	JJ	O	endpoint	amod	17	SENT_70	[p4l948t2690r1252b2762],
16	serum	NN	O	serum	nn	17	SENT_70	[p4l1276t2710r1491b2748],
17	concentration	NN	O	concentration	dep	14	SENT_70	[p4l1514t2691r1988b2748],
18	was	VBD	O	be	cop	19	SENT_70	[p4l2010t2710r2143b2748],
19	23.9	CD	NUMBER	23.9	rcmod	8	SENT_70	[p4l12t2776r153b2832],
20	i	FW	O	i	dep	19	SENT_70	[p4l173t2779r223b2831],
21	16.38	CD	NUMBER	16.38	num	22	SENT_70	[p4l247t2776r425b2832],
22	ng/ml	NN	O	ng/ml	dep	19	SENT_70	[p4l458t2774r655b2846],
23	taken	VBN	O	take	partmod	19	SENT_70	[p4l686t2774r884b2832],
24	24	CD	DURATION	24	num	27	SENT_70	[p4l916t2776r995b2831],
25	hr	NN	DURATION	hr	nn	27	SENT_70	[p4l1028t2774r1106b2831],
26	post	NN	O	post	nn	27	SENT_70	[p4l1137t2779r1280b2846],
27	dose	NN	O	dose	dobj	23	SENT_70	[p4l1313t2774r1479b2832],
28	.	.	O	.	_	0	SENT_70	[p4l1313t2774r1479b2832],

1	There	EX	O	there	expl	2	SENT_71	[p4l1515t2774r1718b2832],
2	was	VBD	O	be	dep	18	SENT_71	[p4l1750t2794r1883b2832],
3	no	DT	O	no	det	4	SENT_71	[p4l1916t2794r1996b2832],
4	difference	NN	O	difference	nsubj	2	SENT_71	[p4l2030t2774r2141b2831, p4l11t2859r260b2916],
5	in	IN	O	in	_	0	SENT_71	[p4l281t2860r348b2915],
6	the	DT	O	the	det	8	SENT_71	[p4l367t2859r478b2916],
7	mean	NN	O	mean	nn	8	SENT_71	[p4l499t2878r688b2916],
8	dosage	NN	O	dosage	prep_in	4	SENT_71	[p4l710t2859r942b2931],
9	of	IN	O	of	_	0	SENT_71	[p4l963t2859r1030b2916],
10	olanzapine	NN	O	olanzapine	prep_of	8	SENT_71	[p4l1043t2859r1418b2931],
11	between	IN	O	between	_	0	SENT_71	[p4l1436t2859r1725b2916],
12	the	DT	O	the	det	13	SENT_71	[p4l1745t2859r1855b2916],
13	C	NN	O	c	prep_between	10	SENT_71	[p4l1878t2859r1926b2916],
14	and	CC	O	and	_	0	SENT_71	[p4l1949t2859r2077b2916],
15	T	NN	O	t	nn	17	SENT_71	[p4l2096t2860r2144b2915],
16	allele	NN	O	allele	nn	17	SENT_71	[p4l13t2943r196b3000],
17	groups	NNS	O	group	prep_between	10	SENT_71	[p4l236t2961r469b3015],
18	(	VBP	O	(	_	0	SENT_71	[p4l512t2943r949b3008],
19	12.75	CD	NUMBER	12.75	num	20	SENT_71	[p4l512t2943r949b3008],
20	i2	NN	O	i2	nsubj	23	SENT_71	[p4l512t2943r949b3008],
21	.88	CD	NUMBER	.88	num	23	SENT_71	[p4l512t2943r949b3008],
22	mg/day	NN	O	mg/day	nn	23	SENT_71	[p4l990t2943r1243b3015],
23	VS.	NNP	O	VS.	xcomp	18	SENT_71	[p4l1280t2962r1371b3000],
24	13.18	CD	NUMBER	13.18	num	25	SENT_71	[p4l1421t2945r1830b3001],
25	i3	NN	O	i3	dep	23	SENT_71	[p4l1421t2945r1830b3001],
26	.88	CD	NUMBER	.88	num	27	SENT_71	[p4l1421t2945r1830b3001],
27	mg/day	NN	O	mg/day	nsubj	18	SENT_71	[p4l1870t2943r2139b3015],
28	,	,	O	,	_	0	SENT_71	[p4l1870t2943r2139b3015],
29	P	NN	O	p	appos	27	SENT_71	[p4l7t3027r330b3092],
30	=	JJ	O	=	amod	32	SENT_71	[p4l7t3027r330b3092],
31	0.70	CD	NUMBER	0.70	tmod	30	SENT_71	[p4l7t3027r330b3092],
32	)	NN	O	)	dep	29	SENT_71	[p4l7t3027r330b3092],
33	.	.	O	.	_	0	SENT_71	[p4l7t3027r330b3092],

1	There	EX	O	there	expl	2	SENT_72	[p4l368t3027r572b3084],
2	was	VBD	O	be	_	0	SENT_72	[p4l606t3046r738b3084],
3	a	DT	O	a	det	4	SENT_72	[p4l775t3046r813b3084],
4	difference	NN	O	difference	nsubj	2	SENT_72	[p4l846t3027r1187b3084],
5	in	IN	O	in	_	0	SENT_72	[p4l1222t3028r1289b3083],
6	the	DT	O	the	det	7	SENT_72	[p4l1322t3027r1433b3084],
7	number	NN	O	number	prep_in	4	SENT_72	[p4l1468t3027r1738b3084],
8	of	IN	O	of	_	0	SENT_72	[p4l1773t3027r1840b3084],
9	subjects	NNS	O	subject	prep_of	7	SENT_72	[p4l1868t3027r2143b3099],
10	between	IN	O	between	_	0	SENT_72	[p4l9t3111r298b3168],
11	the	DT	O	the	det	14	SENT_72	[p4l338t3111r449b3168],
12	two	CD	NUMBER	two	num	14	SENT_72	[p4l490t3116r612b3168],
13	allele	NN	O	allele	nn	14	SENT_72	[p4l656t3111r839b3168],
14	groups	NNS	O	group	prep_between	9	SENT_72	[p4l881t3129r1115b3183],
15	who	WP	O	who	nsubj	16	SENT_72	[p4l1155t3111r1295b3168],
16	needed	VBD	O	need	rcmod	4	SENT_72	[p4l1338t3111r1582b3168],
17	an	DT	O	a	det	18	SENT_72	[p4l1624t3130r1707b3168],
18	increase	NN	O	increase	dobj	16	SENT_72	[p4l1749t3112r2035b3168],
19	in	IN	O	in	_	0	SENT_72	[p4l2077t3112r2144b3167],
20	dosage	NN	O	dosage	prep_in	16	SENT_72	[p4l12t3194r244b3266],
21	after	IN	O	after	_	0	SENT_72	[p4l264t3194r427b3252],
22	week	NN	DURATION	week	prep_after	16	SENT_72	[p4l445t3194r623b3252],
23	one	CD	NUMBER	one	num	22	SENT_72	[p4l641t3214r776b3264],
24	,	,	O	,	_	0	SENT_72	[p4l641t3214r776b3264],
25	but	CC	O	but	_	0	SENT_72	[p4l797t3194r913b3252],
26	this	DT	O	this	nsubj	32	SENT_72	[p4l930t3194r1061b3252],
27	was	VBD	O	be	cop	32	SENT_72	[p4l1080t3214r1212b3252],
28	not	RB	O	not	neg	32	SENT_72	[p4l1231t3199r1342b3252],
29	signiﬁcant	JJ	O	signiﬁcant	amod	32	SENT_72	[p4l1361t3194r1724b3266],
30	(	NN	O	(	nn	32	SENT_72	[p4l1745t3194r1846b3260],
31	30	CD	NUMBER	30	num	32	SENT_72	[p4l1745t3194r1846b3260],
32	subjects	NNS	O	subject	conj_but	2	SENT_72	[p4l1868t3194r2143b3266],
33	with	IN	O	with	_	0	SENT_72	[p4l10t3279r166b3336],
34	the	DT	O	the	det	36	SENT_72	[p4l187t3279r298b3336],
35	C	NN	O	c	nn	36	SENT_72	[p4l322t3279r370b3336],
36	allele	NN	O	allele	prep_with	32	SENT_72	[p4l396t3279r578b3336],
37	vs.	CC	O	vs.	prep	36	SENT_72	[p4l599t3298r690b3336],
38	12	CD	NUMBER	12	num	39	SENT_72	[p4l723t3281r795b3335],
39	subjects	NNS	O	subject	dep	37	SENT_72	[p4l820t3279r1096b3351],
40	with	IN	O	with	_	0	SENT_72	[p4l1118t3279r1274b3336],
41	the	DT	O	the	det	46	SENT_72	[p4l1295t3279r1405b3336],
42	T	NN	O	t	nn	46	SENT_72	[p4l1427t3280r1475b3335],
43	allele	NN	O	allele	nn	46	SENT_72	[p4l1499t3279r1704b3344],
44	)	CD	NUMBER	)	number	45	SENT_72	[p4l1499t3279r1704b3344],
45	(	CD	NUMBER	(	num	46	SENT_72	[p4l1732t3279r1804b3344],
46	P	NN	O	p	prep_with	39	SENT_72	[p4l1732t3279r1804b3344],
47	=	JJ	O	=	amod	46	SENT_72	[p4l1820t3307r1871b3325],
48	0.49	CD	NUMBER	0.49	num	49	SENT_72	[p4l1890t3279r2074b3344],
49	)	NN	O	)	dep	47	SENT_72	[p4l1890t3279r2074b3344],
50	.	.	O	.	_	0	SENT_72	[p4l1890t3279r2074b3344],

1	The	DT	O	the	det	3	SENT_73	[p4l86t3363r218b3420],
2	allele	NN	O	allele	nn	3	SENT_73	[p4l249t3363r432b3420],
3	frequencies	NNS	O	frequency	nsubj	15	SENT_73	[p4l462t3363r858b3435],
4	of	IN	O	of	_	0	SENT_73	[p4l888t3363r955b3420],
5	the	DT	O	the	det	9	SENT_73	[p4l975t3363r1086b3420],
6	C	NN	O	c	nn	9	SENT_73	[p4l1118t3363r1166b3421],
7	and	CC	O	and	_	0	SENT_73	[p4l1198t3363r1325b3420],
8	T	NN	O	t	nn	9	SENT_73	[p4l1354t3364r1401b3419],
9	alleles	NNS	O	allele	prep_of	3	SENT_73	[p4l1432t3363r1650b3420],
10	for	IN	O	for	_	0	SENT_73	[p4l1679t3363r1773b3420],
11	the	DT	O	the	det	13	SENT_73	[p4l1802t3363r1912b3420],
12	whole	JJ	O	whole	amod	13	SENT_73	[p4l1941t3363r2143b3420],
13	group	NN	O	group	prep_for	9	SENT_73	[p4l11t3465r210b3519],
14	were	VBD	O	be	cop	15	SENT_73	[p4l236t3466r402b3504],
15	78	CD	NUMBER	78	_	0	SENT_73	[p4l432t3449r509b3504],
16	and	CC	O	and	_	0	SENT_73	[p4l538t3447r665b3504],
17	22	CD	PERCENT	22	num	18	SENT_73	[p4l693t3449r853b3517],
18	%	NN	PERCENT	%	conj_and	15	SENT_73	[p4l693t3449r853b3517],
19	,	,	O	,	_	0	SENT_73	[p4l693t3449r853b3517],
20	respectively	RB	O	respectively	advmod	15	SENT_73	[p4l882t3447r1314b3519],
21	.	.	O	.	_	0	SENT_73	[p4l882t3447r1314b3519],

1	The	DT	O	the	det	2	SENT_74	[p4l1345t3447r1477b3504],
2	frequency	NN	O	frequency	nsubj	9	SENT_74	[p4l1504t3447r1846b3519],
3	of	IN	O	of	_	0	SENT_74	[p4l1872t3447r1940b3504],
4	the	DT	O	the	det	6	SENT_74	[p4l1959t3447r2069b3504],
5	T	NN	O	t	nn	6	SENT_74	[p4l2096t3448r2144b3503],
6	allele	NN	O	allele	prep_of	2	SENT_74	[p4l13t3531r196b3588],
7	was	VBD	O	be	cop	9	SENT_74	[p4l223t3550r356b3588],
8	17.6	CD	PERCENT	17.6	num	9	SENT_74	[p4l390t3533r589b3588],
9	%	NN	PERCENT	%	_	0	SENT_74	[p4l390t3533r589b3588],
10	in	IN	O	in	_	0	SENT_74	[p4l619t3532r686b3587],
11	the	DT	O	the	det	13	SENT_74	[p4l713t3531r824b3588],
12	male	JJ	O	male	amod	13	SENT_74	[p4l852t3531r1019b3588],
13	subjects	NNS	O	subject	prep_in	9	SENT_74	[p4l1049t3531r1324b3603],
14	and	CC	O	and	_	0	SENT_74	[p4l1355t3531r1481b3588],
15	31	CD	PERCENT	31	num	16	SENT_74	[p4l1510t3533r1651b3588],
16	%	NN	PERCENT	%	conj_and	9	SENT_74	[p4l1510t3533r1651b3588],
17	in	IN	O	in	_	0	SENT_74	[p4l1680t3532r1747b3587],
18	the	DT	O	the	det	20	SENT_74	[p4l1774t3531r1885b3588],
19	female	JJ	O	female	amod	20	SENT_74	[p4l1913t3531r2143b3588],
20	subjects	NNS	O	subject	prep_in	16	SENT_74	[p4l13t3614r305b3686],
21	.	.	O	.	_	0	SENT_74	[p4l13t3614r305b3686],

1	The	DT	O	the	det	2	SENT_75	[p4l324t3614r456b3672],
2	distribution	NN	O	distribution	nsubj	7	SENT_75	[p4l472t3614r881b3672],
3	of	IN	O	of	_	0	SENT_75	[p4l897t3615r965b3672],
4	T	NN	O	t	nn	5	SENT_75	[p4l972t3616r1020b3671],
5	alleles	NNS	O	allele	prep_of	2	SENT_75	[p4l1036t3614r1254b3672],
6	was	VBD	O	be	cop	7	SENT_75	[p4l1269t3634r1402b3672],
7	higher	JJR	O	higher	_	0	SENT_75	[p4l1417t3614r1643b3687],
8	in	IN	O	in	_	0	SENT_75	[p4l1659t3616r1726b3671],
9	subjects	NNS	O	subject	prep_in	7	SENT_75	[p4l1742t3614r2017b3686],
10	not	RB	O	not	neg	11	SENT_75	[p4l2033t3620r2144b3672],
11	gaining	VBG	O	gain	dep	9	SENT_75	[p5l11t14r275b84],
12	10	CD	PERCENT	10	num	13	SENT_75	[p5l306t15r442b70],
13	%	NN	PERCENT	%	dobj	11	SENT_75	[p5l306t15r442b70],
14	of	IN	O	of	_	0	SENT_75	[p5l474t13r541b70],
15	more	JJR	O	more	prep_of	13	SENT_75	[p5l562t32r735b70],
16	of	IN	O	of	_	0	SENT_75	[p5l765t13r832b70],
17	their	PRP$	O	they	poss	19	SENT_75	[p5l852t12r1022b70],
18	body	NN	O	body	nn	19	SENT_75	[p5l1048t12r1211b84],
19	weight	NN	O	weight	prep_of	15	SENT_75	[p5l1239t12r1474b84],
20	compared	VBN	O	compare	prep	11	SENT_75	[p5l1503t12r1838b85],
21	who	WP	O	who	nsubj	22	SENT_75	[p5l1866t12r2006b70],
22	did	VBD	O	do	pcomp	20	SENT_75	[p5l2037t12r2144b70],
23	gain	VB	O	gain	ccomp	22	SENT_75	[p5l11t98r160b168],
24	signiﬁcant	JJ	O	signiﬁcant	amod	26	SENT_75	[p5l197t97r560b168],
25	weight	NN	O	weight	nn	26	SENT_75	[p5l594t96r829b168],
26	(	NN	O	(	dobj	23	SENT_75	[p5l867t96r1073b161],
27	11/27	CD	PERCENT	11/27	number	28	SENT_75	[p5l867t96r1073b161],
28	(	CD	PERCENT	(	amod	26	SENT_75	[p5l1113t97r1364b162],
29	40.7	CD	PERCENT	40.7	num	30	SENT_75	[p5l1113t97r1364b162],
30	%	NN	PERCENT	%	dep	28	SENT_75	[p5l1113t97r1364b162],
31	)	CD	NUMBER	)	dep	43	SENT_75	[p5l1113t97r1364b162],
32	vs.	CC	O	vs.	prep	31	SENT_75	[p5l1401t116r1492b154],
33	0/15	CD	NUMBER	0/15	num	34	SENT_75	[p5l1533t96r1673b160],
34	(	NN	O	(	dep	32	SENT_75	[p5l1713t97r1963b167],
35	100	CD	PERCENT	100	number	36	SENT_75	[p5l1713t97r1963b167],
36	%	NN	PERCENT	%	amod	34	SENT_75	[p5l1713t97r1963b167],
37	)	CD	NUMBER	)	dep	43	SENT_75	[p5l1713t97r1963b167],
38	,	,	O	,	_	0	SENT_75	[p5l1713t97r1963b167],
39	X2	NN	O	x2	appos	37	SENT_75	[p5l2004t84r2141b168],
40	:	:	O	:	_	0	SENT_75	[p5l2004t84r2141b168],
41	11.805	CD	NUMBER	11.805	dep	39	SENT_75	[p5l17t182r256b251],
42	,	,	O	,	_	0	SENT_75	[p5l17t182r256b251],
43	P	NN	O	p	rcmod	26	SENT_75	[p5l275t181r328b237],
44	=	JJ	O	=	amod	43	SENT_75	[p5l345t208r396b227],
45	0.0035	CD	NUMBER	0.0035	tmod	44	SENT_75	[p5l415t181r663b245],
46	)	CD	NUMBER	)	number	47	SENT_75	[p5l415t181r663b245],
47	(	CD	NUMBER	(	num	48	SENT_75	[p5l688t180r903b246],
48	Table	NNP	O	Table	dep	23	SENT_75	[p5l688t180r903b246],
49	I	PRP	O	I	nsubj	50	SENT_75	[p5l925t181r994b245],
50	)	VBP	O	)	ccomp	22	SENT_75	[p5l925t181r994b245],
51	.	.	O	.	_	0	SENT_75	[p5l925t181r994b245],

1	This	DT	O	this	det	2	SENT_76	[p5l1018t180r1170b238],
2	analysis	NN	O	analysis	nsubj	5	SENT_76	[p5l1193t180r1475b252],
3	was	VBD	O	be	cop	5	SENT_76	[p5l1495t200r1628b238],
4	not	RB	O	not	neg	5	SENT_76	[p5l1649t186r1760b238],
5	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_76	[p5l1781t180r2144b252],
6	for	IN	O	for	_	0	SENT_76	[p5l11t264r105b322],
7	the	DT	O	the	det	13	SENT_76	[p5l134t264r245b322],
8	5	CD	NUMBER	5	nn	13	SENT_76	[p5l277t266r312b322],
9	and	CC	O	and	_	0	SENT_76	[p5l346t264r473b322],
10	7	CD	PERCENT	7	number	11	SENT_76	[p5l506t267r603b322],
11	%	NN	PERCENT	%	conj_and	8	SENT_76	[p5l506t267r603b322],
12	weight	NN	O	weight	nn	13	SENT_76	[p5l634t264r869b336],
13	thresholds	NNS	O	threshold	prep_for	5	SENT_76	[p5l898t264r1280b322],
14	.	.	O	.	_	0	SENT_76	[p5l898t264r1280b322],

1	All	DT	O	all	nsubj	20	SENT_77	[p5l1312t264r1414b321],
2	of	IN	O	of	_	0	SENT_77	[p5l1445t264r1512b322],
3	the	DT	O	the	det	4	SENT_77	[p5l1533t264r1644b322],
4	subjects	NNS	O	subject	prep_of	1	SENT_77	[p5l1676t264r1969b336],
5	,	,	O	,	_	0	SENT_77	[p5l1676t264r1969b336],
6	who	WP	O	who	nsubj	7	SENT_77	[p5l2002t264r2143b322],
7	gained	VBD	O	gain	rcmod	1	SENT_77	[p5l11t348r242b420],
8	>	JJR	O	>	dobj	7	SENT_77	[p5l269t350r465b407],
9	10	CD	PERCENT	10	number	10	SENT_77	[p5l269t350r465b407],
10	%	NN	PERCENT	%	amod	8	SENT_77	[p5l269t350r465b407],
11	of	IN	O	of	_	0	SENT_77	[p5l490t348r558b406],
12	their	PRP$	O	they	poss	15	SENT_77	[p5l572t348r741b406],
13	initial	JJ	O	initial	amod	15	SENT_77	[p5l764t348r973b406],
14	body	NN	O	body	nn	15	SENT_77	[p5l994t348r1157b420],
15	weight	NN	O	weight	prep_of	8	SENT_77	[p5l1179t348r1413b420],
16	over	IN	O	over	_	0	SENT_77	[p5l1437t368r1584b406],
17	6	CD	DURATION	6	num	18	SENT_77	[p5l1609t351r1644b406],
18	weeks	NNS	NUMBER	week	prep_over	7	SENT_77	[p5l1668t348r1897b418],
19	,	,	O	,	_	0	SENT_77	[p5l1668t348r1897b418],
20	had	VBD	O	have	_	0	SENT_77	[p5l1924t348r2053b406],
21	at	IN	O	at	quantmod	23	SENT_77	[p5l2078t353r2144b406],
22	least	JJS	O	least	mwe	21	SENT_77	[p5l11t432r175b490],
23	one	CD	NUMBER	one	num	25	SENT_77	[p5l204t452r322b490],
24	C	NN	O	c	nn	25	SENT_77	[p5l354t432r403b490],
25	allele	NN	O	allele	dobj	20	SENT_77	[p5l435t432r635b490],
26	.	.	O	.	_	0	SENT_77	[p5l435t432r635b490],

1	Subjects	NNS	O	subject	nsubj	6	SENT_78	[p5l671t432r958b504],
2	with	IN	O	with	_	0	SENT_78	[p5l987t432r1143b490],
3	a	DT	O	a	det	5	SENT_78	[p5l1175t452r1212b490],
4	C	NN	O	c	nn	5	SENT_78	[p5l1242t432r1292b490],
5	allele	NN	O	allele	prep_with	1	SENT_78	[p5l1323t432r1506b490],
6	gained	VBD	O	gain	_	0	SENT_78	[p5l1536t432r1768b504],
7	a	DT	O	a	det	8	SENT_78	[p5l1798t452r1836b490],
8	mean	NN	O	mean	dobj	6	SENT_78	[p5l1864t452r2054b490],
9	of	IN	O	of	prep	6	SENT_78	[p5l2084t432r2152b490],

1	TABLE	NN	O	table	nn	3	SENT_79	[p5l283t530r527b583],
2	I.	NN	O	i.	nn	3	SENT_79	[p5l556t531r597b584],
3	Distribution	NN	O	distribution	nsubj	12	SENT_79	[p5l640t530r1041b584],
4	of	IN	O	of	_	0	SENT_79	[p5l1065t530r1129b584],
5	C	NN	O	c	nn	8	SENT_79	[p5l1147t530r1193b584],
6	and	CC	O	and	_	0	SENT_79	[p5l1220t530r1339b584],
7	T	NN	O	t	conj_and	5	SENT_79	[p5l1362t531r1407b583],
8	Alleles	NNS	MISC	allele	prep_of	3	SENT_79	[p5l1429t530r1651b584],
9	Based	VBN	MISC	base	_	0	SENT_79	[p5l1673t530r1872b584],
10	on	IN	MISC	on	prepc_based_on	8	SENT_79	[p5l781t643r857b679],
11	Weight	NNP	MISC	Weight	pobj	8	SENT_79	[p5l879t624r1116b693],
12	Gained	VBD	MISC	gain	_	0	SENT_79	[p5l1142t624r1375b679],

1	Weight	NNP	O	Weight	nn	2	SENT_80	[p5l6t773r244b842],
2	gain	NN	O	gain	_	0	SENT_80	[p5l267t775r408b842],
3	(	CD	PERCENT	(	num	4	SENT_80	[p5l435t774r533b835],
4	%	NN	PERCENT	%	dep	2	SENT_80	[p5l435t774r533b835],
5	)	CD	NUMBER	)	num	6	SENT_80	[p5l435t774r533b835],
6	C	NN	O	c	dep	4	SENT_80	[p5l1088t774r1134b828],
7	allele	NN	O	allele	nn	9	SENT_80	[p5l1161t774r1334b828],
8	T	NN	O	t	nn	9	SENT_80	[p5l1864t775r1909b827],
9	allele	NN	O	allele	dep	2	SENT_80	[p5l1935t774r2108b828],

1	Chi-square	JJ	O	chi-square	amod	2	SENT_81	[p5l10t1153r324b1212],
2	analysis	NN	O	analysis	nsubj	16	SENT_81	[p5l354t1153r587b1212],
3	for	IN	O	for	_	0	SENT_81	[p5l614t1153r692b1200],
4	weight	NN	O	weight	nn	5	SENT_81	[p5l718t1153r912b1212],
5	gain	NN	O	gain	dep	6	SENT_81	[p5l939t1154r1062b1212],
6	>	JJR	O	>	prep_for	2	SENT_81	[p5l1093t1155r1255b1201],
7	10	CD	PERCENT	10	number	8	SENT_81	[p5l1093t1155r1255b1201],
8	%	NN	PERCENT	%	amod	6	SENT_81	[p5l1093t1155r1255b1201],
9	distributed	VBN	O	distribute	partmod	6	SENT_81	[p5l1283t1153r1601b1200],
10	by	IN	O	by	_	0	SENT_81	[p5l1625t1153r1694b1212],
11	5HT2CR	NN	O	5ht2cr	nn	13	SENT_81	[p5l1721t1153r1971b1200],
12	-759	CD	NUMBER	-759	num	13	SENT_81	[p5l2001t1154r2145b1200],
13	genotype	NN	O	genotype	agent	9	SENT_81	[p5l8t1228r265b1283],
14	(	CD	NUMBER	(	number	15	SENT_81	[p5l286t1224r406b1277],
15	two	CD	NUMBER	two	dep	13	SENT_81	[p5l286t1224r406b1277],
16	tailed	VBD	O	tail	_	0	SENT_81	[p5l423t1223r587b1271],
17	P	NN	O	p	dobj	16	SENT_81	[p5l601t1224r645b1270],
18	=	JJ	O	=	advmod	16	SENT_81	[p5l659t1246r700b1262],
19	0.0035	CD	NUMBER	0.0035	num	20	SENT_81	[p5l717t1224r938b1277],
20	)	NN	O	)	dep	18	SENT_81	[p5l717t1224r938b1277],
21	.	.	O	.	_	0	SENT_81	[p5l717t1224r938b1277],

1	12.2	CD	NUMBER	12.2	nsubj	10	SENT_82	[p5l14t1409r150b1464],
2	i	FW	O	i	dep	1	SENT_82	[p5l170t1412r221b1463],
3	9.7	CD	PERCENT	9.7	num	4	SENT_82	[p5l240t1409r402b1464],
4	%	NN	PERCENT	%	dep	1	SENT_82	[p5l240t1409r402b1464],
5	over	IN	O	over	_	0	SENT_82	[p5l423t1426r570b1464],
6	their	PRP$	O	they	poss	9	SENT_82	[p5l587t1407r756b1464],
7	initial	JJ	O	initial	amod	9	SENT_82	[p5l774t1407r983b1464],
8	body	NN	O	body	nn	9	SENT_82	[p5l999t1407r1163b1479],
9	weight	NN	O	weight	prep_over	4	SENT_82	[p5l1178t1407r1415b1479],
10	compared	VBN	O	compare	_	0	SENT_82	[p5l1432t1407r1769b1479],
11	to	TO	O	to	_	0	SENT_82	[p5l1785t1412r1849b1464],
12	subjects	NNS	O	subject	prep_to	10	SENT_82	[p5l1869t1407r2145b1479],
13	with	IN	O	with	_	0	SENT_82	[p5l8t1490r164b1548],
14	a	DT	O	a	det	16	SENT_82	[p5l185t1510r223b1548],
15	T	NN	O	t	nn	16	SENT_82	[p5l240t1492r288b1547],
16	allele	NN	O	allele	prep_with	10	SENT_82	[p5l309t1490r491b1548],
17	who	WP	O	who	nsubj	18	SENT_82	[p5l510t1490r650b1548],
18	gained	VBD	O	gain	rcmod	16	SENT_82	[p5l670t1490r901b1563],
19	a	DT	O	a	det	20	SENT_82	[p5l921t1510r959b1548],
20	mean	NN	O	mean	nsubj	23	SENT_82	[p5l976t1510r1167b1548],
21	of	IN	O	of	_	0	SENT_82	[p5l1186t1491r1253b1548],
22	4.7	CD	NUMBER	4.7	prep_of	20	SENT_82	[p5l1264t1493r1364b1548],
23	i	FW	O	i	xcomp	18	SENT_82	[p5l1384t1496r1435b1547],
24	4.2	CD	PERCENT	4.2	number	25	SENT_82	[p5l1453t1493r1634b1548],
25	%	NN	PERCENT	%	amod	23	SENT_82	[p5l1453t1493r1634b1548],
26	.	.	O	.	_	0	SENT_82	[p5l1453t1493r1634b1548],

1	There	EX	O	there	expl	2	SENT_83	[p5l1657t1490r1861b1548],
2	were	VBD	O	be	_	0	SENT_83	[p5l1879t1510r2045b1548],
3	no	DT	O	no	det	5	SENT_83	[p5l2064t1510r2145b1548],
4	statistical	JJ	O	statistical	amod	5	SENT_83	[p5l10t1574r352b1632],
5	differences	NNS	O	difference	nsubj	2	SENT_83	[p5l378t1574r754b1632],
6	in	IN	O	in	_	0	SENT_83	[p5l781t1576r848b1631],
7	the	DT	O	the	det	14	SENT_83	[p5l874t1574r985b1632],
8	percentage	NN	O	percentage	nn	14	SENT_83	[p5l1011t1580r1392b1647],
9	change	NN	O	change	dep	14	SENT_83	[p5l1419t1574r1663b1647],
10	in	IN	O	in	_	0	SENT_83	[p5l1689t1576r1757b1631],
11	SANS	NNS	O	san	prep_in	9	SENT_83	[p5l1785t1574r1989b1632],
12	and	CC	O	and	_	0	SENT_83	[p5l2019t1574r2147b1632],
13	BPRS	NNS	O	bpr	prep_in	9	SENT_83	[p5l7t1658r211b1716],
14	scores	NNS	O	score	prep_in	5	SENT_83	[p5l240t1678r448b1716],
15	or	CC	O	or	_	0	SENT_83	[p5l475t1678r544b1716],
16	olanzapine	NN	O	olanzapine	nn	17	SENT_83	[p5l570t1658r945b1730],
17	dosage	NN	O	dosage	conj_or	14	SENT_83	[p5l973t1658r1205b1730],
18	or	CC	O	or	_	0	SENT_83	[p5l1233t1678r1301b1716],
19	blood	NN	O	blood	nn	20	SENT_83	[p5l1325t1658r1509b1716],
20	level	NN	O	level	conj_or	14	SENT_83	[p5l1534t1658r1696b1716],
21	between	IN	O	between	_	0	SENT_83	[p5l1719t1658r2008b1716],
22	the	DT	O	the	det	23	SENT_83	[p5l2034t1658r2145b1716],
23	groups	NNS	O	group	prep_between	20	SENT_83	[p5l9t1761r243b1814],
24	of	IN	O	of	_	0	SENT_83	[p5l279t1742r347b1800],
25	subjects	NNS	O	subject	prep_of	23	SENT_83	[p5l375t1742r651b1814],
26	when	WRB	O	when	advmod	27	SENT_83	[p5l686t1742r874b1800],
27	categorized	VBN	O	categorize	advcl	2	SENT_83	[p5l911t1742r1304b1814],
28	according	VBG	O	accord	_	0	SENT_83	[p5l1341t1742r1675b1814],
29	to	TO	O	to	prepc_according_to	27	SENT_83	[p5l1707t1748r1771b1800],
30	weight	NN	O	weight	pobj	27	SENT_83	[p5l1806t1742r2042b1814],
31	or	CC	O	or	_	0	SENT_83	[p5l2077t1762r2146b1800],
32	genotype	NN	O	genotype	nn	35	SENT_83	[p5l9t1831r320b1898],
33	(	CD	NUMBER	(	num	35	SENT_83	[p5l345t1826r594b1891],
34	Tables	NNP	O	Tables	nn	35	SENT_83	[p5l345t1826r594b1891],
35	II	NNP	O	II	conj_or	30	SENT_83	[p5l618t1827r675b1883],
36	and	CC	O	and	_	0	SENT_83	[p5l700t1826r827b1884],
37	III	NNP	O	III	conj_or	30	SENT_83	[p5l850t1826r980b1892],
38	)	CD	NUMBER	)	num	37	SENT_83	[p5l850t1826r980b1892],
39	.	.	O	.	_	0	SENT_83	[p5l850t1826r980b1892],

1	DISCUSSION	NN	O	discussion	_	0	SENT_84	[p5l812t2059r1341b2117],

1	From	IN	O	from	_	0	SENT_85	[p5l85t2185r271b2241],
2	these	DT	O	these	det	3	SENT_85	[p5l302t2184r486b2241],
3	data	NNS	O	datum	prep_from	7	SENT_85	[p5l518t2184r688b2254],
4	,	,	O	,	_	0	SENT_85	[p5l518t2184r688b2254],
5	we	PRP	O	we	nsubj	7	SENT_85	[p5l723t2203r818b2241],
6	can	MD	O	can	aux	7	SENT_85	[p5l850t2203r968b2241],
7	conjecture	NN	O	conjecture	_	0	SENT_85	[p5l1001t2185r1356b2256],
8	a	DT	O	a	det	11	SENT_85	[p5l1391t2203r1429b2241],
9	potential	JJ	O	potential	amod	11	SENT_85	[p5l1458t2184r1769b2256],
10	protective	JJ	O	protective	amod	11	SENT_85	[p5l1800t2185r2145b2256],
11	effect	NN	O	effect	tmod	7	SENT_85	[p5l9t2268r195b2325],
12	of	IN	O	of	_	0	SENT_85	[p5l222t2268r290b2325],
13	the	DT	O	the	det	15	SENT_85	[p5l307t2268r417b2325],
14	T	NN	O	t	nn	15	SENT_85	[p5l444t2269r492b2324],
15	allele	NN	O	allele	prep_of	11	SENT_85	[p5l520t2268r703b2325],
16	on	IN	O	on	_	0	SENT_85	[p5l730t2287r810b2325],
17	lack	NN	O	lack	prep_on	7	SENT_85	[p5l837t2268r980b2325],
18	of	IN	O	of	_	0	SENT_85	[p5l1005t2268r1072b2325],
19	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_85	[p5l1092t2268r1455b2340],
20	weight	NN	O	weight	nn	22	SENT_85	[p5l1481t2268r1716b2340],
21	gain	NN	O	gain	nn	22	SENT_85	[p5l1742t2269r1892b2340],
22	(	NN	PERCENT	(	prep_of	17	SENT_85	[p5l1921t2268r2144b2335],
23	210	CD	PERCENT	210	number	24	SENT_85	[p5l1921t2268r2144b2335],
24	%	NN	PERCENT	%	amod	22	SENT_85	[p5l1921t2268r2144b2335],
25	over	IN	O	over	_	0	SENT_85	[p5l9t2371r157b2409],
26	baseline	NN	O	baseline	nn	27	SENT_85	[p5l198t2352r507b2417],
27	)	NN	O	)	prep_over	22	SENT_85	[p5l198t2352r507b2417],
28	following	VBG	DATE	follow	_	0	SENT_85	[p5l554t2352r873b2424],
29	6	CD	DATE	6	num	30	SENT_85	[p5l915t2354r951b2409],
30	weeks	NNS	DATE	week	prep_following	22	SENT_85	[p5l995t2352r1207b2409],
31	of	IN	O	of	_	0	SENT_85	[p5l1251t2352r1319b2409],
32	olanzapine	NN	O	olanzapine	nn	33	SENT_85	[p5l1355t2352r1730b2424],
33	treatment	NN	O	treatment	prep_of	30	SENT_85	[p5l1774t2357r2141b2422],
34	,	,	O	,	_	0	SENT_85	[p5l1774t2357r2141b2422],
35	although	IN	O	although	mark	41	SENT_85	[p5l11t2435r319b2508],
36	this	DT	O	this	nsubj	41	SENT_85	[p5l339t2435r471b2493],
37	could	MD	O	could	aux	41	SENT_85	[p5l493t2435r675b2493],
38	be	VB	O	be	cop	41	SENT_85	[p5l693t2435r771b2493],
39	an	DT	O	a	det	41	SENT_85	[p5l795t2455r878b2493],
40	incidental	JJ	O	incidental	amod	41	SENT_85	[p5l899t2435r1246b2493],
41	ﬁnding	NN	O	ﬁnding	dep	33	SENT_85	[p5l1267t2435r1528b2508],
42	.	.	O	.	_	0	SENT_85	[p5l1267t2435r1528b2508],

1	Previous	JJ	O	previous	amod	2	SENT_86	[p5l1555t2437r1857b2493],
2	authors	NNS	O	author	nsubj	4	SENT_86	[p5l1880t2435r2145b2493],
3	have	VBP	O	have	aux	4	SENT_86	[p5l8t2519r173b2577],
4	shown	VBN	O	show	_	0	SENT_86	[p5l207t2519r427b2577],
5	that	IN	O	that	complm	19	SENT_86	[p5l459t2519r603b2577],
6	in	IN	O	in	_	0	SENT_86	[p5l635t2521r702b2576],
7	subjects	NNS	O	subject	prep_in	19	SENT_86	[p5l736t2519r1012b2591],
8	without	IN	O	without	_	0	SENT_86	[p5l1044t2519r1314b2577],
9	schizophrenia	NN	O	schizophrenia	prep_without	7	SENT_86	[p5l1348t2519r1847b2592],
10	,	,	O	,	_	0	SENT_86	[p5l1348t2519r1847b2592],
11	the	DT	O	the	det	12	SENT_86	[p5l1883t2519r1994b2577],
12	frequency	NN	O	frequency	nsubj	19	SENT_86	[p5l2026t2520r2144b2577, p5l10t2623r254b2675],
13	of	IN	O	of	_	0	SENT_86	[p5l279t2603r347b2661],
14	the	DT	O	the	det	17	SENT_86	[p5l363t2603r474b2661],
15	variant	JJ	O	variant	amod	17	SENT_86	[p5l499t2604r755b2661],
16	T	NN	O	t	nn	17	SENT_86	[p5l780t2604r828b2660],
17	allele	NN	O	allele	prep_of	12	SENT_86	[p5l855t2603r1038b2661],
18	was	VBD	O	be	cop	19	SENT_86	[p5l1063t2623r1196b2661],
19	higher	JJR	O	higher	ccomp	4	SENT_86	[p5l1221t2603r1449b2675],
20	in	IN	O	in	_	0	SENT_86	[p5l1474t2604r1541b2660],
21	non-obese	JJ	O	non-obese	amod	23	SENT_86	[p5l1567t2603r1909b2661],
22	[	NN	O	[	nn	23	SENT_86	[p5l1939t2604r2145b2668],
23	Yuan	NNP	O	Yuan	prep_in	19	SENT_86	[p5l1939t2604r2145b2668],
24	et	FW	O	et	nn	25	SENT_86	[p5l9t2693r73b2745],
25	al.	FW	O	al.	dep	23	SENT_86	[p5l95t2687r194b2758],
26	,	,	O	,	_	0	SENT_86	[p5l95t2687r194b2758],
27	2000	CD	DATE	2000	num	28	SENT_86	[p5l219t2688r425b2752],
28	]	NN	O	]	appos	23	SENT_86	[p5l219t2688r425b2752],
29	.	.	O	.	_	0	SENT_86	[p5l219t2688r425b2752],

1	This	DT	O	this	det	2	SENT_87	[p5l449t2687r602b2745],
2	relationship	NN	O	relationship	nsubj	5	SENT_87	[p5l621t2687r1041b2759],
3	may	MD	O	may	aux	5	SENT_87	[p5l1062t2707r1210b2759],
4	be	VB	O	be	cop	5	SENT_87	[p5l1227t2687r1306b2745],
5	due	JJ	O	due	_	0	SENT_87	[p5l1327t2687r1451b2745],
6	to	TO	O	to	_	0	SENT_87	[p5l1471t2692r1535b2745],
7	higher	JJR	O	higher	amod	9	SENT_87	[p5l1555t2687r1783b2759],
8	transcription	NN	O	transcription	nn	9	SENT_87	[p5l1801t2688r2143b2759, p5l8t2772r143b2829],
9	levels	NNS	O	level	prep_to	5	SENT_87	[p5l159t2771r354b2829],
10	of	IN	O	of	_	0	SENT_87	[p5l371t2771r439b2829],
11	this	DT	O	this	det	12	SENT_87	[p5l445t2771r576b2829],
12	gene	NN	O	gene	prep_of	9	SENT_87	[p5l593t2789r753b2843],
13	which	WDT	O	which	nsubj	14	SENT_87	[p5l768t2771r975b2829],
14	plays	VBZ	O	play	rcmod	12	SENT_87	[p5l991t2771r1173b2843],
15	a	DT	O	a	det	16	SENT_87	[p5l1191t2791r1229b2829],
16	part	NN	O	part	dobj	14	SENT_87	[p5l1242t2776r1389b2843],
17	in	IN	O	in	_	0	SENT_87	[p5l1405t2772r1471b2828],
18	appetite	NN	O	appetite	nn	19	SENT_87	[p5l1489t2772r1770b2843],
19	regulation	NN	O	regulation	prep_in	16	SENT_87	[p5l1786t2771r2145b2843],
20	resulting	VBG	O	result	partmod	19	SENT_87	[p5l8t2855r326b2927],
21	in	IN	O	in	_	0	SENT_87	[p5l343t2856r410b2912],
22	more	JJR	O	more	amod	23	SENT_87	[p5l429t2875r602b2913],
23	resistance	NN	O	resistance	prep_in	20	SENT_87	[p5l621t2856r972b2913],
24	to	TO	O	to	_	0	SENT_87	[p5l991t2860r1055b2913],
25	obesity	NN	O	obesity	prep_to	23	SENT_87	[p5l1076t2855r1335b2927],
26	.	.	O	.	_	0	SENT_87	[p5l1076t2855r1335b2927],

1	Additionally	RB	O	additionally	advmod	9	SENT_88	[p5l1356t2855r1806b2927],
2	,	,	O	,	_	0	SENT_88	[p5l1356t2855r1806b2927],
3	Reynolds	NNP	PERSON	Reynolds	dep	6	SENT_88	[p5l1830t2855r2145b2927],
4	et	FW	O	et	nn	6	SENT_88	[p5l9t2945r73b2997],
5	al.	FW	O	al.	nn	6	SENT_88	[p5l122t2940r199b2997],
6	[	FW	O	[	dep	9	SENT_88	[p5l256t2941r462b3005],
7	2002	CD	DATE	2002	num	8	SENT_88	[p5l256t2941r462b3005],
8	]	NN	O	]	nsubj	9	SENT_88	[p5l256t2941r462b3005],
9	showed	VBD	O	show	_	0	SENT_88	[p5l516t2940r772b2997],
10	that	IN	O	that	complm	32	SENT_88	[p5l818t2940r963b2997],
11	in	IN	O	in	_	0	SENT_88	[p5l1011t2941r1077b2996],
12	patients	NNS	O	patient	prep_in	32	SENT_88	[p5l1124t2941r1408b3012],
13	being	VBG	O	be	auxpass	14	SENT_88	[p5l1454t2940r1647b3012],
14	treated	VBN	O	treat	partmod	12	SENT_88	[p5l1691t2940r1943b2997],
15	with	IN	O	with	_	0	SENT_88	[p5l1989t2940r2146b2997],
16	chlorpromazine	NN	O	chlorpromazine	prep_with	14	SENT_88	[p5l9t3024r549b3096],
17	and	CC	O	and	_	0	SENT_88	[p5l571t3024r698b3081],
18	risperidone	NN	O	risperidone	conj_and	16	SENT_88	[p5l715t3024r1109b3096],
19	for	IN	O	for	_	0	SENT_88	[p5l1127t3024r1222b3081],
20	6	CD	DURATION	6	num	21	SENT_88	[p5l1241t3026r1278b3081],
21	weeks	NNS	NUMBER	week	prep_for	14	SENT_88	[p5l1296t3024r1526b3094],
22	,	,	O	,	_	0	SENT_88	[p5l1296t3024r1526b3094],
23	51	CD	PERCENT	51	num	24	SENT_88	[p5l1550t3026r1690b3082],
24	%	NN	PERCENT	%	nsubj	32	SENT_88	[p5l1550t3026r1690b3082],
25	of	IN	O	of	_	0	SENT_88	[p5l1711t3024r1778b3081],
26	those	DT	O	those	prep_of	24	SENT_88	[p5l1788t3024r1972b3081],
27	with	IN	O	with	_	0	SENT_88	[p5l1989t3024r2146b3081],
28	a	DT	O	a	det	30	SENT_88	[p5l11t3127r48b3165],
29	C	NN	O	c	nn	30	SENT_88	[p5l67t3108r116b3165],
30	allele	NN	O	allele	prep_with	26	SENT_88	[p5l136t3108r319b3165],
31	had	VBD	O	have	aux	32	SENT_88	[p5l336t3108r466b3165],
32	gained	VBN	O	gain	ccomp	9	SENT_88	[p5l484t3108r715b3180],
33	more	RBR	O	more	advmod	34	SENT_88	[p5l732t3127r905b3165],
34	than	IN	O	than	quantmod	35	SENT_88	[p5l922t3108r1084b3165],
35	7	CD	PERCENT	7	num	36	SENT_88	[p5l1105t3110r1202b3165],
36	%	NN	PERCENT	%	dobj	32	SENT_88	[p5l1105t3110r1202b3165],
37	of	IN	O	of	_	0	SENT_88	[p5l1222t3108r1290b3165],
38	their	PRP$	O	they	poss	41	SENT_88	[p5l1298t3108r1467b3165],
39	initial	JJ	O	initial	amod	41	SENT_88	[p5l1485t3108r1694b3165],
40	body	NN	O	body	nn	41	SENT_88	[p5l1709t3108r1873b3180],
41	weight	NN	O	weight	prep_of	36	SENT_88	[p5l1889t3108r2141b3180],
42	,	,	O	,	_	0	SENT_88	[p5l1889t3108r2141b3180],
43	while	IN	O	while	mark	52	SENT_88	[p5l8t3191r196b3249],
44	only	RB	O	only	quantmod	45	SENT_88	[p5l221t3192r367b3264],
45	15	CD	PERCENT	15	num	46	SENT_88	[p5l396t3194r532b3249],
46	%	NN	PERCENT	%	nsubj	52	SENT_88	[p5l396t3194r532b3249],
47	of	IN	O	of	_	0	SENT_88	[p5l558t3192r625b3249],
48	those	DT	O	those	prep_of	46	SENT_88	[p5l640t3191r823b3249],
49	with	IN	O	with	_	0	SENT_88	[p5l847t3191r1003b3249],
50	T	NN	O	t	nn	51	SENT_88	[p5l1026t3193r1074b3248],
51	allele	NN	O	allele	prep_with	48	SENT_88	[p5l1100t3191r1283b3249],
52	met	VBD	O	meet	advcl	32	SENT_88	[p5l1307t3197r1438b3249],
53	this	DT	O	this	det	54	SENT_88	[p5l1460t3191r1592b3249],
54	criterion	NN	O	criterion	dobj	52	SENT_88	[p5l1616t3193r1930b3249],
55	.	.	O	.	_	0	SENT_88	[p5l1616t3193r1930b3249],

1	Additionally	RB	O	additionally	advmod	6	SENT_89	[p5l1955t3191r2143b3249, p5l8t3275r291b3348],
2	,	,	O	,	_	0	SENT_89	[p5l1955t3191r2143b3249, p5l8t3275r291b3348],
3	these	DT	O	these	det	5	SENT_89	[p5l312t3275r495b3333],
4	same	JJ	O	same	amod	5	SENT_89	[p5l515t3295r691b3333],
5	authors	NNS	O	author	nsubj	6	SENT_89	[p5l712t3275r977b3333],
6	[	VBP	O	[	_	0	SENT_89	[p5l999t3275r1336b3348],
7	Reynolds	NNP	O	Reynolds	dobj	6	SENT_89	[p5l999t3275r1336b3348],
8	et	FW	O	et	nn	9	SENT_89	[p5l1355t3281r1419b3333],
9	al.	FW	O	al.	nsubj	14	SENT_89	[p5l1438t3276r1538b3346],
10	,	,	O	,	_	0	SENT_89	[p5l1438t3276r1538b3346],
11	2003	CD	DATE	2003	num	12	SENT_89	[p5l1560t3277r1766b3346],
12	]	NN	O	]	appos	9	SENT_89	[p5l1560t3277r1766b3346],
13	,	,	O	,	_	0	SENT_89	[p5l1560t3277r1766b3346],
14	found	VBD	O	find	rcmod	7	SENT_89	[p5l1787t3275r1985b3333],
15	that	IN	O	that	complm	29	SENT_89	[p5l2001t3275r2146b3333],
16	for	IN	O	for	_	0	SENT_89	[p5l8t3359r103b3417],
17	subjects	NNS	O	subject	nsubj	18	SENT_89	[p5l136t3359r411b3431],
18	receiving	VBG	O	receive	prepc_for	29	SENT_89	[p5l442t3360r762b3431],
19	clozapine	NN	O	clozapine	dobj	18	SENT_89	[p5l790t3359r1111b3431],
20	for	IN	O	for	_	0	SENT_89	[p5l1143t3359r1237b3417],
21	6	CD	DURATION	6	num	22	SENT_89	[p5l1269t3362r1306b3417],
22	months	NNS	NUMBER	month	prep_for	18	SENT_89	[p5l1337t3359r1614b3430],
23	,	,	O	,	_	0	SENT_89	[p5l1337t3359r1614b3430],
24	a	DT	O	a	det	27	SENT_89	[p5l1651t3379r1689b3417],
25	very	RB	O	very	advmod	26	SENT_89	[p5l1717t3379r1870b3431],
26	similar	JJ	O	similar	amod	27	SENT_89	[p5l1902t3359r2146b3417],
27	relationship	NN	O	relationship	nsubj	29	SENT_89	[p5l8t3443r428b3515],
28	was	VBD	O	be	cop	29	SENT_89	[p5l453t3463r586b3501],
29	true	JJ	O	true	ccomp	14	SENT_89	[p5l611t3449r756b3501],
30	in	IN	O	in	_	0	SENT_89	[p5l782t3444r849b3500],
31	that	IN	O	that	complm	44	SENT_89	[p5l874t3443r1019b3501],
32	the	DT	O	the	det	35	SENT_89	[p5l1043t3443r1154b3501],
33	body	NN	O	body	nn	35	SENT_89	[p5l1178t3443r1342b3515],
34	mass	NN	O	mass	nn	35	SENT_89	[p5l1366t3463r1541b3501],
35	index	NN	O	index	nsubj	44	SENT_89	[p5l1567t3443r1757b3501],
36	of	IN	O	of	_	0	SENT_89	[p5l1783t3443r1850b3501],
37	subjects	NNS	O	subject	prep_of	35	SENT_89	[p5l1869t3443r2145b3515],
38	with	IN	O	with	_	0	SENT_89	[p5l8t3528r164b3585],
39	a	DT	O	a	det	41	SENT_89	[p5l183t3547r221b3585],
40	T	NN	O	t	nn	41	SENT_89	[p5l237t3529r284b3584],
41	allele	NN	O	allele	prep_with	37	SENT_89	[p5l303t3528r487b3585],
42	was	VBD	O	be	cop	44	SENT_89	[p5l503t3547r636b3585],
43	signiﬁcantly	RB	O	signiﬁcantly	advmod	44	SENT_89	[p5l655t3528r1084b3635],
44	less	JJR	O	less	prepc_in	29	SENT_89	[p5l1100t3528r1228b3585],
45	than	IN	O	than	_	0	SENT_89	[p5l1245t3528r1406b3585],
46	that	DT	O	that	prep_than	44	SENT_89	[p5l1422t3528r1567b3585],
47	for	IN	O	for	_	0	SENT_89	[p5l1584t3528r1678b3585],
48	subjects	NNS	O	subject	prep_for	46	SENT_89	[p5l1697t3528r1972b3599],
49	with	IN	O	with	_	0	SENT_89	[p5l1989t3528r2146b3585],
50	a	DT	O	a	det	52	SENT_89	[p5l11t3632r49b3669],
51	C	NN	O	c	nn	52	SENT_89	[p5l71t3612r120b3669],
52	allele	NN	O	allele	prep_with	48	SENT_89	[p5l145t3612r328b3669],
53	(	CD	NUMBER	(	num	55	SENT_89	[p5l354t3612r517b3677],
54	0.32	CD	NUMBER	0.32	num	55	SENT_89	[p5l354t3612r517b3677],
55	kg/m	NN	O	kg/m	dep	52	SENT_89	[p5l541t3612r713b3684],
56	vs.	IN	O	vs.	_	0	SENT_89	[p5l765t3632r856b3669],
57	1.12	CD	NUMBER	1.12	num	58	SENT_89	[p5l888t3614r1024b3669],
58	kg/m2	NN	O	kg/m2	prep_vs.	55	SENT_89	[p5l1048t3599r1269b3684],
59	,	,	O	,	_	0	SENT_89	[p5l1048t3599r1269b3684],
60	P	NN	O	p	npadvmod	61	SENT_89	[p5l1290t3613r1343b3668],
61	<	JJR	O	<	dep	44	SENT_89	[p5l1362t3627r1408b3671],
62	0.02	CD	NUMBER	0.02	num	63	SENT_89	[p5l1430t3612r1614b3677],
63	)	NN	O	)	dep	44	SENT_89	[p5l1430t3612r1614b3677],
64	.	.	O	.	_	0	SENT_89	[p5l1430t3612r1614b3677],

1	This	DT	O	this	nsubj	5	SENT_90	[p5l84t3695r237b3753],
2	is	VBZ	O	be	cop	5	SENT_90	[p5l263t3697r318b3753],
3	the	DT	O	the	det	5	SENT_90	[p5l344t3695r455b3753],
4	ﬁrst	NN	O	ﬁrst	nn	5	SENT_90	[p5l481t3696r623b3753],
5	study	NN	O	study	_	0	SENT_90	[p5l650t3695r841b3768],
6	to	TO	O	to	aux	7	SENT_90	[p5l866t3701r930b3753],
7	examine	VB	O	examine	infmod	5	SENT_90	[p5l957t3697r1249b3753],
8	the	DT	O	the	det	9	SENT_90	[p5l1275t3695r1386b3753],
9	relationship	NN	O	relationship	dobj	7	SENT_90	[p5l1411t3695r1831b3768],
10	between	IN	O	between	_	0	SENT_90	[p5l1856t3695r2146b3753],
11	the	DT	O	the	det	14	SENT_90	[p6l8t12r119b70],
12	-7	CD	NUMBER	-7	num	14	SENT_90	[p6l141t15r232b70],
13	59C/T	NN	O	59c/t	nn	14	SENT_90	[p6l238t12r444b76],
14	polymorphism	NN	O	polymorphism	prep_between	9	SENT_90	[p6l460t12r958b85],
15	of	IN	O	of	_	0	SENT_90	[p6l976t13r1044b70],
16	the	DT	O	the	det	18	SENT_90	[p6l1052t12r1163b70],
17	5HT2C	NN	O	5ht2c	nn	18	SENT_90	[p6l1182t13r1428b70],
18	receptor	NN	O	receptor	prep_of	14	SENT_90	[p6l1446t18r1732b85],
19	and	CC	O	and	_	0	SENT_90	[p6l1751t12r1878b70],
20	olanzapine	NN	O	olanzapine	prep_of	14	SENT_90	[p6l1896t13r2144b70, p6l8t97r174b168],
21	.	.	O	.	_	0	SENT_90	[p6l1896t13r2144b70, p6l8t97r174b168],

1	Although	IN	O	although	mark	5	SENT_91	[p6l196t96r539b168],
2	,	,	O	,	_	0	SENT_91	[p6l196t96r539b168],
3	genetics	NNS	O	genetics	nsubj	5	SENT_91	[p6l562t97r843b168],
4	may	MD	O	may	aux	5	SENT_91	[p6l864t116r1012b168],
5	play	VB	O	play	advcl	21	SENT_91	[p6l1030t96r1178b168],
6	a	DT	O	a	det	7	SENT_91	[p6l1199t116r1237b154],
7	role	NN	O	role	dobj	5	SENT_91	[p6l1255t96r1386b154],
8	in	IN	O	in	_	0	SENT_91	[p6l1406t97r1473b153],
9	the	DT	O	the	det	10	SENT_91	[p6l1492t96r1603b154],
10	development	NN	O	development	prep_in	7	SENT_91	[p6l1624t96r2066b168],
11	of	IN	O	of	_	0	SENT_91	[p6l2086t96r2154b154],
12	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_91	[p6l10t180r373b252],
13	weight	NN	O	weight	nn	14	SENT_91	[p6l416t180r651b252],
14	gain	NN	O	gain	prep_of	10	SENT_91	[p6l694t181r844b252],
15	from	IN	O	from	_	0	SENT_91	[p6l887t180r1048b238],
16	atypical	JJ	O	atypical	amod	17	SENT_91	[p6l1093t180r1366b252],
17	antipsychotics	NNS	O	antipsychotic	prep_from	5	SENT_91	[p6l1411t180r1923b252],
18	,	,	O	,	_	0	SENT_91	[p6l1411t180r1923b252],
19	additional	JJ	O	additional	amod	20	SENT_91	[p6l1973t180r2143b238, p6l8t264r209b322],
20	factors	NNS	O	factor	nsubj	21	SENT_91	[p6l230t264r463b322],
21	need	VBP	O	need	_	0	SENT_91	[p6l486t264r649b322],
22	to	TO	O	to	aux	24	SENT_91	[p6l669t269r733b322],
23	be	VB	O	be	auxpass	24	SENT_91	[p6l753t264r832b322],
24	taken	VBN	O	take	xcomp	21	SENT_91	[p6l853t264r1051b322],
25	into	IN	O	into	_	0	SENT_91	[p6l1073t265r1205b322],
26	consideration	NN	O	consideration	prep_into	24	SENT_91	[p6l1229t264r1696b322],
27	such	JJ	O	such	_	0	SENT_91	[p6l1719t264r1876b322],
28	as	IN	O	as	_	0	SENT_91	[p6l1900t284r1972b322],
29	diet	NN	O	diet	nn	31	SENT_91	[p6l1994t264r2142b334],
30	,	,	O	,	_	0	SENT_91	[p6l1994t264r2142b334],
31	exercise	NN	O	exercise	prep_such_as	26	SENT_91	[p6l9t349r304b418],
32	,	,	O	,	_	0	SENT_91	[p6l9t349r304b418],
33	and	CC	O	and	_	0	SENT_91	[p6l338t348r466b406],
34	schizophrenia	NN	O	schizophrenia	nn	35	SENT_91	[p6l496t348r979b420],
35	symptomatology	NN	O	symptomatology	conj_and	31	SENT_91	[p6l1008t348r1593b420],
36	.	.	O	.	_	0	SENT_91	[p6l1008t348r1593b420],

1	Unfortunately	RB	O	unfortunately	advmod	8	SENT_92	[p6l1626t348r2141b420],
2	,	,	O	,	_	0	SENT_92	[p6l1626t348r2141b420],
3	diet	NN	O	diet	nsubjpass	8	SENT_92	[p6l9t433r140b490],
4	and	CC	O	and	_	0	SENT_92	[p6l171t433r298b490],
5	exercise	NN	O	exercise	nsubjpass	8	SENT_92	[p6l328t434r605b490],
6	were	VBD	O	be	auxpass	8	SENT_92	[p6l633t452r800b490],
7	not	RB	O	not	neg	8	SENT_92	[p6l829t438r940b491],
8	monitored	VBN	O	monitor	_	0	SENT_92	[p6l969t433r1324b490],
9	due	JJ	O	due	_	0	SENT_92	[p6l1353t433r1477b490],
10	to	TO	O	to	_	0	SENT_92	[p6l1506t438r1570b490],
11	the	DT	O	the	det	13	SENT_92	[p6l1600t433r1710b490],
12	naturalistic	JJ	O	naturalistic	amod	13	SENT_92	[p6l1740t433r2145b490],
13	nature	NN	O	nature	prep_due_to	8	SENT_92	[p6l9t522r241b574],
14	of	IN	O	of	_	0	SENT_92	[p6l265t517r332b574],
15	this	DT	O	this	det	16	SENT_92	[p6l345t517r477b574],
16	study	NN	O	study	prep_of	13	SENT_92	[p6l500t517r707b589],
17	.	.	O	.	_	0	SENT_92	[p6l500t517r707b589],

1	Anecdotally	RB	O	anecdotally	advmod	5	SENT_93	[p6l82t601r496b673],
2	it	PRP	O	it	nsubjpass	5	SENT_93	[p6l512t602r562b658],
3	has	VBZ	O	have	aux	5	SENT_93	[p6l577t601r697b658],
4	been	VBN	O	be	auxpass	5	SENT_93	[p6l712t601r875b658],
5	suggested	VBN	O	suggest	_	0	SENT_93	[p6l894t601r1235b673],
6	that	IN	O	that	complm	18	SENT_93	[p6l1251t601r1395b658],
7	patients	NNS	O	patient	nsubj	18	SENT_93	[p6l1411t602r1695b673],
8	who	WP	O	who	nsubj	9	SENT_93	[p6l1711t601r1851b658],
9	gain	VB	O	gain	rcmod	7	SENT_93	[p6l1868t602r2018b673],
10	the	DT	O	the	dobj	9	SENT_93	[p6l2034t601r2145b658],
11	most	RBS	O	most	advmod	10	SENT_93	[p6l9t690r175b742],
12	amount	VB	O	amount	dep	9	SENT_93	[p6l193t690r457b742],
13	of	IN	O	of	_	0	SENT_93	[p6l474t685r542b742],
14	weight	NN	O	weight	prep_of	12	SENT_93	[p6l549t685r784b757],
15	from	IN	O	from	_	0	SENT_93	[p6l800t685r962b742],
16	atypical	JJ	O	atypical	amod	17	SENT_93	[p6l980t685r1253b757],
17	antipsychotics	NNS	O	antipsychotic	prep_from	12	SENT_93	[p6l1272t685r1766b757],
18	do	VBP	O	do	ccomp	5	SENT_93	[p6l1785t685r1861b742],
19	the	DT	O	the	det	20	SENT_93	[p6l1877t685r1988b742],
20	best	JJS	O	best	iobj	18	SENT_93	[p6l2003t685r2146b742],
21	clinically	RB	O	clinically	amod	23	SENT_93	[p6l9t768r322b841],
22	[	CD	NUMBER	[	tmod	21	SENT_93	[p6l347t770r615b834],
23	Basson	NNP	PERSON	Basson	dobj	18	SENT_93	[p6l347t770r615b834],
24	et	FW	O	et	nn	25	SENT_93	[p6l637t774r701b826],
25	al.	FW	O	al.	dep	23	SENT_93	[p6l724t769r824b839],
26	,	,	O	,	_	0	SENT_93	[p6l724t769r824b839],
27	2001	CD	DATE	2001	num	28	SENT_93	[p6l850t770r1033b834],
28	]	CD	NUMBER	]	appos	25	SENT_93	[p6l850t770r1033b834],
29	although	IN	O	although	mark	48	SENT_93	[p6l1061t768r1369b841],
30	in	IN	O	in	_	0	SENT_93	[p6l1392t770r1458b825],
31	comparing	VBG	O	compare	prepc_in	48	SENT_93	[p6l1481t770r1849b841],
32	subjects	NNS	O	subject	dobj	31	SENT_93	[p6l1869t768r2145b840],
33	based	VBN	O	base	_	0	SENT_93	[p6l7t852r206b910],
34	on	IN	O	on	prepc_based_on	31	SENT_93	[p6l240t872r321b910],
35	the	DT	O	the	det	40	SENT_93	[p6l355t852r465b910],
36	10	CD	PERCENT	10	number	37	SENT_93	[p6l505t855r642b910],
37	%	NN	PERCENT	%	amod	40	SENT_93	[p6l505t855r642b910],
38	weight	NN	O	weight	nn	40	SENT_93	[p6l677t852r912b924],
39	gain	NN	O	gain	nn	40	SENT_93	[p6l947t853r1096b924],
40	threshold	NN	O	threshold	pobj	31	SENT_93	[p6l1130t852r1479b923],
41	,	,	O	,	_	0	SENT_93	[p6l1130t852r1479b923],
42	no	DT	O	no	det	44	SENT_93	[p6l1516t872r1597b910],
43	signiﬁcant	JJ	O	signiﬁcant	amod	44	SENT_93	[p6l1634t852r1997b924],
44	differences	NNS	O	difference	nsubjpass	48	SENT_93	[p6l2032t852r2144b910, p6l9t936r293b994],
45	in	IN	O	in	_	0	SENT_93	[p6l318t937r385b993],
46	psychopathology	NN	O	psychopathology	prep_in	44	SENT_93	[p6l408t936r986b1008],
47	were	VBD	O	be	auxpass	48	SENT_93	[p6l1009t956r1175b994],
48	found	VBN	O	find	dep	23	SENT_93	[p6l1199t936r1396b994],
49	(	RB	O	(	advmod	48	SENT_93	[p6l1423t936r1637b1002],
50	Table	NNP	O	Table	nn	52	SENT_93	[p6l1423t936r1637b1002],
51	III	NNP	O	III	nn	52	SENT_93	[p6l1662t937r1793b1002],
52	)	NN	O	)	dobj	48	SENT_93	[p6l1662t937r1793b1002],
53	.	.	O	.	_	0	SENT_93	[p6l1662t937r1793b1002],

1	Additionally	RB	O	additionally	advmod	4	SENT_94	[p6l1819t936r2144b994, p6l11t1020r153b1092],
2	,	,	O	,	_	0	SENT_94	[p6l1819t936r2144b994, p6l11t1020r153b1092],
3	there	EX	O	there	expl	4	SENT_94	[p6l178t1020r360b1078],
4	were	VBD	O	be	_	0	SENT_94	[p6l383t1040r548b1078],
5	no	DT	O	no	det	6	SENT_94	[p6l570t1040r651b1078],
6	differences	NNS	O	difference	nsubj	4	SENT_94	[p6l674t1020r1050b1078],
7	in	IN	O	in	_	0	SENT_94	[p6l1073t1021r1139b1077],
8	the	DT	O	the	det	11	SENT_94	[p6l1160t1020r1271b1078],
9	dosage	NN	O	dosage	nn	11	SENT_94	[p6l1294t1020r1526b1092],
10	(	NN	O	(	nn	11	SENT_94	[p6l1552t1020r1849b1092],
11	mg/day	NN	O	mg/day	prep_in	6	SENT_94	[p6l1552t1020r1849b1092],
12	)	CD	NUMBER	)	dep	11	SENT_94	[p6l1552t1020r1849b1092],
13	or	CC	O	or	_	0	SENT_94	[p6l1874t1040r1943b1078],
14	blood	NN	O	blood	nn	15	SENT_94	[p6l1962t1020r2146b1078],
15	level	NN	O	level	prep_in	6	SENT_94	[p6l9t1104r170b1162],
16	of	IN	O	of	_	0	SENT_94	[p6l192t1104r260b1162],
17	olanzapine	NN	O	olanzapine	prep_of	15	SENT_94	[p6l274t1104r650b1176],
18	between	IN	O	between	_	0	SENT_94	[p6l670t1104r960b1162],
19	these	DT	O	these	det	25	SENT_94	[p6l981t1104r1165b1162],
20	two	CD	NUMBER	two	num	21	SENT_94	[p6l1186t1109r1309b1162],
21	groups	NNS	O	group	dep	22	SENT_94	[p6l1333t1122r1566b1176],
22	(	RB	O	(	amod	25	SENT_94	[p6l1592t1104r1806b1169],
23	Table	NNP	O	Table	nn	25	SENT_94	[p6l1592t1104r1806b1169],
24	III	NNP	O	III	nn	25	SENT_94	[p6l1830t1104r1960b1170],
25	)	NN	O	)	prep_between	17	SENT_94	[p6l1830t1104r1960b1170],
26	.	.	O	.	_	0	SENT_94	[p6l1830t1104r1960b1170],

1	Thus	RB	O	thus	advmod	6	SENT_95	[p6l84t1189r278b1259],
2	,	,	O	,	_	0	SENT_95	[p6l84t1189r278b1259],
3	this	DT	O	this	det	5	SENT_95	[p6l307t1189r438b1246],
4	preliminary	JJ	O	preliminary	amod	5	SENT_95	[p6l463t1189r878b1261],
5	study	NN	O	study	nsubj	6	SENT_95	[p6l906t1189r1097b1261],
6	supports	VBZ	O	support	_	0	SENT_95	[p6l1123t1194r1422b1261],
7	a	DT	O	a	det	9	SENT_95	[p6l1450t1208r1488b1246],
8	potential	JJ	O	potential	amod	9	SENT_95	[p6l1512t1189r1823b1261],
9	relationship	NN	O	relationship	dobj	6	SENT_95	[p6l1848t1189r2143b1246, p6l10t1272r153b1344],
10	between	IN	O	between	_	0	SENT_95	[p6l187t1272r476b1330],
11	the	DT	O	the	det	14	SENT_95	[p6l510t1272r620b1330],
12	—	NN	O	—	nn	14	SENT_95	[p6l660t1272r963b1336],
13	759C/T	NN	O	759c/t	nn	14	SENT_95	[p6l660t1272r963b1336],
14	polymorphism	NN	O	polymorphism	prep_between	9	SENT_95	[p6l997t1272r1494b1344],
15	of	IN	O	of	_	0	SENT_95	[p6l1529t1272r1597b1330],
16	the	DT	O	the	det	18	SENT_95	[p6l1623t1272r1734b1330],
17	5HT2C	NN	O	5ht2c	nn	18	SENT_95	[p6l1770t1272r2016b1330],
18	receptor	NN	O	receptor	prep_of	14	SENT_95	[p6l2051t1292r2144b1330, p6l9t1361r222b1428],
19	and	CC	O	and	_	0	SENT_95	[p6l244t1356r372b1414],
20	signiﬁcant	JJ	O	signiﬁcant	amod	22	SENT_95	[p6l393t1356r756b1428],
21	weight	NN	O	weight	nn	22	SENT_95	[p6l776t1356r1011b1428],
22	gain	NN	O	gain	prep_of	14	SENT_95	[p6l1031t1357r1181b1428],
23	with	IN	O	with	_	0	SENT_95	[p6l1201t1356r1357b1414],
24	olanzapine	NN	O	olanzapine	nn	25	SENT_95	[p6l1378t1356r1754b1428],
25	treatment	NN	O	treatment	prep_with	18	SENT_95	[p6l1774t1361r2141b1414],
26	.	.	O	.	_	0	SENT_95	[p6l1774t1361r2141b1414],

1	The	DT	O	the	det	3	SENT_96	[p6l8t1440r140b1498],
2	allele	NN	O	allele	nn	3	SENT_96	[p6l184t1440r367b1498],
3	distribution	NN	O	distribution	_	0	SENT_96	[p6l409t1440r820b1498],
4	reveals	VBZ	O	reveal	rcmod	3	SENT_96	[p6l861t1440r1109b1498],
5	48	CD	PERCENT	48	number	6	SENT_96	[p6l1151t1442r1293b1498],
6	%	NN	PERCENT	%	amod	7	SENT_96	[p6l1151t1442r1293b1498],
7	sensitivity	NN	O	sensitivity	dobj	4	SENT_96	[p6l1338t1441r1699b1512],
8	(	CD	NUMBER	(	number	9	SENT_96	[p6l1742t1440r1973b1505],
9	15/31	CD	NUMBER	15/31	num	10	SENT_96	[p6l1742t1440r1973b1505],
10	)	NN	O	)	dep	7	SENT_96	[p6l1742t1440r1973b1505],
11	and	CC	O	and	_	0	SENT_96	[p6l2019t1440r2147b1498],
12	100	CD	PERCENT	100	number	13	SENT_96	[p6l14t1526r193b1582],
13	%	NN	PERCENT	%	amod	15	SENT_96	[p6l14t1526r193b1582],
14	speciﬁcity	NN	O	speciﬁcity	nn	15	SENT_96	[p6l228t1524r572b1596],
15	(	NN	O	(	dobj	4	SENT_96	[p6l607t1524r665b1589],
16	1	CD	NUMBER	1	number	17	SENT_96	[p6l607t1524r665b1589],
17	1	CD	NUMBER	1	num	15	SENT_96	[p6l678t1524r734b1588],
18	/	:	O	/	punct	3	SENT_96	[p6l678t1524r734b1588],
19	11	CD	NUMBER	11	num	21	SENT_96	[p6l741t1524r838b1589],
20	)	NN	O	)	nn	21	SENT_96	[p6l741t1524r838b1589],
21	statistics	NNS	O	statistics	nsubj	22	SENT_96	[p6l875t1525r1185b1582],
22	(	VBP	O	(	dep	3	SENT_96	[p6l1221t1524r1350b1589],
23	see	VB	O	see	xcomp	22	SENT_96	[p6l1221t1524r1350b1589],
24	Table	NNP	O	Table	dobj	23	SENT_96	[p6l1383t1524r1576b1582],
25	I	PRP	O	I	nsubj	26	SENT_96	[p6l1610t1524r1679b1589],
26	)	VBP	O	)	rcmod	24	SENT_96	[p6l1610t1524r1679b1589],
27	.	.	O	.	_	0	SENT_96	[p6l1610t1524r1679b1589],

1	This	DT	O	this	det	2	SENT_97	[p6l1715t1524r1868b1582],
2	ﬁnding	NN	O	ﬁnding	nsubj	3	SENT_97	[p6l1901t1524r2149b1596],
3	indicates	VBZ	O	indicate	_	0	SENT_97	[p6l9t1609r320b1666],
4	that	IN	O	that	complm	12	SENT_97	[p6l349t1609r494b1666],
5	patients	NNS	O	patient	nsubj	12	SENT_97	[p6l522t1610r806b1681],
6	with	IN	O	with	_	0	SENT_97	[p6l835t1609r991b1666],
7	the	DT	O	the	det	10	SENT_97	[p6l1020t1609r1131b1666],
8	variant	JJ	O	variant	amod	10	SENT_97	[p6l1160t1610r1416b1666],
9	T	NN	O	t	nn	10	SENT_97	[p6l1444t1610r1493b1665],
10	allele	NN	O	allele	prep_with	5	SENT_97	[p6l1524t1609r1707b1666],
11	may	MD	O	may	aux	12	SENT_97	[p6l1737t1628r1885b1681],
12	have	VB	O	have	ccomp	3	SENT_97	[p6l1912t1609r2077b1666],
13	a	DT	O	a	det	15	SENT_97	[p6l2109t1628r2147b1666],
14	lower	JJR	O	lower	amod	15	SENT_97	[p6l9t1693r198b1750],
15	incidence	NN	O	incidence	dobj	12	SENT_97	[p6l244t1693r567b1750],
16	of	IN	O	of	_	0	SENT_97	[p6l613t1693r681b1750],
17	gaining	VBG	O	gain	prepc_of	15	SENT_97	[p6l718t1694r982b1765],
18	substantial	JJ	O	substantial	amod	19	SENT_97	[p6l1026t1693r1415b1750],
19	amounts	NNS	O	amount	dobj	17	SENT_97	[p6l1462t1698r1760b1750],
20	of	IN	O	of	_	0	SENT_97	[p6l1807t1693r1874b1750],
21	weight	NN	O	weight	prep_of	19	SENT_97	[p6l1910t1693r2146b1765],
22	compared	VBN	O	compare	_	0	SENT_97	[p6l9t1777r345b1849],
23	to	TO	O	to	prepc_compared_to	17	SENT_97	[p6l366t1782r430b1834],
24	patients	NNS	O	patient	pobj	17	SENT_97	[p6l452t1778r736b1849],
25	with	IN	O	with	_	0	SENT_97	[p6l757t1777r913b1834],
26	the	DT	O	the	det	28	SENT_97	[p6l936t1777r1046b1834],
27	C	NN	O	c	nn	28	SENT_97	[p6l1070t1777r1119b1834],
28	allele	NN	O	allele	prep_with	24	SENT_97	[p6l1144t1777r1345b1834],
29	.	.	O	.	_	0	SENT_97	[p6l1144t1777r1345b1834],

1	TABLE	NN	O	table	_	0	SENT_98	[p6l453t1909r567b1934],
2	II	CD	NUMBER	ii	dep	1	SENT_98	[p6l580t1910r613b1935],
3	.	.	O	.	_	0	SENT_98	[p6l580t1910r613b1935],

1	Differences	NNS	O	difference	nsubj	6	SENT_99	[p6l633t1909r805b1935],
2	in	IN	O	in	_	0	SENT_99	[p6l816t1910r845b1934],
3	Changes	NNS	O	change	prep_in	1	SENT_99	[p6l857t1909r988b1941],
4	in	IN	O	in	_	0	SENT_99	[p6l999t1910r1028b1934],
5	Psychopathology	NNP	O	Psychopathology	prep_in	3	SENT_99	[p6l1040t1909r1296b1941],
6	Based	VBD	O	base	_	0	SENT_99	[p6l1305t1909r1398b1935],
7	on	IN	O	on	_	0	SENT_99	[p6l1409t1918r1445b1935],
8	Genotype	NNP	O	Genotype	nn	9	SENT_99	[p6l1457t1909r1600b1941],
9	Group	NNP	O	Group	prep_on	6	SENT_99	[p6l1612t1909r1707b1941],

1	C	NN	O	c	_	0	SENT_100	[p6l1066t1973r1087b1999],
2	allele	NN	O	allele	nn	5	SENT_100	[p6l1100t1973r1180b1999],
3	T	NN	O	t	nn	5	SENT_100	[p6l1412t1974r1434b1999],
4	allele	NN	O	allele	nn	5	SENT_100	[p6l1445t1973r1526b1999],
5	P-value	NN	O	p-value	dep	1	SENT_100	[p6l1706t1973r1823b1999],

1	Mean	NN	O	mean	nn	2	SENT_101	[p6l332t2042r418b2067],
2	change	NN	O	change	_	0	SENT_101	[p6l429t2041r536b2073],
3	(	CD	NUMBER	(	dep	2	SENT_101	[p6l549t2041r639b2070],
4	:	:	O	:	_	0	SENT_101	[p6l549t2041r639b2070],
5	:	:	O	:	_	0	SENT_101	[p6l549t2041r639b2070],
6	SD	NN	O	sd	nn	7	SENT_101	[p6l549t2041r639b2070],
7	)	NN	O	)	dep	8	SENT_101	[p6l549t2041r639b2070],
8	in	IN	O	in	dep	26	SENT_101	[p6l652t2042r681b2066],
9	SANS	NN	O	san	nn	10	SENT_101	[p6l693t2041r783b2067],
10	score	NN	PERCENT	score	pobj	8	SENT_101	[p6l795t2050r871b2067],
11	23.7	CD	PERCENT	23.7	number	12	SENT_101	[p6l1016t2042r1106b2067],
12	%	NN	PERCENT	%	amod	10	SENT_101	[p6l1016t2042r1106b2067],
13	(	CD	PERCENT	(	number	14	SENT_101	[p6l1118t2041r1229b2070],
14	38.8	CD	PERCENT	38.8	dep	15	SENT_101	[p6l1118t2041r1229b2070],
15	%	NN	PERCENT	%	dep	10	SENT_101	[p6l1118t2041r1229b2070],
16	)	CD	PERCENT	)	number	17	SENT_101	[p6l1118t2041r1229b2070],
17	27.2	CD	PERCENT	27.2	dep	18	SENT_101	[p6l1362t2042r1452b2067],
18	%	NN	PERCENT	%	dep	10	SENT_101	[p6l1362t2042r1452b2067],
19	(	CD	PERCENT	(	number	20	SENT_101	[p6l1465t2041r1575b2070],
20	27.6	CD	PERCENT	27.6	dep	21	SENT_101	[p6l1465t2041r1575b2070],
21	%	NN	PERCENT	%	dep	10	SENT_101	[p6l1465t2041r1575b2070],
22	)	CD	NUMBER	)	number	23	SENT_101	[p6l1465t2041r1575b2070],
23	0.78	CD	NUMBER	0.78	num	25	SENT_101	[p6l1735t2042r1797b2067],
24	Mean	NN	O	mean	nn	25	SENT_101	[p6l332t2079r418b2103],
25	change	NN	O	change	dep	10	SENT_101	[p6l429t2078r536b2110],
26	(	CD	NUMBER	(	dep	2	SENT_101	[p6l549t2078r640b2107],
27	:	:	O	:	_	0	SENT_101	[p6l549t2078r640b2107],
28	:	:	O	:	_	0	SENT_101	[p6l549t2078r640b2107],
29	SD	NN	O	sd	nn	30	SENT_101	[p6l549t2078r640b2107],
30	)	NN	O	)	dep	31	SENT_101	[p6l549t2078r640b2107],
31	in	IN	O	in	dep	49	SENT_101	[p6l652t2079r681b2103],
32	BPRS	NN	O	bpr	nn	33	SENT_101	[p6l692t2078r781b2104],
33	score	NN	PERCENT	score	pobj	31	SENT_101	[p6l793t2087r870b2104],
34	21.8	CD	PERCENT	21.8	number	35	SENT_101	[p6l1016t2079r1106b2104],
35	%	NN	PERCENT	%	amod	33	SENT_101	[p6l1016t2079r1106b2104],
36	(	CD	PERCENT	(	number	37	SENT_101	[p6l1118t2078r1229b2107],
37	24.6	CD	PERCENT	24.6	dep	38	SENT_101	[p6l1118t2078r1229b2107],
38	%	NN	PERCENT	%	dep	33	SENT_101	[p6l1118t2078r1229b2107],
39	)	CD	PERCENT	)	number	40	SENT_101	[p6l1118t2078r1229b2107],
40	24.2	CD	PERCENT	24.2	dep	41	SENT_101	[p6l1362t2079r1452b2104],
41	%	NN	PERCENT	%	dep	33	SENT_101	[p6l1362t2079r1452b2104],
42	(	CD	PERCENT	(	number	43	SENT_101	[p6l1465t2078r1575b2107],
43	19.5	CD	PERCENT	19.5	dep	44	SENT_101	[p6l1465t2078r1575b2107],
44	%	NN	PERCENT	%	dep	33	SENT_101	[p6l1465t2078r1575b2107],
45	)	CD	NUMBER	)	number	46	SENT_101	[p6l1465t2078r1575b2107],
46	0.77	CD	NUMBER	0.77	num	48	SENT_101	[p6l1735t2079r1796b2104],
47	Mean	NN	O	mean	nn	48	SENT_101	[p6l332t2115r418b2141],
48	weight	NN	O	weight	dep	33	SENT_101	[p6l429t2115r532b2147],
49	(	CD	NUMBER	(	dep	26	SENT_101	[p6l544t2115r635b2144],
50	:	:	O	:	_	0	SENT_101	[p6l544t2115r635b2144],
51	:	:	O	:	_	0	SENT_101	[p6l544t2115r635b2144],
52	SD	NN	O	sd	nn	53	SENT_101	[p6l544t2115r635b2144],
53	)	NN	O	)	npadvmod	26	SENT_101	[p6l544t2115r635b2144],
54	at	IN	O	at	_	0	SENT_101	[p6l648t2117r677b2141],
55	baseline	NN	O	baseline	nn	58	SENT_101	[p6l687t2115r813b2141],
56	(	CD	NUMBER	(	num	58	SENT_101	[p6l825t2115r881b2147],
57	kg	NN	O	kg	nn	58	SENT_101	[p6l825t2115r881b2147],
58	)	NN	O	)	prep_at	26	SENT_101	[p6l825t2115r881b2147],
59	79.9	CD	NUMBER	79.9	number	60	SENT_101	[p6l1045t2116r1106b2141],
60	(	CD	NUMBER	(	dep	2	SENT_101	[p6l1118t2115r1201b2144],
61	22.4	CD	NUMBER	22.4	num	62	SENT_101	[p6l1118t2115r1201b2144],
62	)	NN	O	)	dep	60	SENT_101	[p6l1118t2115r1201b2144],
63	85.2	CD	NUMBER	85.2	number	64	SENT_101	[p6l1390t2116r1452b2141],
64	(	CD	NUMBER	(	dep	60	SENT_101	[p6l1465t2115r1520b2144],
65	16	CD	NUMBER	16	num	66	SENT_101	[p6l1465t2115r1520b2144],
66	)	NN	O	)	dep	64	SENT_101	[p6l1465t2115r1520b2144],
67	0.48	CD	NUMBER	0.48	dep	64	SENT_101	[p6l1735t2116r1797b2141],

1	78	CD	NUMBER	78	num	2	SENT_102	[p6l197t2252r232b2277],
2	Ellingrod	NNP	O	Ellingrod	_	0	SENT_102	[p6l333t2251r502b2283],
3	et	FW	O	et	nn	4	SENT_102	[p6l513t2253r546b2277],
4	al.	FW	O	al.	dep	2	SENT_102	[p6l558t2251r598b2277],
5	.	.	O	.	_	0	SENT_102	[p6l558t2251r598b2277],

1	TABLE	NN	O	table	_	0	SENT_103	[p6l582t2333r696b2358],
2	III	CD	NUMBER	iii	dep	1	SENT_103	[p6l709t2333r756b2359],
3	.	.	O	.	_	0	SENT_103	[p6l709t2333r756b2359],

1	Differences	NNS	O	difference	_	0	SENT_104	[p6l775t2333r947b2359],
2	in	IN	O	in	_	0	SENT_104	[p6l958t2333r988b2358],
3	Changes	NNS	MISC	change	prep_in	1	SENT_104	[p6l1000t2333r1130b2365],
4	in	IN	MISC	in	_	0	SENT_104	[p6l1141t2333r1171b2358],
5	Psychopathology	NN	MISC	psychopathology	prep_in	3	SENT_104	[p6l1182t2333r1445b2365],
6	,	,	O	,	_	0	SENT_104	[p6l1182t2333r1445b2365],
7	and	CC	O	and	_	0	SENT_104	[p6l1459t2333r1515b2359],
8	Olanzapine	NNP	O	Olanzapine	nn	9	SENT_104	[p6l1526t2333r1700b2365],
9	Dose	NNP	O	Dose	conj_and	3	SENT_104	[p6l1711t2333r1784b2359],
10	and	CC	O	and	advmod	9	SENT_104	[p6l1796t2333r1852b2359],

1	Plasma	NN	O	plasma	nn	2	SENT_105	[p6l798t2370r911b2396],
2	Level	NNP	O	Level	nsubj	3	SENT_105	[p6l922t2370r1004b2396],
3	Based	VBD	O	base	_	0	SENT_105	[p6l1014t2370r1107b2396],
4	on	IN	O	on	_	0	SENT_105	[p6l1118t2379r1154b2396],
5	Weight	NNP	O	Weight	nn	7	SENT_105	[p6l1163t2370r1274b2402],
6	Gain	NNP	O	Gain	nn	7	SENT_105	[p6l1286t2370r1359b2396],
7	Threshold	NNP	O	Threshold	prep_on	3	SENT_105	[p6l1369t2370r1524b2396],
8	of	IN	O	of	_	0	SENT_105	[p6l1535t2370r1565b2396],
9	10	CD	PERCENT	10	num	10	SENT_105	[p6l1575t2371r1635b2396],
10	%	NN	PERCENT	%	prep_of	7	SENT_105	[p6l1575t2371r1635b2396],

1	210	CD	PERCENT	210	num	2	SENT_106	[p6l1131t2440r1216b2469],
2	%	NN	PERCENT	%	_	0	SENT_106	[p6l1131t2440r1216b2469],
3	Weight	NNP	O	Weight	dep	2	SENT_106	[p6l1227t2439r1338b2471],
4	gain	NN	O	gain	nn	9	SENT_106	[p6l1349t2440r1415b2471],
5	<	JJR	O	<	amod	9	SENT_106	[p6l1485t2440r1571b2465],
6	10	CD	PERCENT	10	num	7	SENT_106	[p6l1485t2440r1571b2465],
7	%	NN	PERCENT	%	dep	5	SENT_106	[p6l1485t2440r1571b2465],
8	Weight	NNP	O	Weight	nn	9	SENT_106	[p6l1581t2439r1692b2471],
9	gain	NN	O	gain	dep	3	SENT_106	[p6l1703t2440r1769b2471],
10	P-Value	NN	O	p-value	dep	2	SENT_106	[p6l1839t2439r1957b2465],

1	Mean	NN	O	mean	_	0	SENT_107	[p6l469t2510r555b2535],
2	change	NN	O	change	rcmod	1	SENT_107	[p6l566t2509r673b2541],
3	(	CD	NUMBER	(	dep	2	SENT_107	[p6l686t2509r777b2538],
4	:	:	O	:	_	0	SENT_107	[p6l686t2509r777b2538],
5	:	:	O	:	_	0	SENT_107	[p6l686t2509r777b2538],
6	SD	NN	O	sd	nn	7	SENT_107	[p6l686t2509r777b2538],
7	)	NN	O	)	dep	1	SENT_107	[p6l686t2509r777b2538],
8	in	IN	O	in	_	0	SENT_107	[p6l789t2510r818b2534],
9	SANS	NN	O	san	nn	10	SENT_107	[p6l830t2509r920b2535],
10	score	NN	PERCENT	score	prep_in	7	SENT_107	[p6l932t2518r1008b2535],
11	28	CD	PERCENT	28	num	12	SENT_107	[p6l1179t2510r1241b2535],
12	%	NN	PERCENT	%	rcmod	10	SENT_107	[p6l1179t2510r1241b2535],
13	(	CD	PERCENT	(	number	14	SENT_107	[p6l1254t2509r1364b2538],
14	30.4	CD	PERCENT	30.4	num	15	SENT_107	[p6l1254t2509r1364b2538],
15	%	NN	PERCENT	%	dep	12	SENT_107	[p6l1254t2509r1364b2538],
16	)	CD	PERCENT	)	num	18	SENT_107	[p6l1254t2509r1364b2538],
17	23	CD	PERCENT	23	num	18	SENT_107	[p6l1533t2510r1595b2535],
18	%	NN	PERCENT	%	dep	12	SENT_107	[p6l1533t2510r1595b2535],
19	(	CD	PERCENT	(	number	20	SENT_107	[p6l1608t2509r1718b2538],
20	38.6	CD	PERCENT	38.6	num	21	SENT_107	[p6l1608t2509r1718b2538],
21	%	NN	PERCENT	%	dep	18	SENT_107	[p6l1608t2509r1718b2538],
22	)	CD	NUMBER	)	dep	18	SENT_107	[p6l1608t2509r1718b2538],
23	0.69	CD	NUMBER	0.69	num	25	SENT_107	[p6l1868t2510r1930b2535],
24	Mean	NN	O	mean	nn	25	SENT_107	[p6l469t2547r555b2572],
25	change	NN	O	change	rcmod	22	SENT_107	[p6l566t2546r673b2578],
26	(	CD	NUMBER	(	dep	25	SENT_107	[p6l686t2546r776b2575],
27	:	:	O	:	_	0	SENT_107	[p6l686t2546r776b2575],
28	:	:	O	:	_	0	SENT_107	[p6l686t2546r776b2575],
29	SD	NN	O	sd	nn	30	SENT_107	[p6l686t2546r776b2575],
30	)	NN	O	)	dep	12	SENT_107	[p6l686t2546r776b2575],
31	in	IN	O	in	_	0	SENT_107	[p6l789t2547r818b2572],
32	BPRS	NN	O	bpr	nn	33	SENT_107	[p6l829t2546r918b2572],
33	score	NN	PERCENT	score	prep_in	30	SENT_107	[p6l930t2555r1006b2572],
34	29.5	CD	PERCENT	29.5	num	35	SENT_107	[p6l1151t2547r1240b2572],
35	%	NN	PERCENT	%	dep	47	SENT_107	[p6l1151t2547r1240b2572],
36	(	CD	PERCENT	(	num	38	SENT_107	[p6l1253t2546r1336b2575],
37	24	CD	PERCENT	24	num	38	SENT_107	[p6l1253t2546r1336b2575],
38	%	NN	PERCENT	%	dep	35	SENT_107	[p6l1253t2546r1336b2575],
39	)	CD	PERCENT	)	number	40	SENT_107	[p6l1253t2546r1336b2575],
40	18.5	CD	PERCENT	18.5	num	41	SENT_107	[p6l1507t2547r1594b2572],
41	%	NN	PERCENT	%	dep	38	SENT_107	[p6l1507t2547r1594b2572],
42	(	CD	PERCENT	(	number	43	SENT_107	[p6l1607t2546r1690b2575],
43	22	CD	PERCENT	22	dep	44	SENT_107	[p6l1607t2546r1690b2575],
44	%	NN	PERCENT	%	dep	41	SENT_107	[p6l1607t2546r1690b2575],
45	)	CD	NUMBER	)	dep	47	SENT_107	[p6l1607t2546r1690b2575],
46	0.15	CD	NUMBER	0.15	num	47	SENT_107	[p6l1868t2547r1929b2572],
47	Mean	NN	O	mean	dep	30	SENT_107	[p6l469t2584r555b2610],
48	olanzapine	NN	O	olanzapine	nn	50	SENT_107	[p6l566t2584r731b2616],
49	dose	NN	O	dose	nn	50	SENT_107	[p6l742t2584r808b2610],
50	(	NN	O	(	dep	47	SENT_107	[p6l821t2584r911b2613],
51	:	:	O	:	_	0	SENT_107	[p6l821t2584r911b2613],
52	:	:	O	:	_	0	SENT_107	[p6l821t2584r911b2613],
53	SD	NN	O	sd	nn	54	SENT_107	[p6l821t2584r911b2613],
54	)	NN	O	)	dep	10	SENT_107	[p6l821t2584r911b2613],
55	at	IN	O	at	_	0	SENT_107	[p6l924t2586r954b2610],
56	13.6	CD	NUMBER	13.6	number	57	SENT_107	[p6l1180t2585r1240b2610],
57	(	CD	NUMBER	(	prep_at	54	SENT_107	[p6l1253t2584r1336b2613],
58	3.05	CD	NUMBER	3.05	num	59	SENT_107	[p6l1253t2584r1336b2613],
59	)	NN	O	)	dep	67	SENT_107	[p6l1253t2584r1336b2613],
60	12.4	CD	NUMBER	12.4	number	61	SENT_107	[p6l1534t2585r1595b2610],
61	(	CD	NUMBER	(	dep	59	SENT_107	[p6l1607t2584r1690b2613],
62	3.14	CD	NUMBER	3.14	num	63	SENT_107	[p6l1607t2584r1690b2613],
63	)	NN	O	)	dep	61	SENT_107	[p6l1607t2584r1690b2613],
64	0.26	CD	NUMBER	0.26	num	65	SENT_107	[p6l1868t2585r1930b2610],
65	endpoint	NN	O	endpoint	dep	67	SENT_107	[p6l503t2621r637b2653],
66	(	CD	NUMBER	(	num	67	SENT_107	[p6l649t2621r779b2653],
67	mg/day	NN	O	mg/day	dep	72	SENT_107	[p6l649t2621r779b2653],
68	)	CD	NUMBER	)	num	71	SENT_107	[p6l649t2621r779b2653],
69	Mean	NN	O	mean	nn	71	SENT_107	[p6l469t2658r555b2684],
70	olanzapine	NN	O	olanzapine	nn	71	SENT_107	[p6l566t2658r731b2690],
71	plasma	NN	O	plasma	dep	67	SENT_107	[p6l742t2658r852b2690],
72	level	NN	O	level	dep	54	SENT_107	[p6l862t2658r933b2684],
73	(	CD	NUMBER	(	num	72	SENT_107	[p6l945t2658r1036b2687],
74	:	:	O	:	_	0	SENT_107	[p6l945t2658r1036b2687],
75	:	:	O	:	_	0	SENT_107	[p6l945t2658r1036b2687],
76	SD	NN	O	sd	dep	1	SENT_107	[p6l945t2658r1036b2687],
77	)	CD	NUMBER	)	number	78	SENT_107	[p6l945t2658r1036b2687],
78	27	CD	NUMBER	27	num	79	SENT_107	[p6l1205t2659r1240b2684],
79	(	NN	O	(	dep	76	SENT_107	[p6l1253t2658r1354b2687],
80	19.37	CD	NUMBER	19.37	number	81	SENT_107	[p6l1253t2658r1354b2687],
81	)	CD	NUMBER	)	dep	1	SENT_107	[p6l1253t2658r1354b2687],
82	22.19	CD	NUMBER	22.19	num	83	SENT_107	[p6l1515t2659r1595b2684],
83	(	NN	O	(	dep	81	SENT_107	[p6l1608t2658r1691b2687],
84	14.6	CD	NUMBER	14.6	number	85	SENT_107	[p6l1608t2658r1691b2687],
85	)	CD	NUMBER	)	num	86	SENT_107	[p6l1608t2658r1691b2687],
86	0.36	CD	NUMBER	0.36	dep	81	SENT_107	[p6l1868t2659r1930b2684],
87	at	IN	O	at	_	0	SENT_107	[p6l504t2698r533b2722],
88	endpoint	NN	O	endpoint	nn	91	SENT_107	[p6l544t2696r678b2728],
89	(	CD	NUMBER	(	num	91	SENT_107	[p6l690t2696r796b2728],
90	ng/ml	NN	O	ng/ml	nn	91	SENT_107	[p6l690t2696r796b2728],
91	)	NN	O	)	prep_at	86	SENT_107	[p6l690t2696r796b2728],

1	Along	IN	O	along	_	0	SENT_108	[p6l82t2894r288b2967],
2	with	IN	O	with	prepc_along_with	33	SENT_108	[p6l311t2894r467b2952],
3	the	DT	O	the	det	5	SENT_108	[p6l492t2894r603b2952],
4	prior	JJ	O	prior	amod	5	SENT_108	[p6l629t2896r800b2967],
5	study	NN	O	study	pobj	33	SENT_108	[p6l827t2894r1018b2967],
6	that	WDT	O	that	nsubjpass	9	SENT_108	[p6l1042t2894r1187b2952],
7	has	VBZ	O	have	aux	9	SENT_108	[p6l1212t2894r1332b2952],
8	been	VBN	O	be	auxpass	9	SENT_108	[p6l1357t2894r1520b2952],
9	done	VBN	O	do	rcmod	5	SENT_108	[p6l1546t2894r1708b2952],
10	with	IN	O	with	_	0	SENT_108	[p6l1733t2894r1890b2952],
11	risperidone	NN	O	risperidone	nn	13	SENT_108	[p6l1915t2896r2143b2967, p6l9t2978r213b3049],
12	,	,	O	,	_	0	SENT_108	[p6l1915t2896r2143b2967, p6l9t2978r213b3049],
13	chlorpromazine	NN	O	chlorpromazine	prep_with	9	SENT_108	[p6l247t2978r805b3050],
14	,	,	O	,	_	0	SENT_108	[p6l247t2978r805b3050],
15	and	CC	O	and	_	0	SENT_108	[p6l841t2978r968b3036],
16	clozapine	NN	O	clozapine	prep_with	9	SENT_108	[p6l998t2978r1336b3050],
17	,	,	O	,	_	0	SENT_108	[p6l998t2978r1336b3050],
18	and	CC	O	and	_	0	SENT_108	[p6l1371t2978r1499b3036],
19	their	PRP$	O	they	poss	20	SENT_108	[p6l1527t2978r1696b3036],
20	relationship	NN	O	relationship	prep_with	9	SENT_108	[p6l1725t2978r2144b3050],
21	with	IN	O	with	_	0	SENT_108	[p6l8t3062r164b3120],
22	the	DT	O	the	det	25	SENT_108	[p6l182t3062r293b3120],
23	—	NN	O	—	nn	25	SENT_108	[p6l317t3062r619b3126],
24	759C/T	NN	O	759c/t	nn	25	SENT_108	[p6l317t3062r619b3126],
25	polymorphism	NN	O	polymorphism	prep_with	9	SENT_108	[p6l637t3062r1152b3134],
26	,	,	O	,	_	0	SENT_108	[p6l637t3062r1152b3134],
27	the	DT	O	the	det	28	SENT_108	[p6l1174t3062r1285b3120],
28	results	NNS	O	result	nsubj	33	SENT_108	[p6l1304t3062r1541b3120],
29	of	IN	O	of	_	0	SENT_108	[p6l1561t3062r1628b3120],
30	this	DT	O	this	det	31	SENT_108	[p6l1638t3062r1770b3120],
31	study	NN	O	study	prep_of	28	SENT_108	[p6l1790t3062r1981b3134],
32	may	MD	O	may	aux	33	SENT_108	[p6l1999t3082r2147b3134],
33	have	VB	O	have	_	0	SENT_108	[p6l8t3146r173b3204],
34	important	JJ	O	important	amod	35	SENT_108	[p6l214t3147r563b3218],
35	implications	NNS	O	implication	dobj	33	SENT_108	[p6l604t3146r1030b3218],
36	as	IN	O	as	mark	38	SENT_108	[p6l1073t3166r1144b3204],
37	we	PRP	O	we	nsubj	38	SENT_108	[p6l1184t3166r1279b3204],
38	continue	VBP	O	continue	advcl	33	SENT_108	[p6l1320t3147r1618b3204],
39	our	PRP$	O	we	poss	40	SENT_108	[p6l1660t3166r1775b3204],
40	search	NN	O	search	dobj	38	SENT_108	[p6l1817t3146r2040b3204],
41	to	TO	O	to	aux	42	SENT_108	[p6l2081t3151r2145b3204],
42	determine	VB	O	determine	infmod	40	SENT_108	[p6l9t3230r363b3288],
43	the	DT	O	the	det	45	SENT_108	[p6l390t3230r501b3288],
44	genetic	JJ	O	genetic	amod	45	SENT_108	[p6l529t3232r776b3303],
45	factors	NNS	O	factor	dobj	42	SENT_108	[p6l803t3231r1036b3288],
46	involved	VBN	O	involve	partmod	45	SENT_108	[p6l1064t3230r1356b3288],
47	in	IN	O	in	_	0	SENT_108	[p6l1383t3232r1450b3287],
48	the	DT	O	the	det	49	SENT_108	[p6l1477t3230r1588b3288],
49	development	NN	O	development	prep_in	46	SENT_108	[p6l1616t3230r2059b3303],
50	of	IN	O	of	_	0	SENT_108	[p6l2086t3231r2154b3288],
51	antipsychotic	JJ	O	antipsychotic	amod	53	SENT_108	[p6l11t3314r471b3387],
52	weight	NN	O	weight	nn	53	SENT_108	[p6l515t3314r751b3387],
53	gain	NN	O	gain	prep_of	49	SENT_108	[p6l795t3316r961b3387],
54	.	.	O	.	_	0	SENT_108	[p6l795t3316r961b3387],

1	The	DT	O	the	det	3	SENT_109	[p6l1010t3314r1142b3372],
2	clinical	JJ	O	clinical	amod	3	SENT_109	[p6l1187t3314r1434b3372],
3	signiﬁcance	NN	O	signiﬁcance	nsubj	17	SENT_109	[p6l1481t3315r1886b3387],
4	of	IN	O	of	_	0	SENT_109	[p6l1931t3315r1999b3372],
5	the	DT	O	the	det	6	SENT_109	[p6l2034t3314r2145b3372],
6	presence	NN	O	presence	prep_of	3	SENT_109	[p6l8t3418r312b3470],
7	of	IN	O	of	_	0	SENT_109	[p6l331t3398r399b3456],
8	the	DT	O	the	det	11	SENT_109	[p6l408t3398r519b3456],
9	variant	JJ	O	variant	amod	11	SENT_109	[p6l537t3399r793b3456],
10	T	NN	O	t	nn	11	SENT_109	[p6l812t3399r860b3455],
11	allele	NN	O	allele	prep_of	6	SENT_109	[p6l880t3398r1063b3456],
12	may	MD	O	may	aux	14	SENT_109	[p6l1082t3418r1230b3470],
13	be	VB	O	be	cop	14	SENT_109	[p6l1246t3398r1324b3456],
14	important	JJ	O	important	_	0	SENT_109	[p6l1343t3399r1710b3470],
15	,	,	O	,	_	0	SENT_109	[p6l1343t3399r1710b3470],
16	but	CC	O	but	_	0	SENT_109	[p6l1731t3398r1847b3456],
17	needs	VBZ	O	need	conj_but	14	SENT_109	[p6l1866t3398r2062b3456],
18	to	TO	O	to	aux	20	SENT_109	[p6l2081t3404r2145b3456],
19	be	VB	O	be	auxpass	20	SENT_109	[p6l7t3482r85b3540],
20	replicated	VBN	O	replicate	xcomp	17	SENT_109	[p6l113t3482r460b3554],
21	in	IN	O	in	_	0	SENT_109	[p6l488t3483r555b3539],
22	prospective	JJ	O	prospective	amod	23	SENT_109	[p6l583t3483r977b3554],
23	trials	NNS	O	trial	prep_in	20	SENT_109	[p6l1005t3482r1207b3553],
24	,	,	O	,	_	0	SENT_109	[p6l1005t3482r1207b3553],
25	of	IN	O	of	_	0	SENT_109	[p6l1240t3482r1307b3540],
26	a	DT	O	a	det	28	SENT_109	[p6l1329t3502r1367b3540],
27	longer	JJR	O	longer	amod	28	SENT_109	[p6l1395t3482r1613b3554],
28	duration	NN	O	duration	prep_of	23	SENT_109	[p6l1641t3482r1958b3553],
29	,	,	O	,	_	0	SENT_109	[p6l1641t3482r1958b3553],
30	with	IN	O	with	_	0	SENT_109	[p6l1990t3482r2146b3540],
31	greater	JJR	O	greater	amod	32	SENT_109	[p6l9t3571r262b3638],
32	control	NN	O	control	prep_with	20	SENT_109	[p6l306t3566r546b3624],
33	of	IN	O	of	_	0	SENT_109	[p6l591t3566r659b3624],
34	dietary	JJ	O	dietary	amod	37	SENT_109	[p6l696t3566r944b3638],
35	and	CC	O	and	_	0	SENT_109	[p6l990t3566r1117b3624],
36	physiologic	JJ	O	physiologic	amod	37	SENT_109	[p6l1161t3566r1546b3638],
37	factors	NNS	O	factor	prep_of	32	SENT_109	[p6l1590t3566r1824b3624],
38	such	JJ	O	such	_	0	SENT_109	[p6l1870t3566r2027b3624],
39	as	IN	O	as	_	0	SENT_109	[p6l2074t3586r2145b3624],
40	exercise	NN	O	exercise	prep_such_as	37	SENT_109	[p6l9t3651r304b3708],
41	.	.	O	.	_	0	SENT_109	[p6l9t3651r304b3708],

1	Due	JJ	O	due	_	0	SENT_110	[p6l338t3651r477b3708],
2	to	TO	O	to	_	0	SENT_110	[p6l506t3655r570b3708],
3	these	DT	O	these	det	4	SENT_110	[p6l598t3650r782b3708],
4	shortcomings	NNS	O	shortcoming	prep_due_to	21	SENT_110	[p6l813t3650r1275b3722],
5	additional	JJ	O	additional	amod	6	SENT_110	[p6l1306t3650r1656b3708],
6	research	NN	O	research	nsubj	21	SENT_110	[p6l1685t3650r1982b3708],
7	into	IN	O	into	_	0	SENT_110	[p6l2012t3651r2145b3708],
8	the	DT	O	the	det	9	SENT_110	[p6l8t3735r119b3792],
9	area	NN	O	area	prep_into	6	SENT_110	[p6l150t3754r301b3792],
10	of	IN	O	of	_	0	SENT_110	[p6l328t3735r396b3792],
11	genetics	NNS	O	genetics	prep_of	9	SENT_110	[p6l416t3736r716b3807],
12	,	,	O	,	_	0	SENT_110	[p6l416t3736r716b3807],
13	diabetes	NN	O	diabetes	conj_and	11	SENT_110	[p6l748t3735r1052b3805],
14	,	,	O	,	_	0	SENT_110	[p6l748t3735r1052b3805],
15	and	CC	O	and	_	0	SENT_110	[p6l1086t3735r1213b3792],
16	weight	NN	O	weight	nn	17	SENT_110	[p6l1240t3735r1475b3807],
17	gain	NN	O	gain	conj_and	11	SENT_110	[p6l1503t3736r1653b3807],
18	from	IN	O	from	_	0	SENT_110	[p6l1681t3735r1842b3792],
19	atypical	JJ	O	atypical	amod	20	SENT_110	[p6l1872t3735r2146b3807],
20	antipsychotics	NNS	O	antipsychotic	prep_from	17	SENT_110	[p7l11t13r505b85],
21	needs	VBZ	O	need	_	0	SENT_110	[p7l529t13r725b70],
22	to	TO	O	to	aux	24	SENT_110	[p7l747t18r811b70],
23	be	VB	O	be	auxpass	24	SENT_110	[p7l832t13r910b70],
24	pursued	VBN	O	pursue	xcomp	21	SENT_110	[p7l932t13r1232b85],
25	.	.	O	.	_	0	SENT_110	[p7l932t13r1232b85],

1	REFERENCES	NNS	O	reference	_	0	SENT_111	[p7l788t186r1364b244],

1	Allison	NNP	PERSON	Allison	nn	2	SENT_112	[p7l6t319r207b367],
2	DB	NNP	PERSON	DB	_	0	SENT_112	[p7l226t320r331b377],
3	,	,	O	,	_	0	SENT_112	[p7l226t320r331b377],
4	Mentore	NNP	PERSON	Mentore	nn	6	SENT_112	[p7l350t320r592b367],
5	J	NNP	PERSON	J	nn	6	SENT_112	[p7l608t320r643b367],
6	L	NN	PERSON	l	appos	2	SENT_112	[p7l645t320r698b377],
7	,	,	O	,	_	0	SENT_112	[p7l645t320r698b377],
8	Moonseon	NN	O	moonseon	nn	9	SENT_112	[p7l718t320r1006b367],
9	H	NN	O	h	appos	6	SENT_112	[p7l1023t320r1087b377],
10	,	,	O	,	_	0	SENT_112	[p7l1023t320r1087b377],
11	Chandler	NNP	ORGANIZATION	Chandler	nn	12	SENT_112	[p7l1109t319r1376b367],
12	LP	NN	ORGANIZATION	lp	appos	6	SENT_112	[p7l1394t320r1489b377],
13	,	,	O	,	_	0	SENT_112	[p7l1394t320r1489b377],
14	Cappelleri	NNP	PERSON	Cappelleri	nn	16	SENT_112	[p7l1510t319r1807b379],
15	J	NNP	PERSON	J	nn	16	SENT_112	[p7l1822t320r1857b367],
16	C	NNP	PERSON	C	appos	6	SENT_112	[p7l1860t319r1915b377],
17	,	,	O	,	_	0	SENT_112	[p7l1860t319r1915b377],
18	Infante	NNP	O	Infante	nn	19	SENT_112	[p7l1937t319r2146b367],
19	MC	NNP	O	MC	appos	6	SENT_112	[p7l115t390r232b447],
20	,	,	O	,	_	0	SENT_112	[p7l115t390r232b447],
21	Weiden	NNP	PERSON	Weiden	nn	22	SENT_112	[p7l254t389r471b437],
22	PJ	NNP	PERSON	PJ	appos	6	SENT_112	[p7l493t390r580b437],
23	.	.	O	.	_	0	SENT_112	[p7l493t390r580b437],

1	1999a	NN	O	1999a	_	0	SENT_113	[p7l610t391r789b437],
2	.	.	O	.	_	0	SENT_113	[p7l610t391r789b437],

1	Antipsychotic-induced	JJ	O	antipsychotic-induced	amod	3	SENT_114	[p7l813t389r1455b449],
2	weight	NN	O	weight	nn	3	SENT_114	[p7l1476t389r1670b449],
3	gain	NN	O	gain	_	0	SENT_114	[p7l1692t390r1829b449],
4	:	:	O	:	_	0	SENT_114	[p7l1692t390r1829b449],
5	A	DT	O	a	det	8	SENT_114	[p7l1852t390r1899b436],
6	comprehensive	JJ	O	comprehensive	amod	8	SENT_114	[p7l1919t406r2145b449, p7l115t460r334b507],
7	research	NN	O	research	nn	8	SENT_114	[p7l352t460r598b507],
8	synthesis	NN	O	synthesis	dep	3	SENT_114	[p7l618t460r898b519],
9	.	.	O	.	_	0	SENT_114	[p7l618t460r898b519],

1	Am	VBP	O	be	dep	2	SENT_115	[p7l918t460r1018b507],
2	J	NN	O	j	_	0	SENT_115	[p7l1035t461r1070b507],
3	Psychiatry	NNP	O	Psychiatry	dep	2	SENT_115	[p7l1087t460r1395b519],
4	156:1686	CD	DURATION	156:1686	num	3	SENT_115	[p7l1417t462r1866b507],
5	-1696	CD	DURATION	-1696	rcmod	3	SENT_115	[p7l1417t462r1866b507],
6	.	.	O	.	_	0	SENT_115	[p7l1417t462r1866b507],

1	Andreasen	NNP	PERSON	Andreasen	nn	2	SENT_116	[p7l6t542r317b590],
2	N.	NNP	O	N.	_	0	SENT_116	[p7l332t543r394b590],
3	1983	CD	DATE	1983	dep	2	SENT_116	[p7l418t544r562b590],
4	.	.	O	.	_	0	SENT_116	[p7l418t544r562b590],

1	Scale	NNP	O	Scale	nsubj	8	SENT_117	[p7l583t542r731b590],
2	for	IN	O	for	_	0	SENT_117	[p7l746t542r824b590],
3	the	DT	O	the	det	4	SENT_117	[p7l838t542r929b590],
4	assessment	NN	O	assessment	prep_for	1	SENT_117	[p7l946t547r1272b590],
5	of	IN	O	of	_	0	SENT_117	[p7l1287t542r1343b590],
6	negative	JJ	O	negative	amod	7	SENT_117	[p7l1351t543r1595b602],
7	symptoms	NNS	O	symptom	prep_of	4	SENT_117	[p7l1612t547r1900b602],
8	(	VBP	O	(	_	0	SENT_117	[p7l1918t542r2142b596],
9	SANS	NNS	O	san	dobj	8	SENT_117	[p7l1918t542r2142b596],
10	)	CD	NUMBER	)	tmod	8	SENT_117	[p7l1918t542r2142b596],
11	.	.	O	.	_	0	SENT_117	[p7l1918t542r2142b596],

1	Iowa	NNP	LOCATION	Iowa	nn	2	SENT_118	[p7l116t614r254b660],
2	City	NNP	LOCATION	City	_	0	SENT_118	[p7l272t613r406b672],
3	,	,	O	,	_	0	SENT_118	[p7l272t613r406b672],
4	Iowa	NNP	LOCATION	Iowa	appos	2	SENT_118	[p7l427t614r577b660],
5	:	:	O	:	_	0	SENT_118	[p7l427t614r577b660],
6	The	NNP	O	The	nn	7	SENT_118	[p7l599t613r708b660],
7	University	NNP	O	University	dep	2	SENT_118	[p7l726t614r1032b672],
8	of	IN	O	of	_	0	SENT_118	[p7l1050t613r1106b660],
9	Iowa	NNP	LOCATION	Iowa	prep_of	7	SENT_118	[p7l1119t614r1269b660],
10	.	.	O	.	_	0	SENT_118	[p7l1119t614r1269b660],

1	Basile	NNP	PERSON	Basile	nn	2	SENT_119	[p7l7t696r184b743],
2	VS	NNP	O	VS	_	0	SENT_119	[p7l199t696r297b754],
3	,	,	O	,	_	0	SENT_119	[p7l199t696r297b754],
4	Masellis	NNP	O	Masellis	nn	5	SENT_119	[p7l316t696r555b743],
5	M	NNP	O	M	appos	2	SENT_119	[p7l571t697r643b754],
6	,	,	O	,	_	0	SENT_119	[p7l571t697r643b754],
7	DeLuca	NNP	PERSON	DeLuca	nn	8	SENT_119	[p7l664t697r884b743],
8	V	NNP	O	V	appos	2	SENT_119	[p7l898t697r957b754],
9	,	,	O	,	_	0	SENT_119	[p7l898t697r957b754],
10	Meltzer	NNP	PERSON	Meltzer	nn	11	SENT_119	[p7l976t696r1198b743],
11	HY	NNP	O	HY	appos	2	SENT_119	[p7l1215t697r1323b754],
12	,	,	O	,	_	0	SENT_119	[p7l1215t697r1323b754],
13	Kennedy	NNP	PERSON	Kennedy	nn	15	SENT_119	[p7l1343t696r1598b755],
14	J	NNP	O	J	nn	15	SENT_119	[p7l1613t697r1648b743],
15	L.	NNP	O	L.	appos	2	SENT_119	[p7l1650t697r1702b743],
16	2002	CD	DATE	2002	dep	15	SENT_119	[p7l1723t698r1872b743],
17	.	.	O	.	_	0	SENT_119	[p7l1723t698r1872b743],

1	-7	CD	NUMBER	-7	num	4	SENT_120	[p7l1896t698r1971b743],
2	59C/T	JJ	O	59c/t	amod	4	SENT_120	[p7l1977t696r2146b749],
3	genetic	JJ	O	genetic	amod	4	SENT_120	[p7l116t768r319b826],
4	variation	NN	O	variation	_	0	SENT_120	[p7l338t768r599b814],
5	of	IN	O	of	_	0	SENT_120	[p7l619t767r675b814],
6	the	DT	O	the	det	8	SENT_120	[p7l687t767r778b814],
7	5HT2C	NN	O	5ht2c	nn	8	SENT_120	[p7l799t767r1002b814],
8	receptor	NN	O	receptor	prep_of	4	SENT_120	[p7l1022t771r1257b826],
9	and	CC	O	and	_	0	SENT_120	[p7l1279t767r1383b814],
10	clozapine-induced	JJ	O	clozapine-induced	amod	11	SENT_120	[p7l1402t767r1916b826],
11	weight	NN	O	weight	prep_of	4	SENT_120	[p7l1934t767r2142b826],
12	.	.	O	.	_	0	SENT_120	[p7l1934t767r2142b826],

1	Lancet	NNP	O	Lancet	_	0	SENT_121	[p7l116t838r311b884],
2	360:1790	CD	NUMBER	360:1790	num	1	SENT_121	[p7l330t839r782b884],
3	—	CD	NUMBER	—	number	4	SENT_121	[p7l330t839r782b884],
4	1791	CD	DATE	1791	num	1	SENT_121	[p7l330t839r782b884],
5	.	.	O	.	_	0	SENT_121	[p7l330t839r782b884],

1	Basson	NNP	PERSON	Basson	nn	2	SENT_122	[p7l7t935r212b981],
2	BR	NNP	O	BR	_	0	SENT_122	[p7l234t935r337b992],
3	,	,	O	,	_	0	SENT_122	[p7l234t935r337b992],
4	Kinon	NNP	ORGANIZATION	Kinon	nn	5	SENT_122	[p7l363t935r536b981],
5	BJ	NNP	ORGANIZATION	BJ	appos	2	SENT_122	[p7l559t935r651b992],
6	,	,	O	,	_	0	SENT_122	[p7l559t935r651b992],
7	Taylor	NNP	ORGANIZATION	Taylor	nn	8	SENT_122	[p7l676t934r863b993],
8	CC	NN	ORGANIZATION	cc	appos	2	SENT_122	[p7l887t934r987b992],
9	,	,	O	,	_	0	SENT_122	[p7l887t934r987b992],
10	Syzymanksi	FW	O	syzymanksi	appos	2	SENT_122	[p7l1015t934r1361b993],
11	KA	NN	O	ka	dep	10	SENT_122	[p7l1384t934r1489b992],
12	,	,	O	,	_	0	SENT_122	[p7l1384t934r1489b992],
13	Gilmore	NNP	ORGANIZATION	Gilmore	nn	14	SENT_122	[p7l1517t934r1746b982],
14	JA	NNP	ORGANIZATION	JA	appos	2	SENT_122	[p7l1767t934r1860b992],
15	,	,	O	,	_	0	SENT_122	[p7l1767t934r1860b992],
16	Tollefson	NNP	PERSON	Tollefson	nn	17	SENT_122	[p7l1886t934r2146b981],
17	GD	NN	O	gd	appos	2	SENT_122	[p7l118t1004r225b1052],
18	.	.	O	.	_	0	SENT_122	[p7l118t1004r225b1052],

1	2001	CD	DATE	2001	_	0	SENT_123	[p7l258t1007r407b1052],
2	.	.	O	.	_	0	SENT_123	[p7l258t1007r407b1052],

1	Factors	NNS	O	factor	nsubj	10	SENT_124	[p7l440t1006r653b1052],
2	inﬂuencing	VBG	O	inﬂuencing	partmod	1	SENT_124	[p7l683t1005r1007b1064],
3	acute	JJ	O	acute	amod	5	SENT_124	[p7l1035t1009r1187b1052],
4	weight	NN	O	weight	nn	5	SENT_124	[p7l1216t1005r1409b1064],
5	change	NN	O	change	dobj	2	SENT_124	[p7l1439t1005r1641b1064],
6	in	IN	O	in	_	0	SENT_124	[p7l1670t1006r1726b1051],
7	patients	NNS	O	patient	prep_in	2	SENT_124	[p7l1754t1006r1988b1064],
8	with	IN	O	with	_	0	SENT_124	[p7l2017t1005r2146b1052],
9	schizophrenia	NN	O	schizophrenia	prep_with	7	SENT_124	[p7l117t1075r516b1135],
10	treated	VBN	O	treat	_	0	SENT_124	[p7l526t1075r734b1123],
11	with	IN	O	with	_	0	SENT_124	[p7l744t1075r873b1123],
12	olanz	NN	O	olanz	nn	13	SENT_124	[p7l885t1075r1034b1123],
13	apine	NN	O	apine	prep_with	10	SENT_124	[p7l1040t1076r1210b1135],
14	,	,	O	,	_	0	SENT_124	[p7l1040t1076r1210b1135],
15	haloperidol	NN	O	haloperidol	prep_with	10	SENT_124	[p7l1225t1075r1548b1135],
16	or	CC	O	or	_	0	SENT_124	[p7l1560t1091r1616b1123],
17	risperidone	NN	O	risperidone	prep_with	10	SENT_124	[p7l1628t1075r1966b1135],
18	.	.	O	.	_	0	SENT_124	[p7l1628t1075r1966b1135],

1	J	NNP	O	J	nn	3	SENT_125	[p7l1980t1076r2016b1123],
2	Clin	NNP	O	Clin	nn	3	SENT_125	[p7l2027t1075r2146b1123],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_125	[p7l116t1146r424b1206],
4	62:23	CD	NUMBER	62:23	number	5	SENT_125	[p7l443t1148r593b1194],
5	1-238	CD	NUMBER	1-238	num	3	SENT_125	[p7l602t1148r791b1194],
6	.	.	O	.	_	0	SENT_125	[p7l602t1148r791b1194],

1	Lappalainen	NN	PERSON	lappalainen	nn	2	SENT_126	[p7l9t1230r370b1289],
2	J	NN	PERSON	j	_	0	SENT_126	[p7l381t1230r416b1277],
3	,	,	O	,	_	0	SENT_126	[p7l420t1269r429b1287],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_126	[p7l445t1229r629b1289],
5	L	NNP	PERSON	L	appos	2	SENT_126	[p7l639t1230r692b1287],
6	,	,	O	,	_	0	SENT_126	[p7l639t1230r692b1287],
7	Den	NNP	O	Den	nn	8	SENT_126	[p7l709t1230r824b1277],
8	M	NNP	O	M	appos	5	SENT_126	[p7l836t1230r908b1287],
9	,	,	O	,	_	0	SENT_126	[p7l836t1230r908b1287],
10	Oz	NNP	O	Oz	nn	11	SENT_126	[p7l925t1229r998b1277],
11	M	NNP	O	M	appos	5	SENT_126	[p7l1012t1230r1084b1287],
12	,	,	O	,	_	0	SENT_126	[p7l1012t1230r1084b1287],
13	Ozaki	NNP	PERSON	Ozaki	nn	14	SENT_126	[p7l1101t1229r1267b1277],
14	N	NNP	O	N	appos	5	SENT_126	[p7l1280t1230r1343b1287],
15	,	,	O	,	_	0	SENT_126	[p7l1280t1230r1343b1287],
16	Yu	NNP	PERSON	Yu	nn	17	SENT_126	[p7l1356t1230r1438b1277],
17	D-H	NNP	PERSON	D-H	appos	5	SENT_126	[p7l1452t1230r1585b1287],
18	,	,	O	,	_	0	SENT_126	[p7l1452t1230r1585b1287],
19	Virkkunen	NNP	PERSON	Virkkunen	nn	20	SENT_126	[p7l1599t1229r1912b1277],
20	M	NNP	O	M	appos	5	SENT_126	[p7l1923t1230r1995b1287],
21	,	,	O	,	_	0	SENT_126	[p7l1923t1230r1995b1287],
22	et	FW	O	et	nn	23	SENT_126	[p7l2012t1234r2064b1277],
23	al.	FW	O	al.	appos	5	SENT_126	[p7l2079t1229r2142b1277],
24	1995	CD	DATE	1995	dep	23	SENT_126	[p7l121t1303r265b1348],
25	.	.	O	.	_	0	SENT_126	[p7l121t1303r265b1348],

1	Identiﬁcation	NNP	O	Identiﬁcation	_	0	SENT_127	[p7l298t1301r698b1359],
2	,	,	O	,	_	0	SENT_127	[p7l298t1301r698b1359],
3	expression	NN	O	expression	conj_and	1	SENT_127	[p7l730t1302r1048b1360],
4	,	,	O	,	_	0	SENT_127	[p7l730t1302r1048b1360],
5	and	CC	O	and	_	0	SENT_127	[p7l1081t1301r1186b1348],
6	pharmacology	NN	O	pharmacology	conj_and	1	SENT_127	[p7l1214t1301r1617b1360],
7	of	IN	O	of	_	0	SENT_127	[p7l1646t1301r1701b1348],
8	a	DT	O	a	det	9	SENT_127	[p7l1725t1317r1756b1348],
9	Cys23	NN	O	cys23	prep_of	6	SENT_127	[p7l1786t1301r2144b1360],
10	.	.	O	.	_	0	SENT_127	[p7l1786t1301r2144b1360],

1	—	NN	O	—	_	0	SENT_128	[p7l1786t1301r2144b1360],
2	.	.	O	.	_	0	SENT_128	[p7l1786t1301r2144b1360],

1	Ser23	NN	O	ser23	nn	2	SENT_129	[p7l1786t1301r2144b1360],
2	substitution	NN	O	substitution	_	0	SENT_129	[p7l117t1373r462b1420],
3	in	IN	O	in	_	0	SENT_129	[p7l486t1374r541b1419],
4	the	DT	O	the	det	12	SENT_129	[p7l564t1373r655b1420],
5	human	JJ	O	human	amod	12	SENT_129	[p7l678t1373r880b1420],
6	5-HT2C	NN	O	5-ht2c	nn	12	SENT_129	[p7l905t1373r1129b1420],
7	receptor	NN	O	receptor	nn	12	SENT_129	[p7l1152t1377r1389b1432],
8	gene	NN	O	gene	nn	12	SENT_129	[p7l1412t1388r1544b1432],
9	(	NN	O	(	nn	12	SENT_129	[p7l1569t1373r1641b1426],
10	H	NN	O	h	nn	12	SENT_129	[p7l1569t1373r1641b1426],
11	TRZC	NN	O	trzc	nn	12	SENT_129	[p7l1642t1373r1841b1426],
12	)	NN	O	)	prep_in	2	SENT_129	[p7l1642t1373r1841b1426],
13	.	.	O	.	_	0	SENT_129	[p7l1642t1373r1841b1426],

1	Genomics	NNS	O	genomic	_	0	SENT_130	[p7l1869t1372r2146b1420],
2	27:274	CD	NUMBER	27:274	num	1	SENT_130	[p7l116t1447r466b1492],
3	-279	CD	NUMBER	-279	num	1	SENT_130	[p7l116t1447r466b1492],
4	.	.	O	.	_	0	SENT_130	[p7l116t1447r466b1492],

1	Overall	JJ	O	overall	amod	2	SENT_131	[p7l10t1542r222b1590],
2	J	NN	O	j	_	0	SENT_131	[p7l240t1543r275b1590],
3	,	,	O	,	_	0	SENT_131	[p7l279t1582r288b1600],
4	Gorham	NNP	PERSON	Gorham	nn	5	SENT_131	[p7l313t1542r545b1590],
5	D.	NNP	O	D.	appos	2	SENT_131	[p7l566t1543r626b1590],
6	1962	CD	DATE	1962	dep	5	SENT_131	[p7l654t1545r799b1590],
7	.	.	O	.	_	0	SENT_131	[p7l654t1545r799b1590],

1	Brief	JJ	O	brief	amod	3	SENT_132	[p7l822t1543r971b1590],
2	psychiatric	JJ	O	psychiatric	amod	3	SENT_132	[p7l984t1542r1300b1602],
3	rating	NN	O	rating	_	0	SENT_132	[p7l1320t1543r1499b1602],
4	scale	NN	O	scale	dep	3	SENT_132	[p7l1518t1543r1670b1590],
5	.	.	O	.	_	0	SENT_132	[p7l1518t1543r1670b1590],

1	Psychol	NNP	O	Psychol	nn	2	SENT_133	[p7l1694t1542r1913b1602],
2	Rep	NNP	O	Rep	_	0	SENT_133	[p7l1934t1543r2042b1602],
3	10	CD	NUMBER	10	num	2	SENT_133	[p7l2067t1544r2142b1590],
4	:	:	O	:	_	0	SENT_133	[p7l2067t1544r2142b1590],

1	Perry	NNP	PERSON	Perry	nn	2	SENT_134	[p7l9t1711r169b1769],
2	PJ	NNP	PERSON	PJ	_	0	SENT_134	[p7l182t1711r270b1767],
3	,	,	O	,	_	0	SENT_134	[p7l182t1711r270b1767],
4	Sanger	NNP	ORGANIZATION	Sanger	nn	5	SENT_134	[p7l288t1710r489b1769],
5	T	NN	ORGANIZATION	t	appos	2	SENT_134	[p7l502t1711r556b1768],
6	,	,	O	,	_	0	SENT_134	[p7l502t1711r556b1768],
7	Beasley	NNP	PERSON	Beasley	nn	8	SENT_134	[p7l571t1710r794b1769],
8	C.	NNP	O	C.	appos	2	SENT_134	[p7l808t1710r863b1757],
9	1997	CD	DATE	1997	dep	8	SENT_134	[p7l884t1712r1029b1757],
10	.	.	O	.	_	0	SENT_134	[p7l884t1712r1029b1757],

1	Olanzapine	JJ	O	olanzapine	amod	3	SENT_135	[p7l1047t1710r1373b1769],
2	plasma	NN	O	plasma	nn	3	SENT_135	[p7l1386t1710r1594b1769],
3	concentrations	NNS	O	concentration	_	0	SENT_135	[p7l1606t1711r2026b1757],
4	and	CC	O	and	_	0	SENT_135	[p7l2042t1710r2147b1757],
5	clinical	JJ	O	clinical	amod	6	SENT_135	[p7l116t1780r320b1828],
6	response	NN	O	response	conj_and	3	SENT_135	[p7l346t1796r598b1840],
7	in	IN	O	in	_	0	SENT_135	[p7l624t1781r679b1827],
8	acutely	RB	O	acutely	advmod	9	SENT_135	[p7l708t1780r914b1840],
9	ill	JJ	O	ill	amod	11	SENT_135	[p7l940t1780r996b1827],
10	schizophrenic	JJ	O	schizophrenic	amod	11	SENT_135	[p7l1025t1780r1416b1840],
11	patients	NNS	O	patient	prep_in	3	SENT_135	[p7l1442t1781r1690b1840],
12	.	.	O	.	_	0	SENT_135	[p7l1442t1781r1690b1840],

1	J	NNP	O	J	nn	3	SENT_136	[p7l1719t1781r1754b1828],
2	Clin	NNP	O	Clin	nn	3	SENT_136	[p7l1781t1780r1899b1828],
3	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_136	[p7l1926t1780r2144b1840, p7l115t1852r418b1911],
4	17:472	CD	NUMBER	17:472	number	5	SENT_136	[p7l442t1854r786b1899],
5	-476	CD	NUMBER	-476	num	3	SENT_136	[p7l442t1854r786b1899],
6	.	.	O	.	_	0	SENT_136	[p7l442t1854r786b1899],

1	Reynolds	NNP	O	Reynolds	nn	2	SENT_137	[p7l9t1935r269b1994],
2	GP	NNP	O	GP	_	0	SENT_137	[p7l286t1935r387b1993],
3	,	,	O	,	_	0	SENT_137	[p7l286t1935r387b1993],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_137	[p7l404t1935r588b1994],
5	AJ	NNP	PERSON	AJ	appos	2	SENT_137	[p7l597t1935r691b1993],
6	,	,	O	,	_	0	SENT_137	[p7l597t1935r691b1993],
7	Zhang	NNP	PERSON	Zhang	nn	8	SENT_137	[p7l709t1935r892b1994],
8	XB	NNP	O	XB	appos	5	SENT_137	[p7l903t1936r1005b1982],
9	.	.	O	.	_	0	SENT_137	[p7l903t1936r1005b1982],

1	2002	CD	DATE	2002	_	0	SENT_138	[p7l1024t1937r1173b1982],
2	.	.	O	.	_	0	SENT_138	[p7l1024t1937r1173b1982],

1	Association	NNP	O	Association	_	0	SENT_139	[p7l1189t1935r1517b1982],
2	of	IN	O	of	_	0	SENT_139	[p7l1532t1935r1588b1982],
3	antipsychotic	JJ	O	antipsychotic	amod	6	SENT_139	[p7l1598t1935r1978b1994],
4	druginduced	JJ	O	druginduced	amod	6	SENT_139	[p7l1993t1935r2145b1994, p7l115t2006r341b2053],
5	weight	NN	O	weight	nn	6	SENT_139	[p7l352t2006r546b2065],
6	gain	NN	O	gain	prep_of	1	SENT_139	[p7l559t2007r682b2065],
7	with	IN	O	with	_	0	SENT_139	[p7l694t2006r823b2053],
8	a	DT	O	a	det	12	SENT_139	[p7l838t2022r869b2053],
9	5-HT2C	NN	O	5-ht2c	nn	12	SENT_139	[p7l881t2006r1105b2053],
10	receptor	NN	O	receptor	nn	12	SENT_139	[p7l1118t2010r1354b2065],
11	gene	NN	O	gene	nn	12	SENT_139	[p7l1366t2021r1498b2065],
12	polymorphism	NN	O	polymorphism	prep_with	1	SENT_139	[p7l1510t2006r1934b2065],
13	.	.	O	.	_	0	SENT_139	[p7l1510t2006r1934b2065],

1	Lancet	NNP	O	Lancet	_	0	SENT_140	[p7l1952t2007r2146b2053],
2	35922086-2087	CD	NUMBER	35922086-2087	dep	1	SENT_140	[p7l117t2078r569b2124],
3	.	.	O	.	_	0	SENT_140	[p7l117t2078r569b2124],

1	Reynolds	NNP	O	Reynolds	nn	2	SENT_141	[p7l9t2174r269b2233],
2	GP	NNP	O	GP	_	0	SENT_141	[p7l285t2174r385b2232],
3	,	,	O	,	_	0	SENT_141	[p7l285t2174r385b2232],
4	Zhang	NNP	PERSON	Zhang	nn	8	SENT_141	[p7l402t2174r585b2233],
5	Z	NNP	PERSON	Z	nn	8	SENT_141	[p7l596t2175r646b2232],
6	,	,	O	,	_	0	SENT_141	[p7l596t2175r646b2232],
7	Zhang	NNP	PERSON	Zhang	appos	8	SENT_141	[p7l662t2174r846b2233],
8	X.	NNP	O	X.	appos	2	SENT_141	[p7l855t2175r912b2221],
9	2003	CD	DATE	2003	num	8	SENT_141	[p7l929t2176r1079b2221],
10	.	.	O	.	_	0	SENT_141	[p7l929t2176r1079b2221],

1	Polymorphism	NN	O	polymorphism	_	0	SENT_142	[p7l1095t2174r1511b2233],
2	of	IN	O	of	_	0	SENT_142	[p7l1524t2174r1580b2221],
3	the	DT	O	the	det	5	SENT_142	[p7l1586t2174r1678b2221],
4	promoter	NN	O	promoter	nn	5	SENT_142	[p7l1690t2178r1954b2233],
5	region	NN	O	region	prep_of	1	SENT_142	[p7l1966t2175r2146b2233],
6	of	IN	O	of	_	0	SENT_142	[p7l116t2245r172b2292],
7	the	DT	O	the	det	11	SENT_142	[p7l192t2245r283b2292],
8	serotonin	NN	O	serotonin	nn	11	SENT_142	[p7l312t2246r578b2292],
9	5-HT2C	NN	O	5-ht2c	nn	11	SENT_142	[p7l607t2245r830b2292],
10	receptor	NN	O	receptor	nn	11	SENT_142	[p7l857t2249r1093b2304],
11	gene	NN	O	gene	prep_of	1	SENT_142	[p7l1120t2260r1252b2304],
12	and	CC	O	and	_	0	SENT_142	[p7l1280t2245r1386b2292],
13	clozapine-induced	JJ	O	clozapine-induced	amod	15	SENT_142	[p7l1413t2245r1926b2304],
14	weight	NN	O	weight	nn	15	SENT_142	[p7l1952t2245r2146b2304],
15	gain	NN	O	gain	conj_and	11	SENT_142	[p7l115t2316r253b2375],
16	.	.	O	.	_	0	SENT_142	[p7l115t2316r253b2375],

1	Am	VBP	O	be	dep	2	SENT_143	[p7l273t2316r373b2362],
2	J	NN	O	j	_	0	SENT_143	[p7l389t2316r424b2363],
3	Psychiatry	NNP	O	Psychiatry	nn	5	SENT_143	[p7l442t2315r749b2375],
4	160:677	CD	NUMBER	160:677	num	5	SENT_143	[p7l772t2317r1152b2363],
5	—	NN	O	—	dep	2	SENT_143	[p7l772t2317r1152b2363],
6	679	CD	NUMBER	679	rcmod	5	SENT_143	[p7l772t2317r1152b2363],
7	.	.	O	.	_	0	SENT_143	[p7l772t2317r1152b2363],

1	Shih	NNP	PERSON	Shih	nn	2	SENT_144	[p7l10t2398r141b2446],
2	JC	NNP	PERSON	JC	_	0	SENT_144	[p7l165t2399r258b2456],
3	,	,	O	,	_	0	SENT_144	[p7l165t2399r258b2456],
4	Zhu	NNP	PERSON	Zhu	nn	8	SENT_144	[p7l286t2398r399b2446],
5	Q	NNP	O	Q	nn	8	SENT_144	[p7l426t2398r485b2457],
6	,	,	O	,	_	0	SENT_144	[p7l426t2398r485b2457],
7	Chen	NNP	PERSON	Chen	appos	8	SENT_144	[p7l515t2398r664b2446],
8	K.	NNP	O	K.	appos	2	SENT_144	[p7l690t2399r750b2446],
9	1996	CD	DATE	1996	num	8	SENT_144	[p7l783t2400r928b2446],
10	.	.	O	.	_	0	SENT_144	[p7l783t2400r928b2446],

1	Determination	NN	O	determination	_	0	SENT_145	[p7l957t2399r1378b2446],
2	of	IN	O	of	_	0	SENT_145	[p7l1405t2399r1460b2446],
3	transcription	NN	O	transcription	nn	5	SENT_145	[p7l1478t2399r1854b2458],
4	initiation	NN	O	initiation	nn	5	SENT_145	[p7l1880t2399r2146b2446],
5	sites	NNS	O	site	prep_of	1	SENT_145	[p7l117t2471r245b2517],
6	and	CC	O	and	_	0	SENT_145	[p7l265t2470r370b2517],
7	promoter	NN	O	promoter	nn	8	SENT_145	[p7l387t2474r651b2529],
8	activity	NN	O	activity	prep_of	1	SENT_145	[p7l670t2471r884b2529],
9	of	IN	O	of	_	0	SENT_145	[p7l902t2470r958b2517],
10	the	DT	O	the	det	14	SENT_145	[p7l969t2470r1060b2517],
11	human	JJ	O	human	amod	14	SENT_145	[p7l1079t2470r1281b2517],
12	5-HT2A	NN	O	5-ht2a	nn	14	SENT_145	[p7l1302t2470r1528b2517],
13	receptor	NN	O	receptor	nn	14	SENT_145	[p7l1544t2474r1779b2529],
14	gene	NN	O	gene	prep_of	1	SENT_145	[p7l1798t2485r1944b2529],
15	.	.	O	.	_	0	SENT_145	[p7l1798t2485r1944b2529],

1	Behav	NNP	O	Behav	nn	3	SENT_146	[p7l1965t2470r2147b2517],
2	Brain	NNP	O	Brain	nn	3	SENT_146	[p7l114t2541r278b2587],
3	Res	NNP	O	Res	_	0	SENT_146	[p7l297t2541r399b2588],
4	73:59	CD	NUMBER	73:59	number	5	SENT_146	[p7l419t2542r698b2588],
5	-62	CD	NUMBER	-62	num	3	SENT_146	[p7l419t2542r698b2588],
6	.	.	O	.	_	0	SENT_146	[p7l419t2542r698b2588],

1	Stahl	NNP	PERSON	Stahl	nn	2	SENT_147	[p7l10t2637r162b2685],
2	SM	NNP	O	SM	_	0	SENT_147	[p7l183t2637r290b2685],
3	.	.	O	.	_	0	SENT_147	[p7l183t2637r290b2685],

1	1998	CD	DATE	1998	_	0	SENT_148	[p7l317t2639r462b2685],
2	.	.	O	.	_	0	SENT_148	[p7l317t2639r462b2685],

1	Neuropharmacology	NNP	O	Neuropharmacology	_	0	SENT_149	[p7l485t2637r1067b2697],
2	of	IN	O	of	_	0	SENT_149	[p7l1086t2638r1141b2685],
3	obesity	NN	O	obesity	prep_of	1	SENT_149	[p7l1154t2637r1368b2697],
4	:	:	O	:	_	0	SENT_149	[p7l1154t2637r1368b2697],
5	My	PRP$	O	my	poss	6	SENT_149	[p7l1390t2638r1482b2697],
6	receptors	NNS	O	receptor	nsubj	7	SENT_149	[p7l1500t2642r1763b2697],
7	made	VBD	O	make	dep	1	SENT_149	[p7l1783t2637r1936b2685],
8	me	PRP	O	I	nsubj	9	SENT_149	[p7l1956t2654r2040b2685],
9	eat	VB	O	eat	ccomp	7	SENT_149	[p7l2060t2642r2147b2685],
10	it	PRP	O	it	dobj	9	SENT_149	[p7l115t2709r170b2755],
11	.	.	O	.	_	0	SENT_149	[p7l115t2709r170b2755],

1	J	NNP	O	J	nn	3	SENT_150	[p7l191t2709r225b2755],
2	Clin	NNP	O	Clin	nn	3	SENT_150	[p7l244t2708r362b2755],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_150	[p7l381t2708r689b2767],
4	59:447	CD	NUMBER	59:447	number	5	SENT_150	[p7l708t2710r1056b2755],
5	-448	CD	NUMBER	-448	num	3	SENT_150	[p7l708t2710r1056b2755],
6	.	.	O	.	_	0	SENT_150	[p7l708t2710r1056b2755],

1	Tecott	NNP	ORGANIZATION	Tecott	nn	2	SENT_151	[p7l8t2791r186b2838],
2	LH	NNP	ORGANIZATION	LH	_	0	SENT_151	[p7l207t2791r312b2848],
3	,	,	O	,	_	0	SENT_151	[p7l207t2791r312b2848],
4	Sun	NNP	ORGANIZATION	Sun	nn	5	SENT_151	[p7l338t2790r449b2838],
5	LM	NNP	ORGANIZATION	LM	appos	2	SENT_151	[p7l470t2791r582b2848],
6	,	,	O	,	_	0	SENT_151	[p7l470t2791r582b2848],
7	Akana	NNP	PERSON	Akana	nn	8	SENT_151	[p7l603t2790r793b2838],
8	SF	NNP	O	SF	appos	2	SENT_151	[p7l814t2790r905b2848],
9	,	,	O	,	_	0	SENT_151	[p7l814t2790r905b2848],
10	Strack	NNP	ORGANIZATION	Strack	nn	11	SENT_151	[p7l929t2790r1117b2838],
11	AM	NNP	ORGANIZATION	AM	appos	2	SENT_151	[p7l1134t2791r1252b2848],
12	,	,	O	,	_	0	SENT_151	[p7l1134t2791r1252b2848],
13	Lowenstein	NNP	PERSON	Lowenstein	nn	14	SENT_151	[p7l1276t2791r1606b2838],
14	DH	NNP	O	DH	appos	2	SENT_151	[p7l1627t2791r1739b2848],
15	,	,	O	,	_	0	SENT_151	[p7l1627t2791r1739b2848],
16	Dallman	NNP	PERSON	Dallman	nn	17	SENT_151	[p7l1763t2790r2010b2838],
17	MF	NN	O	mf	appos	2	SENT_151	[p7l2029t2791r2143b2848],
18	,	,	O	,	_	0	SENT_151	[p7l2029t2791r2143b2848],
19	Julis	NNP	PERSON	Julis	nn	20	SENT_151	[p7l113t2861r253b2908],
20	D.	NNP	O	D.	appos	2	SENT_151	[p7l283t2862r342b2908],
21	1995	CD	DATE	1995	dep	20	SENT_151	[p7l379t2863r524b2908],
22	.	.	O	.	_	0	SENT_151	[p7l379t2863r524b2908],

1	Eating	NNP	O	Eating	nn	2	SENT_152	[p7l557t2862r752b2920],
2	disorder	NN	O	disorder	_	0	SENT_152	[p7l779t2861r1014b2908],
3	and	CC	O	and	_	0	SENT_152	[p7l1044t2861r1149b2908],
4	epilepsy	NN	O	epilepsy	conj_and	2	SENT_152	[p7l1178t2861r1411b2920],
5	in	IN	O	in	_	0	SENT_152	[p7l1439t2862r1494b2907],
6	mice	NNS	O	mouse	prep_in	2	SENT_152	[p7l1523t2862r1654b2908],
7	lacking	VBG	O	lack	partmod	2	SENT_152	[p7l1683t2861r1894b2920],
8	5-HT2C	NN	O	5-ht2c	nn	10	SENT_152	[p7l1921t2861r2145b2908],
9	serotonin	NN	O	serotonin	nn	10	SENT_152	[p7l117t2932r384b2978],
10	receptors	NNS	O	receptor	dobj	7	SENT_152	[p7l402t2935r679b2990],
11	.	.	O	.	_	0	SENT_152	[p7l402t2935r679b2990],

1	Nature	NNP	O	Nature	_	0	SENT_153	[p7l701t2932r906b2978],
2	374:542	CD	NUMBER	374:542	number	3	SENT_153	[p7l925t2932r1308b2978],
3	-546	CD	NUMBER	-546	num	1	SENT_153	[p7l925t2932r1308b2978],
4	.	.	O	.	_	0	SENT_153	[p7l925t2932r1308b2978],

1	Tsai	NNP	PERSON	Tsai	nn	2	SENT_154	[p7l8t3015r131b3061],
2	S-J	NNP	PERSON	S-J	_	0	SENT_154	[p7l151t3014r255b3071],
3	,	,	O	,	_	0	SENT_154	[p7l151t3014r255b3071],
4	Hong	NNP	O	Hong	nn	5	SENT_154	[p7l277t3015r432b3073],
5	C-J	NNP	O	C-J	appos	2	SENT_154	[p7l450t3014r560b3071],
6	,	,	O	,	_	0	SENT_154	[p7l450t3014r560b3071],
7	Yu	NNP	O	Yu	nn	8	SENT_154	[p7l579t3015r662b3061],
8	YW-Y	NNP	O	YW-Y	appos	2	SENT_154	[p7l678t3015r864b3072],
9	,	,	O	,	_	0	SENT_154	[p7l678t3015r864b3072],
10	Lin	NNP	PERSON	Lin	nn	11	SENT_154	[p7l885t3015r982b3060],
11	C-H	NNP	O	C-H	appos	2	SENT_154	[p7l1001t3014r1130b3061],
12	.	.	O	.	_	0	SENT_154	[p7l1001t3014r1130b3061],

1	2002	CD	DATE	2002	_	0	SENT_155	[p7l1152t3016r1301b3061],
2	.	.	O	.	_	0	SENT_155	[p7l1152t3016r1301b3061],

1	-7	CD	NUMBER	-7	num	4	SENT_156	[p7l1327t3016r1402b3061],
2	59C/T	JJ	O	59c/t	amod	4	SENT_156	[p7l1407t3014r1577b3066],
3	genetic	JJ	O	genetic	amod	4	SENT_156	[p7l1595t3015r1799b3073],
4	variation	NN	O	variation	_	0	SENT_156	[p7l1816t3015r2078b3061],
5	of	IN	O	of	_	0	SENT_156	[p7l2097t3014r2153b3061],
6	the	DT	O	the	det	8	SENT_156	[p7l115t3084r207b3131],
7	5HT2C	NN	O	5ht2c	nn	8	SENT_156	[p7l227t3084r429b3131],
8	receptor	NN	O	receptor	prep_of	4	SENT_156	[p7l448t3088r683b3143],
9	and	CC	O	and	_	0	SENT_156	[p7l703t3084r808b3131],
10	clozapine-induced	JJ	O	clozapine-induced	amod	11	SENT_156	[p7l826t3084r1339b3143],
11	weight	NN	O	weight	prep_of	4	SENT_156	[p7l1357t3084r1565b3143],
12	.	.	O	.	_	0	SENT_156	[p7l1357t3084r1565b3143],

1	Lancet	NNP	O	Lancet	_	0	SENT_157	[p7l1587t3085r1782b3131],
2	360:17	CD	NUMBER	360:17	number	3	SENT_157	[p7l1802t3086r1986b3131],
3	90	CD	NUMBER	90	num	1	SENT_157	[p7l1991t3086r2071b3131],
4	.	.	O	.	_	0	SENT_157	[p7l1991t3086r2071b3131],

1	Umbricht	NN	O	umbricht	nn	2	SENT_158	[p7l8t3166r285b3214],
2	D	NN	O	d	_	0	SENT_158	[p7l310t3167r370b3224],
3	,	,	O	,	_	0	SENT_158	[p7l310t3167r370b3224],
4	Kane	NNP	PERSON	Kane	nn	5	SENT_158	[p7l399t3167r548b3214],
5	JM	NN	O	jm	appos	2	SENT_158	[p7l571t3167r678b3214],
6	.	.	O	.	_	0	SENT_158	[p7l571t3167r678b3214],

1	1996	CD	DATE	1996	_	0	SENT_159	[p7l711t3168r855b3214],
2	.	.	O	.	_	0	SENT_159	[p7l711t3168r855b3214],

1	Medical	JJ	O	medical	amod	2	SENT_160	[p7l883t3166r1109b3214],
2	complications	NNS	O	complication	_	0	SENT_160	[p7l1134t3166r1525b3226],
3	of	IN	O	of	_	0	SENT_160	[p7l1550t3167r1606b3214],
4	new	JJ	O	new	amod	6	SENT_160	[p7l1624t3183r1741b3214],
5	antipsychotic	JJ	O	antipsychotic	amod	6	SENT_160	[p7l1767t3166r2147b3226],
6	drugs	NNS	O	drug	prep_of	2	SENT_160	[p7l116t3236r291b3296],
7	.	.	O	.	_	0	SENT_160	[p7l116t3236r291b3296],

1	Schizophr	NNP	O	Schizophr	nn	2	SENT_161	[p7l315t3236r600b3296],
2	Bull	NNP	O	Bull	_	0	SENT_161	[p7l617t3236r737b3284],
3	22:475	CD	NUMBER	22:475	number	4	SENT_161	[p7l756t3238r1105b3284],
4	-483	CD	NUMBER	-483	num	2	SENT_161	[p7l756t3238r1105b3284],
5	.	.	O	.	_	0	SENT_161	[p7l756t3238r1105b3284],

1	Yuan	NN	O	yuan	nn	2	SENT_162	[p7l6t3320r161b3367],
2	X	NN	O	x	_	0	SENT_162	[p7l183t3320r240b3377],
3	,	,	O	,	_	0	SENT_162	[p7l183t3320r240b3377],
4	Yamada	NNP	PERSON	Yamada	nn	5	SENT_162	[p7l263t3319r503b3367],
5	K	NNP	PERSON	K	appos	2	SENT_162	[p7l525t3320r586b3377],
6	,	,	O	,	_	0	SENT_162	[p7l525t3320r586b3377],
7	Ishiyama-Shigemoto	NNP	O	Ishiyama-Shigemoto	nn	8	SENT_162	[p7l612t3319r1203b3379],
8	S	NNP	O	S	appos	2	SENT_162	[p7l1228t3319r1277b3377],
9	,	,	O	,	_	0	SENT_162	[p7l1228t3319r1277b3377],
10	Koyama	NNP	PERSON	Koyama	nn	11	SENT_162	[p7l1304t3320r1540b3379],
11	W	NNP	PERSON	W	appos	2	SENT_162	[p7l1559t3320r1635b3377],
12	,	,	O	,	_	0	SENT_162	[p7l1559t3320r1635b3377],
13	Nonaka	NNP	PERSON	Nonaka	nn	14	SENT_162	[p7l1661t3319r1885b3367],
14	K.	NNP	O	K.	appos	2	SENT_162	[p7l1907t3320r1967b3366],
15	2000	CD	DATE	2000	dep	14	SENT_162	[p7l1994t3321r2142b3367],
16	.	.	O	.	_	0	SENT_162	[p7l1994t3321r2142b3367],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_163	[p7l116t3389r501b3437],
2	of	IN	O	of	_	0	SENT_163	[p7l517t3389r573b3437],
3	polymorphic	JJ	O	polymorphic	amod	4	SENT_163	[p7l580t3389r935b3449],
4	loci	NNS	O	locus	prep_of	1	SENT_163	[p7l950t3389r1046b3437],
5	in	IN	O	in	_	0	SENT_163	[p7l1060t3390r1115b3436],
6	the	DT	O	the	det	8	SENT_163	[p7l1130t3389r1221b3437],
7	promoter	NN	O	promoter	nn	8	SENT_163	[p7l1236t3394r1498b3449],
8	region	NN	O	region	prep_in	1	SENT_163	[p7l1513t3390r1693b3449],
9	of	IN	O	of	_	0	SENT_163	[p7l1708t3389r1764b3437],
10	the	DT	O	the	det	14	SENT_163	[p7l1771t3389r1863b3437],
11	serotonin	NN	O	serotonin	nn	14	SENT_163	[p7l1879t3390r2146b3437],
12	5-HT2C	NN	O	5-ht2c	nn	14	SENT_163	[p7l117t3460r340b3507],
13	receptor	NN	O	receptor	nn	14	SENT_163	[p7l367t3464r602b3519],
14	gene	NN	O	gene	prep_of	8	SENT_163	[p7l627t3475r759b3519],
15	and	CC	O	and	_	0	SENT_163	[p7l786t3460r892b3507],
16	their	PRP$	O	they	poss	17	SENT_163	[p7l916t3460r1055b3507],
17	association	NN	O	association	prep_in	1	SENT_163	[p7l1082t3461r1396b3507],
18	with	IN	O	with	_	0	SENT_163	[p7l1421t3460r1550b3507],
19	obesity	NN	O	obesity	prep_with	17	SENT_163	[p7l1575t3460r1776b3519],
20	and	CC	O	and	_	0	SENT_163	[p7l1802t3460r1907b3507],
21	Type	NN	O	type	conj_and	19	SENT_163	[p7l1932t3461r2072b3519],
22	II	CD	NUMBER	ii	num	23	SENT_163	[p7l2098t3461r2146b3506],
23	diabetes	NNS	O	diabetes	dep	17	SENT_163	[p7l116t3530r366b3577],
24	.	.	O	.	_	0	SENT_163	[p7l116t3530r366b3577],

1	Diabetologia	NNP	O	Diabetologia	_	0	SENT_164	[p7l389t3530r750b3589],
2	43:373	CD	NUMBER	43:373	number	3	SENT_164	[p7l767t3532r1116b3577],
3	-376	CD	NUMBER	-376	num	1	SENT_164	[p7l767t3532r1116b3577],
4	.	.	O	.	_	0	SENT_164	[p7l767t3532r1116b3577],

